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Cellular senescence is often defined as an irreversible cell cycle arrest of mitotic 
cells, however post-mitotic cells, including adipocytes and neurones, have also been 
shown to display senescent-like characteristics, such as elevated SA-β-Gal activity 
and increased production of pro-inflammatory cytokines, in response to persistent 
DNA damage. Our group have shown that a persistent DDR can occur at telomeres 
independently of length. We investigated the possibility of telomere dysfunction being 
associated with senescence in a non-rapidly dividing cell type, which is not subject to 
repeated end-replication problem-associated telomere shortening. 
We show that telomere damage can be induced in cardiomyocyte cell lines with X-
irradiation or oxidative stress in the absence of cell division, with live-cell imaging 
revealing the presence of persistent DNA damage foci. Endonuclease-mediated 
telomere-specific double-strand DNA breaks trigger a senescent-like phenotype in 
cardiomyocytes in vitro, including elevated SA-β-Gal activity, p21 expression, 
hypertrophy and decrease of proliferation marker Ki-67.  
We observed an age-dependent increase in telomere dysfunction in both murine and 
human cardiomyocytes, occurring independently of telomere length. Furthermore, 
murine cardiomyocytes in vivo are associated with numerous markers of 
senescence, such as p15, p16 and p21 elevation, along with increased TGF-β 
expression and increased prevalence of senescence-associated distension of 
satellites. 
Increased oxidative stress via MnSOD-/+, Catalase-/-, or MAO-A overexpression 
(resulting in excess H2O2 production), can drive telomere dysfunction in murine 
cardiomyocytes in vivo, which correlates with a decrease in heart function, both of 
which can be rescued with anti-oxidant supplementation.  
Finally, we show that rapamycin, a drug shown to increase lifespan and delay age-
related diseases in numerous organisms, can attenuate the accumulation of TAF in 
murine cardiomyocytes in vivo, and is associated with a decrease in senescence 
markers. 
Our data provide evidence that telomere dysfunction occurs independently of length 
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1.1 Introduction to Senescence 
 
Once upon a time, it was believed that human cells had the capability of proliferating 
indefinitely in vitro, given suitable culture conditions, however, this paradigm was 
revised when in 1961 Hayflick and Moorhead showed that human fibroblast cells 
grown in vitro have a limited proliferative capacity (Hayflick and Moorhead, 1961; 
Hayflick, 1965). This was demonstrated by co-culturing young and old fibroblasts and 
observing that the older ones entered an irreversible cell cycle arrest sooner than the 
younger ones, thus showing that proliferation cessation is, contrary to previous 
criticism, not merely an artefact of poor cell culture conditions (Hayflick and 
Moorhead 1961; Hayflick 1965). This observed proliferative cessation is now referred 
to as cellular senescence, however, a universal and concise definition for cellular 
senescence is a much-debated subject, as initially senescence was regarded as a 
state of irreversible growth arrest in somatic cells, however research has emerged 
which argues that even post-mitotic cells can elicit a senescent-like phenotype 
(Minamino et al., 2009; Jurk et al., 2012). Moreover, in addition to cell cycle arrest, 
senescent cells also display various other phenotypic changes, which will be 
discussed in greater detail throughout.   
Physiologically, senescence is thought to act as a tumour suppressor mechanism by 
inhibiting the division of pre-cancerous cells (Serrano et al., 1997; Ramsey and 
Sharpless, 2006), and evidence is emerging which implicates roles for senescent 
cells in various other biological processes, such as wound healing (Jun and Lau, 
2010) and  embryonic development (Rajagopalan and Long, 2012; Muñoz-Espín et 
al., 2013a; Storer et al., 2013). In contrast to this, senescent cells have also been 
linked to contributing to a severe decline in tissue homeostasis (Campisi and d'Adda 
di Fagagna, 2007), driving age-related diseases (Baker et al., 2011), inducing 
paracrine senescence (Hubackova et al., 2012a; Nelson et al., 2012; Acosta et al., 
2013), and even promoting a pro-tumourigenic microenvironment (Alspach et al., 
2013).  Senescence can therefore be considered antagonistically pleiotropic; as a 




1.2 Senescence Causes 
 
Senescence can be induced by different factors, which vary dependent on cell and 
tissue type. In this section, I will explain different mechanisms which have been 
implicated in driving cellular senescence. 
 
1.2.1 DNA Damage 
 
DNA damage, in particular double-strand breaks (DSBs), has been shown to trigger 
cellular senescence in various cell lines (Di Leonardo et al., 1994). In response to 
DNA damage, several members of the phosphoinositide-3-kinase-related protein 
kinase (PIKK) family can be activated and subsequently amplify the DNA damage 
signal, allowing downstream effector proteins to take the necessary action in relation 
to halting the cell cycle, the restructuring of chromatin and repairing the DNA damage 
(Rouse, 2002). Furthermore, Ataxia-telangiectasia Mutated (ATM) and DNA-
dependent protein kinase (DNA-PK) mainly respond to double strand breaks, 
whereas Ataxia-telangiectasia and Rad3-related (ATR) is activated by stalled DNA 
replication forks and single-stranded breaks (SSBs) (Falck et al., 2005). The binding 
of these proteins to sites of damage is aided by other proteins, for example, ATR 
binding is mediated by ATRIP (Zou, 2003), whereas DNA-PK recruitment is facilitated 
by the Ku70-Ku80 heterodimer (Tanya and Stephen, 1993).  
Upon a DSB, autophosphorylation occurs on Ser1981 of the ATM dimer, resulting in 
dimer dissociation, which consequently frees the kinase domain of monomeric ATM, 
thus allowing the phosphorylation of downstream substrates containing the ATM 
consensus target sequence (Bakkenist and Kastan, 2003). ATM phosphorylates 
histone H2AX, known as gamma-H2AX (γH2AX), which in turn recruits additional 
ATM to the lesion, thus initiating a positive feedback loop which amplifies the DDR 
signal, which is capable of spreading up to several hundreds of kilobases from the 
break (Rogakou et al., 1999; Meier et al., 2007; Iacovoni et al., 2010). This process is 
facilitated by DDR mediators p53-binding protein 1 (53BP1) and mediator of DNA 
damage checkpoint (MDC1), which facilitate the interaction between ATM and 
γH2AX (Bekker-Jensen et al., 2005; Lou et al., 2006). Independently of ATM 
activation, multiple proteins get recruited to the site of damage, including 53BP1, 
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BRCA1 and the MRN complex (Kastan, 2008). ATM recruitment to double strand 
breaks has been shown to be facilitated by the NBS1 protein of the evolutionary 
conserved Mre11-Rad50-Nbs1 (MRN) complex (Carson et al., 2003). Moreover, 
activated ATM kinase can then phosphorylate substrates such as BRCA1, 53BP1, 
NBS1 and histone H2AX, which can all play a role in the DDR (Fig 1.1) (Kastan, 
2008).  
 
Figure 1-1 Scheme for DDR-induced Signalling Pathway (Kastan, 2008). 
Following a stress-induced DSB, numerous DDR proteins, including 53BP1, BRCA1 
and the MRN-complex (NBS1, Rad50 and Mre11) are recruited to the site of 
damage. ATM becomes phosphorylated and can activate p53 to signal for apoptosis 
of growth arrest, unless the lesion is repaired, and the cell can re-enter the cell cycle.  
 
SSBs elicit binding of the single-stranded DNA-binding protein replication protein 
(RPA), which acts to recruit ATR (Cortez et al., 2001). However, during DSB repair, 
processing of the DSB leads to exposed single-stranded DNA which recruits RPA, 
and thus both ATR and ATM can be present at the same lesion in an ATM-
dependent manner (Jazayeri et al., 2006). Persistence of ATR and ATM above a 
certain threshold can lead to CHK2 phosphorylation by ATM, which can activate key 
cell cycle determinants such as the cell-division cycle 25 (CDC25) phosphatases and 
the tumour suppressor protein p53. Moreover, CDC25 phosphatases are required for 
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progression from G1 to S phase during cell replication, and thus the cell cycle is 
rapidly arrested upon their DDR-induced inactivation (Mailand et al., 2000). This cell 
cycle arrest can be bypassed by overexpression of the cell cycle regulator cyclin-
dependent kinase 1 (CDK1), however this leads to increased DNA damage and 
decreased cell survival following genotoxic stress (Mailand et al., 2000). Activated 
CHK2, and ATM, can phosphorylate p53 at Ser-15 and Ser-20 respectively, which 
dissociates p53 from its negative regulator MDM2, leading to p53 stabilisation and 
transcription of downstream proteins such as the cyclin dependent cell cycle inhibitor 
p21. Subsequently, p21 leads to a stable cell cycle arrest (Di Leonardo et al., 1994; 
Deng et al., 1995; d'Adda di Fagagna et al., 2003; Herbig et al., 2004). In addition, in 
a large number of cell lines, the cyclin-dependent kinase inhibitor p16 is also 
expressed in response to a persistent DDR and thus provides an extra enforcer of 
cell cycle inhibition (Stein et al., 1999; Beauséjour et al., 2003; Jacobs and de Lange, 
2004). However, there is still doubt about the factors responsible for p16 activation, 
since data indicates that p16 is induced during senescence independently from a 
DDR (Herbig et al., 2004). Moreover, the p53-p21 and p16-Rb pathways will be 
discussed in greater depth later on.  
DNA damage occurs frequently from both endogenous and exogenous sources, with 
estimates from mouse and human fibroblasts suggesting that thousands of SSBs and 
around 10 DSBs are generated per cell every day (Lieber, 2010). SSBs are thought 
to be less threatening to genomic integrity per se, however they can form DSBs if 
encountered by the DNA replication machinery during S phase (Kuzminov, 1999). 
DSBs arising during S phase are usually repaired via homologous recombination 
(HR), by using the homologous sister chromatid DNA as a template for efficient repair 
(Saleh-Gohari et al., 2005). DSBs can also occur stochastically due to aberrant 
nuclear enzyme activity, ionising radiation and reactive oxygen species (ROS), and 
are often repaired by non-homologous end joining (NHEJ), a mechanism which 
ligates broken strands in the absence of sister chromatid DNA (Riballo et al., 2004).  
Upon eliciting a DDR, cell-cycle progression is temporary halted until the DNA 
damage has been resolved (Jackson and Bartek, 2009). However, if the DNA 
damage is not resolved or exceeds a certain threshold, cells may initiate senescence 
or apoptosis. Furthermore, due to a basal rate of DNA damage being constantly 
induced and repaired, it is difficult to ascertain the exact thresholds, both numerically 
and temporally, for when the cellular decision is made to enter senescence or 
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undergo apoptosis. Research into DNA damage uses a number of different genotoxic 
agents, for example, neocarzinostatin is a protein-chromophore complex which is a 
very-potent DNA damaging agent and known for its anti-tumour activity, and 
etoposide is a cytotoxic agent which causes DNA damage by inhibiting 
topoisomerase II from re-ligating DNA strands, both of which have been shown to 
increase SA-β-Gal activity in human fibroblasts following exposure (Hewitt et al., 
2012). In addition, less specific DNA damaging agents are used such as ionising 
radiation or hydrogen peroxide (H2O2), which is a strong oxidiser that can cause both 
single and double strand breaks in the DNA, and following H2O2 exposure, human 
fibroblasts have been shown to enter a G1 cell cycle arrest and display elevated SA-
β-Gal activity (Duan et al., 2005). Understanding the threshold for DNA damage-
induced senescence is also made more difficult due to the varying forms of DNA 
damage induced. For example, etoposide-induced DNA damage results in a bimodal 
repair kinetic, with 90% of foci having half-lives of around 2 hours, whereas 10% of 
the foci have half-lives of around 12 hours (Shibata et al., 2011). These observations 
compliment the two-lesion kinetic (TLK) model of DSB, which proposes there are 
simple DSBs which are rapidly repaired, and complex DSBs, which may contain 
additional damage such as base deletions, or strand breaks, and thus take 
significantly longer to repair (Stewart, 2001; Ma et al., 2005).    
 
1.2.2 Telomeres and Replicative Senescence 
 
Genomic DNA in eukaryotic organisms is packaged into chromosomes, which due to 
their linearity have physical ends. However, eukaryotes have evolved complex DNA 
repair machinery which recognise exposed ends of DNA, and elicit a DNA Damage 
Response (DDR) in attempt to repair them, however, early observations revealed that 
the ends of chromosomes were resistant to a DDR and subsequent fusion reactions, 
which would otherwise occur in other broken and exposed regions of the genome 
(McClintock, 1938; McClintock, 1941). Interestingly, it was shown that introduction of 
linear plasmids into eukaryotic cells were unstable and prone to recombination with 
the genome, however, this could be stabilised with the addition of G-rich repeats from 
yeast chromosome ends (Orr-Weaver et al., 1981; Szostak and Blackburn, 1982; 
Shampay et al., 1984). These ends of chromosomes were shown to be distinct from 
genomic DNA in that they consist of a 5’-3’ genetic repeat of code, consisting of the 
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hexamer 5’-TTAGGG-3’ in mammalian species and other variations across most, if 
not all, eukaryotes from yeast to vertebrates (Blackburn, 1991). These repeat 
sequences were coined ‘telomeres’ and were also shown to end with a G-rich 3’ 
single-stranded overhang (Klobutcher et al., 1981; Henderson and Blackburn, 1989). 
In addition, telomeres were also shown to be unique from the rest of the genome by 
associating with a 6-subunit protein complex: TRF1, TRF2, POT1, RAP1, TIN2 and 
POT1 (de Lange, 2005). Both TRF1 and TRF2 contain SANT/Myb-type DNA-binding 
domains (DBD) in their carboxy terminus which recognise and bind to the sequence 
5’-YTAGGGTTR-3’ in double-stranded DNA, and can form homodimers as well as 
high order oligomers, thus providing numerous DBDs for the protein complex to bind 
to large sequences of telomeric DNA (Bianchi et al., 1999; Court et al., 2005; 
Hanaoka et al., 2005). In addition, POT1 also has a DBD with a high affinity for the 
single stranded 5’(T)TAGGGTTAG-3’ sequence found on the 3’ G-rich overhangs on 
telomeres (Lei et al., 2004; Ye et al., 2004). Rap1 associates with TRF2, and both 
TRF1 and TRF2 bind to TIN2, which interacts with the TPP1/POT1 heterodimer, thus 
creating a stable telomere-binding complex, with multiple telomeric DNA binding 
sites, thus allowing the 6-subunit protein complex high specificity and affinity for 
telomeric repeats. Electron microscopy images showed that purified telomeric 
restriction fragments were able to form a lariat-like structure in vitro, thought to be a 
consequence of the invasion and subsequent binding of the 3’ overhang into the 
downstream duplex telomeric DNA (Griffith et al., 1999). The formation of the lariat-
like structure, coined the ‘t-loop’ was shown to be dependent on the telomere-
associated protein TRF2 (Griffith et al., 1999). Moreover, the formation of the t-loop 
provides an elegant mechanism which physically “shelters” the end of the 
chromosome from DDR proteins, and thus the name shelterin was given to the 6-
protein complex which associates with telomeres and facilitates this process (de 
Lange, 2005). However, TRF2 inhibition in both mouse and humans has been shown 
to activate ATM kinase at telomeres (Karlseder et al., 1999; Celli and de Lange, 
2005), which in turn leads to the accumulation of DDR proteins such as MDC1, 
53BP1 and γH2AX at telomeres, resulting in p53 upregulation and a p21-mediated 
G1/S cell cycle arrest (Karlseder et al., 1999; d'Adda di Fagagna et al., 2003; Takai 
et al., 2003). Furthermore, TRF2 inhibition also leads to NHEJ-mediated and end-to-
end chromosome fusions (van Steensel et al., 1998; Smogorzewska et al., 2002; 
Celli and de Lange, 2005). The mechanism for this NHEJ suppression, results from 
TRF2 and its binding partner RAP1 having an inhibitory effect on DNA-PK and 
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ligase-IV-mediated NHEJ (Bae and Baumann, 2007). Whilst TRF2 inhibition leads to 
an ATM-dependent DDR at telomeres, POT1 deletion results in ATR-dependent DDR 
and phosphorylation of Chk1 (Hockemeyer et al., 2006; Guo et al., 2007), 
highlighting that telomeres are associated with two proteins which independently 
repress the two major DDR pathways, thus differentiating telomeres from internal 
DSBs. Interestingly, dysfunctional telomeres elicit an ATM-dependent DDR in which 
CHK2 is not phosphorylated, which is distinct from ATM-dependent genomic DSBs 
(Cesare et al., 2013). In addition, telomere dysfunction, unlike genomic DSBs, does 
not activate a G2/M checkpoint, but allows mitosis to complete before arresting cells 
in p53-dependent G1 cell cycle arrest (Cesare et al., 2013).  
Telomere dysfunction can also arise as a consequence of telomere attrition, resulting 
from an inability of the telomere sequence to be fully replicated during DNA 
replication. DNA polymerase can only synthesise DNA in the 5’-3’ direction, thus 
resulting in a leading and lagging strand of DNA. The lagging strand requires the 
binding of RNA primers to enable DNA polymerase to bind to and replicate DNA, 
followed by the degradation of the RNA primer and replacement with DNA. However, 
the final attached RNA primer does not have a DNA template behind it, and 
eventually succumbs to degradation, thus resulting in telomere shortening; a 
phenomenon coined the ‘end replication problem’ (Olovnikov, 1971; Watson, 1972). 
It is thought that telomere shortening and associated dysfunction is responsible for 
triggering replicative senescence, and it has been observed that different cell types 
have a reproducible number of times they can divide before entering senescence, 
known as their ‘Hayflick limit’. Moreover, it has been proposed that telomeres reflect 
a cell’s replication history, thus acting as a molecular clock (Harley et al., 1990; 
Harley et al., 1992). However, the end replication problem is only predicted to result 
in a loss of around 20 base pairs per cell division, whereas evidence suggests that 
around 50-200 base pairs of telomere DNA are lost each cell division. Interestingly, it 
has been shown that telomere attrition is accelerated by oxidative stress (von 
Zglinicki et al., 1995; von Zglinicki et al., 2000), and thus telomeres appear not to 
represent merely a tally counter for replication history, but a proxy for their history of 
cellular stress as well.  
Once telomeres reach a critical length, it is thought that steric constraints on the t-
loop structure cause the 3’ overhang to dissociate from its complementary DNA 
strand, thus linearising the telomere, or ‘uncapping’, therefore exposing the physical 
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end of the telomere to the nucleoplasm where it can be recognised as DNA damage 
and lead to p53-dependent cell cycle arrest (Herbig et al., 2004). Moreover, 
dysfunctional telomeres accumulate DDR proteins such as γH2AX, 53BP1, MRE11, 
which subsequently signal through ATM, to p53, which upregulates p21, leading to 
G1 cell cycle arrest (Herbig et al., 2004). Inhibition of ATM results in cells re-entering 
the cell cycle, suggesting that a persistent DDR signal is required for cell cycle arrest 
(Herbig et al., 2004). An on-going DNA damage response at telomeres has been 
shown to contribute to the development of the senescence phenotype (d'Adda di 
Fagagna et al., 2003; Passos et al., 2010). It has been proposed that a threshold of 5 
telomeric DNA damage foci can predict the onset of senescence in human fibroblasts 
(Kaul et al., 2012). Interestingly, if senescence pathways are bypassed, for example 
by p53 inactivation with SV40 transformation, cells can continue to proliferate with 
extremely short telomeres, until the level of telomere erosion causes complete 
telomere de-protection and cells enter a state of crisis, as defined by chromosomal 
fusions and eventually cell death (Counter et al., 1992).  
Germline immortality is dependent upon a telomere maintenance mechanism to 
prevent replicative senescence or crisis occurring as a result of telomere shortening. 
Moreover, eukaryotes evolved a solution to the end-replication-problem, which is 
dependent upon the ribonucleoprotein telomerase. Telomerase is a reverse 
transcriptase, which consists of a catalytic domain, known as Telomerase Reverse 
transcriptase (TERT), which recognises the 3’-OH group at the end of the G-rich 
overhang and elongates the telomeric DNA (Blasco, 2005). Moreover, this elongation 
is made possible by the Telomerase RNA Component (TERC), which also binds to 
the 3’ overhang and creates a template for TERT to add complementary nucleotides 
(Elizabeth, 2001). Telomerase activity is essential for telomere length maintenance in 
human germ and stem cells, and defective telomerase can lead to disease 
pathologies, for example dyskeratosis, in which patients have severely shortened 
telomeres   (Mitchell et al., 1999). Telomerase activity is either absent or negligible in 
other somatic cells, therefore resulting in proliferation-associated telomere shortening 
(Wright et al., 1996; Yui et al., 1998), however, replicative senescence in somatic 
cells can be avoided via ectopic expression of telomerase, which replenishes the 
telomeric DNA and thus maintains the telomeres from reaching a critical length 
(Bodnar et al., 1998b). This was first shown by transfection of both retinal pigment 
epithelial cells and foreskin fibroblasts with the telomerase catalytic subunit; it was 
15 
 
observed that the cells were still proliferating when the data was published, having 
already exceeded their Haylflick limit by 20 population doublings. Moreover, they 
showed decreased SA-β-Gal activity and had significantly elongated telomeres 
(Bodnar et al., 1998a). However, upregulated telomerase activity cannot prevent 
genotoxic stress-induced senescence, for example hTERT overexpressing human 
fibroblasts still enter cellular senescence following exposure to high doses of X-
irradiation (Hewitt et al., 2012), and H2O2 treatment has also been shown to induce 
senescence in human fibroblasts independently of telomere length  (Chen et al., 
2001). 
Telomere length maintenance in the germline and stem cell populations is essential 
for the persistent proliferative potential by ensuring telomere lengths are substantial 
enough to prevent uncapping and subsequent cell cycle arrest. However, telomere 
maintenance mechanisms are also hijacked by cancer cells to assist immortality, with 
around 85% of human cancers presenting an upregulation of telomerase activity 
(Shay and Bacchetti, 1997). Almost all other cancer types maintain telomere length 
with a telomerase-independent mechanism known as Alternate Lengthening of 
Telomeres (ALT) (Heaphy et al., 2011). Furthermore, ALT has been shown to rely on 
a recombination event (Dunham et al., 2000), however the exact mechanism for 
telomere elongation requires further research. 
Contrary to the regulation of telomere attrition, mechanisms have also evolved which 
limit telomerase-mediated elongation of telomeres, for example, telomere length in 
many immortalised human cell lines is stable, despite persistent telomerase 
upregulation (van Steensel and de Lange, 1997). Furthermore, different species are 
associated with different telomere lengths (Kipling and Cooke, 1990), which are kept 
constant throughout numerous generations (Wright et al., 1996), suggesting the 
process of telomere elongation is controlled in the germline. Various shelterin 
proteins are involved in telomere elongation regulation; overexpression of TRF1 in 
the HT1080 tumour cell line leads to gradual telomere shortening, and conversely, 
expression of a dominant-negative TRF1 resulted in telomere elongation (van 
Steensel and de Lange, 1997), suggesting that TRF1 acts as a negative regulator of 
telomere elongation. TRF2 has also shown to be a negative regulator of telomere 
elongation, as TRF2 overexpression accelerates telomere shortening, however 
neither TRF1 nor TRF2 overexpression have any effect on telomerase expression 
levels (Smogorzewska and van, 2000). Moreover telomere elongation can be 
16 
 
induced by introducing a mutant POT1 with deficient TRF2 binding, however the 
mechanism of this effect is yet to be understood (Kendellen et al., 2009).  
 
1.2.3 Telomere-Associated DNA Damage Foci 
 
Telomere shortening and dysfunction, leading to a persistent DDR and cell cycle 
arrest is well documented in vitro (as discussed above). However, it is not fully 
understood if telomere shortening per se has a pathological effect in vivo. The study 
of telomere dysfunction in mice has largely involved producing telomerase-null mice, 
which lack either functional TERT or TERC activity, and therefore cannot elongate 
telomeres, including the germline, and thus with each successive generation, 
progeny are born with shorter telomeres (Lee et al., 1998; Hande et al., 1999; Karl 
Lenhard et al., 1999). However, the physiological relevance of this is questionable, 
considering that the level of telomere shortening in these models is far greater than 
what would be expected in wild-type mice. Telomerase-null mice lose around 4-5 
kilobases of telomere per generation (Blasco et al., 1997; Rudolph et al., 1999), and 
wild-type mice lose around 15 kilobases of telomeric DNA throughout their lifetime 
(Vera et al., 2012). No significant alterations in lifespan were observed after 
comparing G3 TERC-/- mice to wild-type mice (Rudolph et al., 1999). Considering 
that G3 mice are born with telomere lengths comparable to those found in severely 
aged mice, and G3 mice continue to show telomere shortening throughout their life, 
this would suggest that telomere shortening is not having an effect on lifespan. G6 
TERC-/- mice do display significantly shortened lifespans, but this level of telomere 
shortening cannot be considered physiological (Rudolph et al., 1999), and is more 
akin to a telomerase-defective disease such as dyskeratosis congentia (Mitchell et 
al., 1999).  
Our group observed an age-dependent increase in telomeres co-localising with a 
DDR in murine hepatocytes and enterocytes, however, interestingly, Q-FISH analysis 
revealed that this was occurring independently of telomere length, which contradicted 
the hypothesis that telomere dysfunction is driven purely by attrition and subsequent 
uncapping (Hewitt et al., 2012). Our group and another showed in vitro that SA-β-Gal 
activity could be increased upon treatment with genotoxic stresses, such as X-
irradiation, H2O2 or neocarzinostatin, all of which are known to cause DSBs, and we 
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observed a DDR detectable by γH2AX occurring in both genomic and telomeric DNA 
(Fumagalli et al., 2012; Hewitt et al., 2012). However, with time genomic DDR foci 
are resolved, whereas telomeric DDR remained persistent (Fumagalli et al., 2012; 
Hewitt et al., 2012). Several models were proposed to explain this phenomenon.  It 
has been observed that oxidative damage disrupts the recognition of telomeres by 
TRF1 and TRF2 (Opresko et al., 2005), and thus the observed DDR foci at telomeres 
could occur due to telomere uncapping, however telomeres devoid of TRF2 are 
known to undergo end-to-end fusions (van Steensel et al., 1998) , which we did not 
observe (Hewitt et al., 2012). Another group observed spontaneous DDR foci at 
telomeres in human cancer cells, which retained an abundance of TRF2, yet a DDR 
was present (Cesare et al., 2009). Considering this, another possibility could be that 
genotoxic stress leads to t-loop uncapping, whilst retaining enough TFR2 to inhibit 
NHEJ, without affecting initiation of a DDR. Finally, we proposed that similar to 
genomic DNA, genotoxic stress could lead to physical DSBs within the telomeric 
region which remain persistent due to presence of TRF2 inhibiting a DDR. Moreover, 
an endonuclease-induced DSB next to ectopically expressed TRF2 remained 
persistent, thus suggesting that the inhibitory effect of TRF2 on DNA repair is 
independent of telomeric location and t-loop (Fumagalli et al., 2012).  
To differentiate stress-induced telomere dysfunction from telomere-shortening 
induced dysfunction, we shall herein refer to the varying proposed mechanisms of 
telomere dysfunction as either Telomere-Associated Foci (TAF) or Telomere-Induced 
Foci (TIF) respectively. Furthermore, TIF are thought mainly to arise due to 
uncapping, either as a result of steric constraints on critically short telomeres, or due 
to inhibition of shelterin proteins, whereas TAF have been proposed to arise due to 
physical DSBs within telomeric regions (Hewitt et al., 2012), although further 





Figure 1-2. Schematic of Telomere-Associated Foci (TAF). It has been proposed 
that DSBs occurring within telomeres are irreparable due to the inhibitory action of 
the shelterin complex on DNA repair proteins (Hewitt et al., 2012). 
 
To conclude, it would appear that the inhibitory effect of TRF2 on DNA-PK and ligase 
IV prevents healthy telomeres from undergoing NHEJ-mediated end-to-end fusions 
(Smogorzewska et al., 2002; Bae and Baumann, 2007), however, in the context of 
telomere dysfunction independently of length, TRF2 serves to inhibit DNA repair. In 
this context, telomeres can be considered both a molecular clock for telomere 
shortening, as well as a molecular diary for past genotoxic stress due to their 
irreparability.  
 
1.2.4 Oncogene-Induced Senescence 
 
Oncogenes are genes that when are over-expressed or mutated, have the potential 
to turn a normal cell into a cancer cell. Before the concept of oncogene-induced 
senescence (OIS) had arisen, Ras was identified as an oncogene, capable of 
transforming immortalised rat cells once activated (Der et al., 1982; Parada et al., 
1982). However, RAS activation alone was shown not to be capable of transforming 
normal primary embryonic cells, and required additional mutations, such as p53 
inhibition by large T antigen, for transformation to occur (Land et al., 1983). OIS was 
first characterised, when an activated allele of the mitogenic signal transducer RAS 
(H-ras V12), was introduced into human fibroblasts (Serrano et al., 1997). At first, the 
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cells displayed hyper-proliferation however soon displayed an accumulation of p16 
and p53 accompanied with a G1 cell cycle arrest, which could by bypassed by 
inhibition of either of the aforementioned tumour suppressor proteins (Serrano et al., 
1997). These observations show that initiation of cellular senescence is not simply a 
consequence of the number of cell divisions, as oncogenic stimuli can induce 
senescence prematurely. Many cell types have now been shown to acquire a 
senescent phenotype after the aberrant function of various oncogenes, including 
MEK, MOS, RAF and BRAF (Serrano et al., 1997; Zhu et al., 1998; Michaloglou et 
al., 2005).  
There are many proposed models for the mechanism which drives OIS, such as 
hyper-proliferation leading to replication errors and subsequent DDR activation (Di 
Micco et al., 2006), or by altering intra-cellular levels of ROS production which could 
also lead to genotoxic stress (Lee et al., 1999a). Interestingly, OIS can be bypassed 
in mouse cells grown under hypoxic conditions (Lee et al., 1999a). Other research 
has shown that Rb-mediated formation of heterochromatin, leads to suppression of 
E2F target genes and subsequent cellular senescence (Narita et al., 2003). These 
models of OIS induction are not mutually exclusive and it will be important to 
ascertain the relationship between these different mechanisms.  
OIS has recently been observed to occur in vivo in both mice and humans, for 
example, as a barrier to t-cell lymphoma development (Braig et al., 2005), and ras 
positive senescent cells have been shown to exist in pre-malignant tumours, but not 
in malignant, and interestingly inactivation of PTEN specifically in mouse prostate 
leads to invasive prostate cancer (Collado et al., 2005). Therefore OIS appears to 
have a physiological role in tumour suppression in vivo, and is not simply an artefact 
of cell culture, as once thought.   
 
1.3 Senescence Control Pathways 
 
Senescence is often induced and maintained by either the p53 or p16-Rb tumour 
suppressor pathways. These signal transduction cascades can react with one 
another, although they can each stop cell-cycle progression independently. Which of 
these pathways induces senescence appears to be both species-specific and cell-
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specific, although examples exist of senescence induction via alternative pathways 
(Olsen et al., 2002; Michaloglou et al., 2005). 
 
1.3.1 P53-P21  
 
P53 is transcription factor, encoded by the TP53 gene, which is activated in response 
to various stresses, including the overexpression of oncogenes, and DNA damage, 
and is responsible for the regulation of the expression of numerous genes involved in 
processes such as DNA repair, apoptosis and senescence (Harms et al., 2004; 
Green and Chipuk, 2006). P53 has therefore been bestowed with monikers such as 
the ‘guardian of the genome’ (el-Deiry et al., 1993) and the ‘cellular gatekeeper’ 
(Levine, 1997). Classically, the activation of p53 can be described in 3 steps: 
stabilisation of p53 via ATR/ATM-mediated phosphorylation, DNA binding, and the 
activation of target genes by interaction with the transcriptional machinery (Kruse and 
Gu, 2009).  
First discovered in mice, one of the main regulators of p53 is mouse double minute 2 
homolog (MDM2), or HDM2 in humans, an E3 ubiquitin-protein ligase which acts to 
regulate both the activity and expression of p53 in several ways. MDM2 can facilitate 
the nuclear export of p53, thus inhibiting any transcriptional activity (Tao and Levine, 
1999), as well as ubiquitinating p53 for proteosomal degradation (Haupt et al., 1997; 
Kubbutat et al., 1997). MDM2 can also inhibit p53-mediated transactivation by 
binding to and inhibiting the transactivation domain of p53 (Momand et al., 1992). 
MDM2 is itself inhibited by the alternative-reading-frame (ARF) protein (Sherr and 
McCormick, 2002), thus highlighting various regulation points in the p53 pathway. 
Interestingly, the MDM2 gene is a transcriptional target of p53, therefore instigating a 
negative feedback loop which acts to maintain p53 homeostasis (Wu and Levine, 
1997). One mechanism of p53 stabilisation involves in the inhibition of the mdm2-p53 
interaction through N-terminal phosphorylation of Ser15 and Ser20 or Ser18 and 
Ser23, in humans and mice respectively (Kruse and Gu, 2009). These 
phosphorylation reactions are performed by DDR protein kinases such as ATR, ATM, 
DNA-PK, Chk1 and Chk2, in response to cellular stressors such as DNA damage 
(Shieh et al., 1997; Shieh et al., 2000; Appella and Anderson, 2001).  
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Cellular senescence can be triggered in response to stimuli such as telomere 
dysfunction or DNA damage, which lead to an activated DDR, and the subsequent 
up-regulation of the p53 transcriptional target gene CDKN1A, which encodes cyclin-
dependent kinase inhibitor 1 (p21)  (Brown et al., 1997). P21 contains a PCNA 
binding domain, which allows p21 to compete with PCNA for binding to DNA-
polymerase-δ, therefore physically inhibiting DNA synthesis (Moldovan et al., 2007). 
Another mechanism for p21-mediated cell cycle inhibition is through its CDK-cyclin 
inhibitory domain, which can inhibit various cyclin-dependent kinases (CDKs), in 
particular CDK2, which is responsible for the phosphorylation of retinoblastoma 
protein (pRb), which in turn releases and activates E2F, which is responsible for the 
transcription of numerous cell cycle regulators such as cyclin A, cyclin D1, cyclin E, 
Cdc2 and Cdc25A (Dyson, 1998). However, p21 is not a stalwart maker of 
irreversible cell cycle arrest, as p21 expression is elevated in response to transient 
cell cycle arrest in response to acute DNA damage, however, the exact threshold of 
DNA damage required to trigger the decision to enter cellular senescence remains 
elusive (Barnouin et al., 2002). Interestingly, both telomere dysfunction-induced 
senescence and DNA damage-induced senescence can be evaded through the 
down-regulation or inhibition of either p53 or p21, and likewise, with the inhibition of 
upstream DDR proteins such as CHK2 or ATM (Brown et al., 1997; Gire et al., 2004).  
The p53 pathway acts to halt cell-cycle progression in cells which have endured 
serious DNA damage, thus helping to prevent the possibility of the dissemination of 
potentially oncogenic mutations (Bartkova et al., 2005; Gorgoulis et al., 2005). In fact, 
compromised p53 function, due to mutation of the TP53 gene, is found in around 
50% of all human cancers, and the significant majority of the remaining cancers 
display aberrant function of p53 regulators, for example, the MDM2 gene is amplified 
in at least 7% of TP53 wild-type cancers (Momand et al., 1998; Vousden and Lu, 
2002). In the case of cells which lack or have aberrant p53 function, mitotic 
catastrophe often occurs, therefore acting as another anti-tumour mechanism, 
however a subset of cancer cells overcome this and succeed in surviving through the 
activation of telomerase, or ALT, to stabilise telomere length (Hanahan and 






Another important pathway in the induction of senescence is the p16-pRb pathway, 
which can be activated following p53-p21 pathway induction, however, it can also be 
activated independently of p53 (Jacobs and de Lange, 2004). P16 is a tumour 
suppressor protein which inhibits cell cycle progression from G1 to S phase (Agarwal 
et al., 2013). The mechanism of action involves p16 inhibiting the interaction between 
CDK4/6 and cyclin D1, therefore preventing pRb phosphorylation, and inhibiting the 
dissociation and subsequent activation of E2F (Vidal and Koff, 2000). p16 has 
emerged as a good marker for senescence, as it has been observed to accumulate 
in a wide variety of cell lines under multiple senescence-inducing stimuli (Lowe and 
Sherr, 2003; Campisi, 2005). However, elucidating the exact nature of the p16-pRb 
pathway activation will be difficult, as there are not only cell-specific differences, but 
also species-specific differences. Moreover, in response to telomeric disruption, 
mouse fibroblasts will only engage the p53 pathway, whereas human cells will 
engage both the p53 pathway and the p16-pRb pathway (Smogorzewska and de 
Lange, 2002). Interestingly, p53 inhibition can reverse senescent arrest in a variety of 
cell types; however, the phenotype cannot be reversed in cells which have engaged 
the p16-pRb pathway (Beauséjour et al., 2003). Moreover, this irreversible 
proliferation arrest is thought to occur through the generation of SAHFs, which can 
modify the chromatin to repress a number of genes, including E2F target genes 
(Narita et al., 2003). Once a SAHF is developed, the condensed chromatin can be 
maintained in the absence of p16-pRb pathway proteins (Narita et al., 2003), and 
thus may help to explain the irreversibility of p16-pRb-induced senescence.   
Exactly how p16 is expressed in response to senescence-inducing stimuli remains 
unclear, but it is has been suggested to be causative of the observed repression of 
Polycomb INK4a repressors such as CBX7 or BMI1, coinciding with p16-pRb 
induced senescence (Gil et al., 2004; Bracken et al., 2007). What is more, in both 
mice and human fibroblasts, replicative lifespan has been increased via the 
overexpression of CBX7 or BMI1, thus strengthening the idea of the involvement of 
Polycomb INK4a repressors in cellular senescence (Itahana et al., 2003; Gil et al., 
2004). Interestingly, a reduction of p16-pRb signalling results in the stabilisation of 
p53 due to the activation of E2F, which is a transcription factor for ARF which inhibits 




1.3.3 Role of ROS in Senescence 
 
Atoms or molecules which have unpaired valence electrons are known as free 
radicals, and are highly reactive. Reactive Oxygen Species (ROS) in particular, are 
oxygen-containing chemically reactive molecules, which include free radicals such as 
hydroxyl radical and superoxide anion, as well other oxidisers, for example hydrogen 
peroxide (H2O2). ROS play important physiological roles, for example, as signalling 
molecules in several pathways (D'Autréaux and Toledano, 2007), as well as being 
produced by macrophages and neutrophils to combat microbial pathogens (Dupre-
Crochet et al., 2013). However, molecules and cellular structures can be damaged 
via oxidative stress caused by unregulated ROS levels, which can act in a chain-
reaction caused by a ROS molecule ionising another molecule to stabilise its own 
electron configuration, consequently turning the target into a ROS molecule (Cui et 
al., 2012). In the 1950s, Denham Harman proposed the ‘free radical theory of 
ageing’, which hypothesised that an accumulation of free radical damage over time 
could be driving organismal ageing (Harman, 1956). In eukaryotic cells, the majority 
of intra-cellular ROS are generated as a by-product of mitochondrial oxidative 
phosphorylation, due to leakage of electrons from the electron transport chain (ETC), 
and subsequent reduction of oxygen to form superoxide anion (Quinlan et al., 2013). 
Superoxide anion is not a strong oxidant per se, however it can undergo further 
redox reactions with other molecules to form stronger oxidants such as hydroxyl 
radicals and H2O2. Considering the role of mitochondria in ROS production, Denham 
Harman updated the ‘free radical theory of ageing’, to implicate mitochondria as the 
main drivers of ROS-driven ageing (Harman, 1972). It has subsequently been 
postulated that ROS, produced as a consequence of oxidative phosphorylation, can 
cause mtDNA mutations which lead to deficient oxidative phosphorylation activity, 
which in turn leads to further electron leakage and increased ROS production, 
therefore instigating a positive feedback, or ‘vicious cycle’ (Alexeyev et al., 2004). To 
counteract ROS damage, cells have evolved a number of antioxidant enzymes, for 
example superoxide dismutases (SODs) are a family of metalloenzymes which 
convert superoxide anion into H2O2, which can then be broken down into water and 
oxygen by either catalase or glutathione peroxidases (Fridovich, 1995). To combat 
superoxide anion generated either on the inner side of the inner mitochondrial 
membrane, or in the mitochondrial matrix, a specific form of SOD is expressed in the 
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mitochondrial matrix which contains manganese in the active site (MnSOD) 
(Fridovich, 1995).   
In addition to oxidative phosphorylation, other intra-cellular sources of ROS 
generation include NADPH oxidases (NOX), xanthine oxidase, nitric oxide synthase 
and mono-amine oxidase (MAO-A) (Holmstrom and Finkel, 2014). MAO-A localises 
to the outer mitochondrial membrane and is involved in catalysing the oxidative 
deamination of monoamines, which produces H2O2 as a by-product (Youdim et al., 
2006). ROS can also be generated by extra-cellular sources, for example ionising 
radiation from both X- and γ-rays, originating from either outer-space or decay of 
terrestrial radioactive elements, constantly pass through our body, which generate 
free radicals, usually as a consequence of the ionising particles reacting with cellular 
water (Lieber, 2010). Other sources of ROS include herbicides, pesticides and 
cigarette smoke (Valavanidis et al., 2009).     
Elevated ROS levels have been linked with oncogene-induced- and stress-induced 
senescence and replicative senescence (Saretzki et al., 2003; Ramsey and 
Sharpless, 2006; Passos et al., 2007). Treatment of cells with sub-lethal doses of 
hydrogen peroxide has been shown to induce senescence in human fibroblasts via 
the p53 pathway (Chen et al., 1998). ROS can directly damage DNA, resulting in a 
DDR which may lead to senescence (Chen et al., 1995; Lu and Finkel, 2008a). von 
Zglinicki et al., 1995, first showed that mild oxidative stress leads to accelerated 
telomere shortening (von Zglinicki et al., 1995) suggesting that ROS-driven single 
strand breaks at telomeres could accelerate telomere shortening (von Zglinicki, 
2002). It was later shown that mitochondrial superoxide levels increase with 
replicative age and can also lead to accelerated telomere shortening (Passos et al., 
2007).  Interestingly, mitochondrial superoxide levels can be decreased by the 
overexpression of TERT, independent of telomere length, in human fibroblasts 
exposed to oxidative stress (Ahmed et al., 2008).  This suggests that telomerase can 
have functions in mitochondria independent of its role in the nucleus, however, the 
mechanisms have not yet been elucidated. Furthermore, recent research has shown 
that mitochondrial telomerase leads to less DNA damage in the nucleus, possibly 
due to reduced ROS (Singhapol et al., 2013). 
A comprehensive causal relationship between senescence and ROS remains elusive 
as it has been shown that ROS production can be induced by downstream effectors 
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of the DDR/senescence checkpoint (Polyak et al., 1997; Macip et al., 2002; Macip et 
al., 2003). The DDR protein ATM exists as an inactive dimer, which, in response to 
irradiation, undergoes autophosphorylation resulting in dimer dissociation and the 
initiation of its cellular kinase activity (Bakkenist and Kastan, 2003). However, 
hydrogen peroxide has recently been shown to activate dimeric ATM in the absence 
of DNA damage and suggests that cells have developed an intrinsic mechanism to 
sense ROS (Guo et al., 2010; Perry and Tainer, 2011). ROS levels have been shown 
to increase with replicative senescence and OIS (Furumoto et al., 1998; Lee et al., 
1999b), with the majority being produced from dysfunctional mitochondria (Lu and 
Finkel, 2008a; Moiseeva et al., 2009). It has previously been shown that a positive 
feedback loop involving sustained activation of the checkpoint gene CDKN1A (p21) 
results in both the induction of mitochondrial dysfunction and increased production of 
reactive oxygen species (ROS) via a signalling cascade through GADD45-
MAPK14(p38MAPK)-GRB2-TGFBR2-TGFβ (Passos et al., 2010)(Figure 1-3). 
OIS via expression of V12Ras, has been shown to increase production of 
mitochondrial ROS, and interestingly, human diploid fibroblasts grown in 1% oxygen, 
were unable to undergo Ras-induced OIS (Lee et al., 1999a). Similarly, MEFs were 
shown to accumulate more DNA damage when cultured in 20% compared to 3% 
oxygen, and were resistant to stress-induced senescence when cultured in a hypoxic 
environment (Parrinello et al., 2003). HDFs have been shown to undergo more 
population doublings before entering senescence when cultured in 3% compared to 






Figure 1-3. A Stochastic feedback loop model predicts the kinetics of DDR 
growth arrest at the single cell level (Passos et al., 2010). Red and black circles 
represent telomeric and non-telomeric DSBs respectively, which signal to TP53 and 
CDKN1A, resulting in growth arrest. The signalling cascade continues through 
GADD45-MAPK14-TGFβ, resulting in mitochondrial dysfunction and elevated ROS 
production, which in turn causes further DSBs, thus instigating a feedback loop which 
sustains cellular senescence. 
 
1.3.4 mTOR Signalling 
 
All eukaryotic organisms express the target of rapamycin (TOR) signalling pathway 
(known as mTOR in mammalian organisms). Moreover, this pathway is responsible 
for sensing both nutrient and energy abundance to coordinate cellular responses 
such as growth, proliferation, autophagy, protein synthesis and many others (Zoncu 
et al., 2011). The mTOR protein belongs to PIKK family and acts as the catalytic 
subunit in two well described complexes known as mTOR complex 1 (mTORC1) and 
mTORC2, which have a variety of shared and non-shared proteins, for example the 
MTORC1 and MTORC2 complexes can be distinguished by the binding of the 





Interestingly, the intervention of dietary restriction, by experimentally reducing the 
amount of food an organism has access to, yet without causing malnutrition, has 
been shown to increase the lifespan of in many organisms from yeast to mammals 
(Mair et al., 2003). Moreover, it would appear that DR acts mainly through the 
inhibition of mTORC1 and experiments have shown that manipulation of nutrient 
sensing pathways has led to a similar increased lifespan in a range of different 
organisms (Zoncu et al., 2011). In fact, experiments performed in yeast and flies, 
involving the genetic down-regulation of mTORC1 pathway components, coupled 
with DR, provided no additive effect on lifespan, thus strengthening this hypothesis 
(Kaeberlein et al., 2005; Bjedov et al., 2010).  
In response to growth stimuli, activated mTORC1 signals to promote protein 
translation and growth and proliferation (Fingar and Blenis, 2004). Rapamycin is a 
drug which inhibits mTORC1 signalling, however does not appear to affect mTORC2 
signalling, a mechanism proposed to act via dissociating raptor from the mTORC1 
complex (Yip et al., 2010). Feeding rapamycin to aged mice has been shown to 
significantly extend lifespan (Harrison et al., 2009). Beneficial effects of mTORC1 
inhibition on cellular ageing may be attributable to a number of factors. Moreover, 
mTORC1 inhibition results in a decrease in protein translation and therefore exerts 
less stress on protein folding systems, thus reducing the number of mis-folded 
protein aggregates (Zoncu et al., 2011). Consequently, research has shown that a 
sustained rapamycin diet in a mouse model for Huntingdon’s disease resulted in the 
reduction of toxic huntingtin aggregates (Brinda et al., 2004). Activated mTORC1 
signalling inhibits autophagy, however rapamycin treatment can counteract this and 
upregulate autophagy, which complements data showing that lifespan extension is 
dependent on autophagy in drosophila and nematodes (Hansen et al., 2008; Bjedov 
et al., 2010). mTOR inhibition has been shown to impact on cellular senescence. 
Recently, it has been shown that rapamycin suppresses replicative senescence in 
rodent embryonic cells (Pospelova et al., 2012) and in oncogene-induced 
senescence (Kolesnichenko et al., 2012). Furthermore, mTORC1 inhibition has been 
shown to suppress the secretion of numerous pro-inflammatory cytokines in 
senescent fibroblasts (Laberge et al., 2015). Moreover, this secretory phenotype is a 
hallmark of senescent cells and has been shown to have detrimental effects on 
surrounding cells (Coppé et al., 2010a), a phenomenon which will be discussed in 




1.4 Senescence Phenotype 
 
The term senescence traditionally referred to somatic mitotic cells which had 
permanently lost the ability to divide, as opposed to cells that are simply in a 
quiescent state, i.e. those which have the potential to divide, but are currently 
residing in the G0 phase of the cell cycle. More recently, evidence has arisen which 
shows that cellular senescence is induced by very specific signalling programs, and 
besides cell cycle arrest, is associated with other phenotypes such as  apoptosis 
resistance, altered gene expression, a specific secretory phenotype and elevated 
ROS (Campisi and d'Adda di Fagagna, 2007; Coppé et al., 2008). Furthermore, 
these characteristics have also been observed in post-mitotic neurons and 
adipocytes (Minamino et al., 2009; Jurk et al., 2012), suggesting that senescence is 
more multi-faceted than just permanent cell cycle arrest, and that a redefinition of 
senescence may be required. In the following section, I will describe in more details 
characteristics of the senescent phenotype. 
 
1.4.1 Growth Arrest 
 
The quintessential senescent phenotype is the inability of a cell to advance through 
the cell cycle. Despite this arrest, cells still continue to be metabolically active but 
tend to stay locked in the G1 phase of the cell cycle (Di Leonardo et al., 1994; Herbig 
et al., 2004). Moreover, observations have shown cells to arrest in alternate stages of 
the cell cycle, for example G2/M (Wada et al., 2004). The reasons for cells arresting 
at particular phases of the cell cycle are attributable to activation of different cell cycle 
inhibitors, such as p16 and p21 (Herbig et al., 2004). 
 
1.4.2 Apoptosis Resistance 
 
Apoptosis is a mechanism for programmed cell death, followed by the removal and 
degradation of the resultant cellular debris by cells such as phagocytes (Ellis et al., 
1991). Apoptosis plays vital roles in organism development, however, like 
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senescence, it can also act as a mechanism to suppress tumourigenesis in times of 
severe cellular stress (Green and Evan, 2002). Under a particular stress condition, 
one cell type might preferentially senesce, whereas another may apoptose, although 
this decision can be altered by  proteins which are involved in apoptotic signalling, for 
example, caspase inhibition has been shown to switch doxorubicin-induced 
apoptosis to senescence in a neuroblastoma cell line (Rebbaa et al., 2003). Exactly 
how senescent cells manage to evade apoptosis remains unknown, however, both 
the apoptosis and senescence pathways are influenced by the p53 tumour 
suppressor protein and thus the cell’s response to the p53 pathway may be what 
influences the subsequent cell fate (Seluanov et al., 2001).  
 
1.4.3 Altered Gene Expression 
 
Gene expression in senescent cells varies significantly compared to their 
corresponding quiescent and dividing cells, for example, activators and inhibitors of 
the cell cycle are often differentially expressed in senescent cells (Mason et al., 2004; 
Jackson and Pereira-Smith, 2006). Senescent cells commonly express the cyclin-
dependent  kinase inhibitors (CDKI) p16 and p21, which are downstream of the 
retinoblastoma (pRb) and p53 proteins respectively (Campisi, 2001; Braig and 
Schmitt, 2006). Moreover, both pRb and p53 are crucial transcriptional regulators in 
two of the major tumour suppressor pathways often perturbed in cancer (Sherr and 
McCormick, 2002). In addition, senescent cells have also been shown to down-
regulate the expression of proteins that are involved in cell cycle progression (e.g. 
cyclin A, cyclin B, c-FOS, replication dependent histones and PCNA (Seshadri and 
Campisi, 1990; Stein et al., 1991; Pang and Chen, 1994; Narita et al., 2003)). Many 
of the above mentioned genes are not expressed due to their transcription factor E2F 
being silenced by pRb, which is kept in a hypophosphorylated state by p16 and p21. 
Moreover, pRb also has the ability to remodel the chromatin structure into punctate 
structures coined Senescence-Associated Heterochomatin Foci (SAHF), which can 
physically block the transcription machinery from accessing certain E2F target genes 
(Narita et al., 2003). The mechanism for chromatin reorganisation is thought to act 
through the ability of Rb-family members to recruit histone deacetylases (HDACs) to 
E2F-dependent promoters, which consequently results in the deacetylation of 
neighbouring histones. Moreover, this increases the positive charge of the histones, 
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therefore allowing the histone to bind more strongly to the negatively charged DNA, 
thus creating heterochromatin which represses gene expression (Narita et al., 2003).  
In addition, senescent cells also display differentially expressed genes with functions 
other than proliferative arrest. Moreover, research has shown senescent cells to up-
regulate proteins which can be secreted, such as extracellular matrix components, 
growth factors and inflammation factors (Shelton et al., 1999; Yoon et al., 2004; 
Trougakos et al., 2006). Antibody array experiments first showed the upregulation of 
these secretory cytokines in senescent cells and this senescence associated 
secretome is referred to as the Senescence-Associated Secretory Phenotype 
(SASP) and is associated with both stress, replicative and oncogene senescence 
(Coppé et al., 2008). The SASP has been suggested to have beneficial effects via 
the signalling of warning signals to cells in the surrounding microenvironment 
(Kuilman and Peeper, 2009). In addition, another possibility is that the SASP is a 
mechanism to recruit immune cells to clear senescent cells from the tissue (Chien et 
al., 2011), which will be discussed further later on. However, the SASP has also been 
implicated in the transformation of pre-malignant epithelial cells, for example, SASPs 
have been shown to  promote invasiveness and induce an epithelial-mesenchymal 
transition via a paracrine mechanism that relies heavily upon the SASP factors IL-6 
and IL-8 (Coppé et al., 2008).  
 
1.4.4 Senescence Markers 
 
For decades, scientists have been trying to find specific markers for senescent cells, 
which would allow for their specific detection both in vitro and in vivo. Hitherto, the 
search for a truly specific senescence marker has remained elusive, and although 
markers have been found, none are solely capable of identifying the senescent state 
alone (Lawless et al., 2010). By definition, senescent cells do not replicate and 
therefore proliferation markers can be used to identify cells which are not senescent, 
although this still would show false negatives for cells that are in a quiescent state or 
post-mitotic. Currently used proliferation markers include labelled synthetic 
nucleoside analogues which get incorporated into the DNA, for example 3H-thymidine 
or 5-bromodeoxyuridine. Antibodies for replication specific proteins can also be used 
such as Ki-67 and PCNA (Lawless et al., 2010).  
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Senescence-Associated Beta-Galactosidase (SA-β-Gal) was the first marker used to 
specifically detect the difference between a senescent mitotic cell compared to a cell 
that is quiescent or post-mitotic (Dimri et al., 1995). However, SA-β-Gal has been 
shown to be limited by the fact it can be detected in cells which have been cultured at 
confluence for prolonged periods of time (Severino et al., 2000) and thus not fully 
specific to the senescent state. Research has also shown that there is no difference 
in SA-β-Gal activity in either fibroblast cells or skin tissues sections taken from 
donors of different ages, therefore questioning SA-β-Gal as a marker for cellular 
ageing in vivo (Severino et al., 2000). In addition, why senescent cells have 
increased beta-galactosidase activity at pH6 is unknown, however it is believed that 
senescent cells display elevated levels of lysosomal biogenesis and it has been 
shown that cells with defective lysosomal beta-galactosidase do not express SA-β-
Gal even at late passages when the cells have gone through replicative senescence 
(Lee et al., 2006).  
In recent years, p16 has become a commonly used marker of senescence as it has 
been shown to be a principal mediator of senescence (Krishnamurthy et al., 2004), 
however, despite being upregulated in a large number of cell lines undergoing 
senescence, there are examples of p16 being expressed in pre-senescent cells, for 
example WI-38 fibroblasts, and therefore it cannot be considered a universal 
senescence marker (Beauséjour et al., 2003; Itahana et al., 2003). In addition p16 
levels have been shown to increase with age in almost all examined organs  in a 
variety of mice and rats, however, an increase was also observed in post-mitotic 
tissues in the brain and heart, suggesting that p16 as a senescence marker may lack 
specificity (Melk et al., 2003; Krishnamurthy et al., 2004). 
Other markers of senescence, include the presence of Senescence-Associated 
Heterochromatin Foci (SAHF) (Narita et al., 2003), which appear in some but not all 
cell lines, and Senescence-Associated DNA Damage Foci (SDF) (d'Adda di Fagagna 
et al., 2003; Takai et al., 2003). It has recently been observed that both mouse and 
human fibroblasts display an unravelling of centromeric DNA, which has been coined 
senescent-associated distension of satellites (SADs) (Swanson et al., 2013). SADs 
are particularly interesting as a marker for cellular senescence, as they are also 
found in cells from Hutchinson Guilford Progeria patients (Swanson et al., 2013), 
moreover, it will be interesting to see if SADs are present in other senescent cell 
types. Phosphorylated p38MAPK is a novel DDR-independent regulator of the SASP 
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which has been detected in response to various senescence-inducing stimuli in 
human fibroblasts, however p38MAPK can also phosphorylated independently of 
senescence (Freund et al., 2011). 
To conclude, hitherto there is not a marker solely specific to senescent cells, and 
perhaps due to the multifarious phenotype of senescent cells, the identification of a 
single marker may prove difficult, and thus when analysing senescence, it is 
advisable to use a combination of markers. 
 
1.5 Physiological Role of Senescence 
 
Senescence has been traditionally thought of as a mechanism to suppress 
uncontrolled proliferation, thus acting as an important barrier to suppress 
tumourigenesis (Serrano et al., 1997). However, research is emerging which shows 
that senescent cells are involved in a multifarious array of other organismal 
processes such as tissue repair (Krizhanovsky et al., 2008), wound healing (Jun and 
Lau, 2010), and embryonic development (Rajagopalan and Long, 2012; Muñoz-
Espín et al., 2013b; Storer et al., 2013).   
 
1.5.1 Anti-tumour mechanism 
 
We have previously described some of the causes of cellular senescence, including 
DNA damage, telomere dysfunction and OIS, all of which provide proficient 
mechanisms for preventing uncontrollable proliferation in vitro; herein we will discuss 
the evidence for these mechanisms providing a barrier to tumourigenesis in vivo. 
Human nevi are extremely common, and their monoclonality dictates they should be 
considered as pre-malignant lesions, however they are able to stay in a state of cell-
cycle arrest for many decades and rarely undergo tumourigenesis (Robinson et al., 
1998). Interestingly, the vast majority of nevi present oncogenic mutations, most 
commonly BRAFV600E, which would seem contradictory to their quiescent nature, if it 
were not for our understanding of OIS (Pollock et al., 2003). Moreover BRAF is a 
downstream effector of RAS, the first oncogene shown to induce OIS in vitro 
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(Serrano et al., 1997). Furthermore, constitutive activation of BRAFV600E can induce 
cell cycle arrest and increase expression of p16INK4a and SA-β-Gal activity in 
melanocytes in vitro (Michaloglou et al., 2005). Nevi were subsequently analysed for 
detection of senescent markers in vivo, and were shown to display both p16INK4a and 
SA-β-Gal activity in the absence of telomere shortening, thus suggesting that OIS 
can driving cell cycle arrest in vivo (Michaloglou et al., 2005). Contrary to this, 
another study attempted to categorise the difference between benign nevus cells and 
transformed melanocytes in terms of senescence, and found no variation between 
many markers, including γH2AX, p53, p16INK4a, SA-β-Gal, PML bodies, 
heterochromatin foci (DAPI, H3K9Me) and nuclear size (Tran et al., 2012). 
Considering that around 25% of melanomas are either associated with, or arise from 
a pre-existing nevus (Marks et al., 1990; Bevona et al., 2003; Tsao et al., 2003), and 
senescence is considered to be a state of permanent cell cycle arrest, this means 
either not all of the cells present in the nevi are senescent, or OIS-induced nevi cells 
are not permanently arrested, thus questioning if these cells are truly senescent.  
Ras activity has been implicated in driving OIS in other human tumour settings, for 
example senescent cells have been shown to accumulate in neurofibromatosis type 
1 lesions (Courtois-Cox et al., 2006). Neurofibromatosis type 1 is a familial cancer 
syndrome which is prevalent in patients who have a loss-of-function mutation in the 
tumour suppressor neurofibromin 1 (NF1) (Courtois-Cox et al., 2006). Moreover, NF1 
is a negative regulator of Ras activity, and thus a loss-of-function mutation leads to 
hyperactive Ras, resulting in the formation of neurofibromas, a type of neoplastic 
lesion, which are associated with numerous senescence markers (Courtois-Cox et 
al., 2006). Senescent cells have also been observed in other pre-malignant lesions, 
for example biopsies of pre-malignant intraepithelial neoplasia (PIN) and pre-
malignant human colon adenomas, have shown to be associated with senescence 
cells, and it is thought that further mutations are required in order for these benign 
lesions to transform into malignant tumours (Chen et al., 2005; Bartkova et al., 2006; 
Kuilman et al., 2008; Fujita et al., 2009).  
Although senescent cells have been shown to be associated with pre-malignant 
lesions, this correlation does not imply causality in suppression of malignancy. 
However, in many mouse tumour models, for example HRASG12V-induced mammary 
tumours (Sarkisian et al., 2007), BRAFV600E-induced melanomas (Goel et al., 2009), 
BRAFV600E-induced lung tumours (Dankort et al., 2007), genetic deletion of TP53 or 
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CDKN2A, resulted in an attenuation of senescence and development of malignancy, 
therefore providing evidence for a causal link between senescence induction and 
tumour suppression (Dankort et al., 2007; Sarkisian et al., 2007; Goel et al., 2009).  
Unfortunately, patients do succumb to malignant carcinomas, and thus senescence 
is not an infallible natural response, however, some malignant tumour cells are still 
able to be stimulated to enter cellular senescence in vivo (Shay and Roninson, 
2004), and thus the efficacy of many anti-cancer treatments exploit this by targeting 
DNA damage signalling pathways which can induce either senescence or apoptosis, 
thus inhibiting tumour progression (Schmitt et al., 2002; Coppé et al., 2010b). 
Moreover, restoration of p53 function has been shown to result in tumour regression 
in vivo (Ventura et al., 2007; Xue et al., 2007).   
Whilst activation of senescence in pre-malignant and even malignant cells appears to 
be a viable method of intervention for inducing cell cycle arrest in individual cells, 
research suggests that the persistence of senescent cells could be contributing to 
pathological ageing (Baker et al., 2008; Baker et al., 2011) and even driving 
tumourigenesis in neighbouring cells (Pribluda et al., 2013); an issue I will discuss in 




Cellular senescence and apoptosis are the main cellular responses to damage, and 
can both be activated by common triggers such as oncogenic stress or DNA 
damage, as reviewed in (Campisi and d'Adda di Fagagna, 2007). However, 
apoptosis has long been shown to play important roles in embryogenesis, and in this 
context is referred to as ‘programmed cell death’; a well-known example being the 
death of interdigital webs in the formation of digits in higher vertebrates (Lindsten et 
al., 2000). Research is now emerging which suggests that senescence also plays 
important roles in embryogenesis development (Muñoz-Espín et al., 2013a; Storer et 
al., 2013). Transient accumulation of senescent natural killer (NK) cells have been 
observed during uterine neovascularisation, a key developmental stage which 
involves vascular remodelling to provide a maternal blood supply to embryo 
(Rajagopalan and Long, 2012). In addition, embryonic trophoblast cells were 
observed to secrete HLA-G, which triggers a senescence-like response in nearby NK 
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cells by activating the CD158d receptor, which initiates signalling through DNA-PK, 
Akt and NF-κB, leading to p21 activity, and ultimately resulting in a SASP which 
increases vascular permeability and promotes angiogenesis (Rajagopalan and Long, 
2012). Further studies have shown that mouse embryogenesis appears to rely on 
senescent cells for the remodelling of numerous other tissues, such as the 
endolymphatic sac of the inner ear, the mesonephros (Muñoz-Espín et al., 2013a). 
Moreover, an accumulation of senescent cells has also been shown to be present 
during embryogenesis at the apical ectodermal ridge (AER) and the neural roof plate 
(Storer et al., 2013). Interestingly, p21-/- mice failed to accumulate senescent cells at 
the AER, and showed severe patterning defects in the limbs (Storer et al., 2013). 
These cells shared some similar characteristics to OIS cells, including expression of 
p15, p21 and mediators of the SASP, however varied in that they were not 
associated with a DDR or p16 (Storer et al., 2013). Furthermore, developmental-
associated senescent cells were not associated with IL-6 or IL-8, which have been 
implicated as mediators of senescence reinforcement (Acosta et al., 2008). 
Interestingly, senescent cells in the AER were shown to be cleared by an apoptosis 
and macrophage-mediated phagocytosis, however it remains unknown whether 
these cells underwent apoptosis prior to clearance or if the macrophages induce 
apoptosis (Storer et al., 2013).  
In adults, senescence has also been associated with the natural maturation of 
placental syncytiotrophoblasts (Chuprin et al., 2013) and megakaryocytes 
(Besancenot et al., 2010). Megakaryocyte senescence shares a similar phenotype to 
developmental senescence, in that it is p21-dependent, but devoid of p16 or p53 
upregulation (Besancenot et al., 2010). 
Senescence during development has now been observed across numerous species, 
including quail (Nacher et al., 2006), chicken (Storer et al., 2013), mouse (Muñoz-
Espín et al., 2013a; Storer et al., 2013) and human (Muñoz-Espín et al., 2013a) 
embryos. These observations suggest that developmental senescence could be an 
evolutionary conserved mechanism in embryogenesis across multiple species. 
However, due to a lack of a universal marker for senescence, there is an ongoing 
debate on what actually constitutes senescence, and thus caution has to be taken in 
defining observed phenotypes. Moreover, SA-β-Gal activity has been observed in 
proliferating cells of the visceral endoderm layer of the yolk sack (Huang and Rivera-
Pérez, 2014), thus questioning the specificity of the marker in this context, or 
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highlighting the potential for developmental senescence to be a separate 
phenomenon to, for example OIS thus requiring a distinction in definition.   
  
1.5.3 Wound Healing 
 
Wound healing is a highly co-ordinated process which involves haemostasis, 
inflammation, proliferation and remodelling. Moreover, each of these phases is 
associated with a number of soluble factors, a number of which have been shown to 
associate with the SASP (Tomasek et al., 2002; Midwood et al., 2004). Senescent 
cells have been shown to accumulate at sites of subcutaneous wounding, and it was 
observed that the matricellular protein CCN1, which is highly expressed at sites of 
wound repair, could trigger fibroblast senescence, by inducing a DDR  and activating 
p53 (Jun and Lau, 2010). In addition, CCN1 also activates the ROS generating 
RAC1-NOX1 complex, which induces ROS-dependent p16 activation. Senescent 
cells were shown to be associated with the secretion of anti-fibrotic genes, and a 
knock-in CCN1 mutant showed a lack of senescence accumulation and increased 
fibrosis at sites of wounding. Moreover, fibrosis could be attenuated with topical 
application of CCN1 (Jun and Lau, 2010). To specifically target senescent cells in 
wound healing, the Campisi group developed a p16-3MR transgenic mouse, in which 
the p16INK4a promoter drives the expression of 3MR, a fusion protein consisting of the 
herpes simplex virus-1 thymidine kinase, which induces apoptosis upon ganciclovir 
treatment, conjugated to a red fluorescence protein (RFP) reporter. After wounding 
with a dermal skin punch, an accumulation of RFP positive cells and p16 mRNA, was 
observed, peaking at 6 days and returning to basal levels at 9. In ganciclovir treated 
p16-3MR mice, there was no increase in p16 following wounding, and interestingly, 
the wound took significantly longer to heal (Demaria et al., 2014). These 
observations suggest that senescent cells facilitate the speed of wound healing, 
however are not essential. Several SASP components are shown to be upregulated 
following dermal skin wounding, including CCL5, PAI-1, VEGF and PDGF-A. 
Furthermore, PDGF-A from senescent cells was shown to facilitate wound healing by 
driving myofibroblast differentiation, promoting optimal granulation tissue formation 




1.5.4 Immune Clearance 
 
During embryonic development, senescent cells in the AER and mesonephros 
become surrounded by macrophages at days E13.5-E14.5 (Muñoz-Espín et al., 
2013a; Storer et al., 2013). However, in Cdkn1a-/- mice, this recruitment of 
macrophages to senescent cells does not occur, therefore suggesting a causal role 
for senescent cells driving macrophage recruitment during development (Storer et al., 
2013). 
It is thought that the SASP factors secreted from DNA-damage-induced senescent 
cells can attract phagocytic cells (Xue et al., 2007; Kuilman and Peeper, 2009; 
Campisi, 2013). In the liver, there is evidence for an immune surveillance of 
senescent cells which is mediated by CD4+ T cells (Kang et al., 2011). Moreover, 
transduction of hepatocytes with oncogene Nras (NrasG12V) lead to cellular 
senescence, shown by increased p16, p21 and ERK phosphorylation, in all Nras 
expressing cells, which was associated with immune cell clustering around the 
senescent hepatocytes (Kang et al., 2011). All Nras positive senescent hepatocytes 
were subsequently cleared over the course of 2 months, whereas cell numbers of 
NrasG12V/D38A cells, lacking downstream pathway signalling (Khwaja et al., 1997), 
remained constant. Furthermore, Terminal deoxynucleotidyl transferase dUTP nick 
end labelling (TUNEL) assay revealed that the senescent hepatocytes were not 
being removed by apoptosis (Kang et al., 2011). These data suggest a causal role for 
the immune system in removing senescent cells, further strengthened by the 
observation that among patients with a hepatitis C infection, those with HIV were 
shown to have a greater accumulation of p-16 positive senescent hepatocytes 
compared to immune-competent patients (Kang et al., 2011).  
Despite evidence showing that there is an immune system-mediated clearance of 
senescent cells, an age-dependent increase in senescent cells has been observed in 
numerous tissues across several mammalian species (Dimri et al., 1995; Paradis et 
al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007). 
There is therefore an age-dependent imbalance between the rate of senescence 
generation and clearance of senescent cells. Evidence has emerged which shows 
that the immune system does mount a response to remove cells which have 
undergone damage-induced senescence, however this mechanism is thought to 
decline with age (Xue et al., 2007; Kang et al., 2011; Hoenicke and Zender, 2012). 
38 
 
Furthermore, it has been observed that there is an age-dependent decrease in the 
ability of haematopoetic stem cells (HSCs) to undergo lymphoid differentiation (Wang 
et al., 2011), therefore leading to a decrease T cells, which have been shown to drive 
senescence clearance (Kang et al., 2011). It is therefore tempting to speculate that 
an age-dependent decline in the immune system could allow for senescent cells to 
accumulate as a result of attenuated clearance capabilities, however further is 
required before such hypotheses can be conclusively proven. 
 
1.6 Senescence and Ageing 
 
Contrary to the above described beneficial roles, senescent cells have also been 
implicated in having pathological effects (Baker et al., 2008; Baker et al., 2011). In 
the context of wound healing and embryonic development, the presence of 
senescent cells is only transient (Jun and Lau, 2010; Demaria et al., 2014), however 
persistent senescent cells are thought to accumulate in aged organisms (Dimri et al., 
1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan 
et al., 2007). Moreover, evidence is emerging that chronic persistence of senescent 
cells may contribute to a decline in tissue homeostasis, promote age-related 
diseases, and even contribute to a pro-tumourigenic micro-environment (Alspach et 
al., 2013). 
 
1.6.1 Pro-tumourigenic properties 
 
Senescence has been shown to act as a barrier to uncontrolled proliferation in 
response to various stimuli (Serrano et al., 1997; d'Adda di Fagagna et al., 2003), 
therefore it would seem paradoxical that the same mechanism could act to promote 
tumourigenesis. However, besides cell cycle arrest, one of the fundamental 
senescence traits is the SASP (Coppé et al., 2008), and whilst this may have a 
beneficial role in wound healing (Jun and Lau, 2010; Demaria et al., 2014), where the 
SASP is only acute and transient, it appears that chronic SASP can have detrimental 
effects. Moreover, both senescent mesothelial and fibroblast cells secrete Vascular 
Endothelial Growth Factor (VEGF), which can stimulate endothelial cell migration and 
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invasion (Coppé et al., 2006; Ksiazek et al., 2008). Pre-malignant epithelial cells can 
be stimulated to undergo an epithelial-mesenchymal transition (EMT), leading to an 
invasion of the basement membrane, by prolonged exposure to IL-6 and IL-8, both of 
which are highly upregulated in numerous senescent cell types, (Coppé et al., 2008). 
Invasiveness of tumour cells has been shown to be increased by matrix 
metalloproteinases (MMPs), which are secreted by both senescent keratinocytes and 
fibroblasts (Millis et al., 1992; Kang et al., 2003; Coppé et al., 2010b).   
In vivo, co-injection of keratinocytes with senescent fibroblasts into nude mice, leads 
to a significantly increased rate of tumour formation when compared to co-injection of 
keratinocytes with pre-senescent fibroblasts (Krtolica et al., 2001). In addition, tumour 
formation rate has been shown to be significantly accelerated when senescent cells 
are injected into already malignant cancer cells (Krtolica et al., 2001; Liu and 
Hornsby, 2007; Bhatia et al., 2008; Bartholomew et al., 2009). Evidence therefore 
implicates senescent cells in promoting tumourigenesis in an experimental setting, 
however further research is required to determine if tumourigenesis is promoted by 
naturally occurring senescent cells in vivo. In contrast to the observed pro-
tumourigenic effects, the anti-angiogenic factor maspin has been observed to be 
secreted by senescent keratinocytes (Nickoloff et al., 2004). To add further 
complication, IL-6 and IL-8 have been associated with tumour suppression in human 
colon adenomas, yet implicated in driving tumourigenesis in carcinogen-induced skin 
tumours (Ancrile et al., 2007), therefore implying that there isn’t a universal effect of 
the SASP on the tumourigenic environment, and has varying effects dependent on 
cell and tissue type.  
Interestingly, patients on immunosuppressive therapy, or sufferers from HIV, are 
known to have increased rates of hepatocellular carcinoma, and as discussed 
previously, senescent cells are known to accumulate in the liver of these patients, 
and thus it is interesting to speculate if persistent senescence could be contributing 
to the observed increase in tumourigenesis in this context (Hensel et al., 2011). 
The role of senescent cells in tumourigenesis appears to be multi-faceted, and 
considering cancer is pre-dominantly an age-associated disease, and thus often 
presents past a fertile age, there is little selective pressure to remove deleterious 
effects of senescent cells in aged organisms. This may help to resolve the apparent 
paradox of senescent cells having both anti- and pro-tumourigenic properties, a 
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phenomenon which is consistent with the evolutionary theory of antagonistic 
pleiotropy, which proposes that a biological process may have either detrimental or 
beneficial outcomes depending upon the setting in which the trait is activated 




In addition to tumour promotion, senescent cells have been implicated in driving 
other pathological effects, for example, an accumulation of senescent cells has been 
observed in multiple diseases (Martin and Buckwalter, 2003; Erusalimsky and Kurz, 
2005) (Noureddine et al., 2011).  
Ageing is commonly associated with sarcopenia, and evidence is mounting that a 
decline in proliferative potential of muscle stem cells could be driving this age-
associated loss of muscle mass. Moreover, data shows that activated p38 kinase 
leads to an accumulation p16 and increased SA-β-gal activity in muscle stem cells in 
both mice and humans, and inhibition of p38 can attenuate this increase in 
senescence, resulting in improved muscle regeneration after injury (Bernet et al., 
2014; Cosgrove et al., 2014; Sousa-Victor et al., 2014).  
An upregulation of both p16 and p21, as well as an increase in SA-β-Gal activity has 
been observed in various cell types involved in idiopathic pulmonary fibrosis (IPF) 
(Aoshiba et al., 2003; Aoshiba et al., 2013; Hecker et al., 2014). Treatment of mice 
with the DNA-damaging agent bleomycin induces many features of IPF, however, 
this effect can be attenuated when mice are treated with a chemical inhibitor for 
NOX4, a NAPDH-dependent oxidase which generates excessive ROS, as well as 
with the anti-inflammatory rupatadine (Lv et al., 2013; Hecker et al., 2014). 
Furthermore, elevated ROS and inflammation are associated with cellular 
senescence, and inhibition of these attenuates the bleomycin-induced increase in 
p16, p21 as well as subsequent fibrotic damage, thus implying that senescence could 
be involved in driving the pathological IPF (Lv et al., 2013; Hecker et al., 2014). 
If lipid accumulation exceeds a certain threshold in adipocyte tissue, an inflammatory 
response, involving the recruitment of macrophages, occurs which is associated with 
various pathologies such as insulin resistance and liver steatosis (Gregor and 
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Hotamisligil, 2011). It has been observed in adipose tissue of both mice and humans, 
that obesity and the subsequent immune response is associated with an upregulation 
of both p21 and p53, as well as in increase in SA-β-gal activity and SASP activation 
(Minamino et al., 2009; Tchkonia et al., 2010; Markowski et al., 2013). Interestingly, 
adipose-specific deletion of p53 in mice protects against high fat diet-induced insulin 
resistance, reduces the expression of pro-inflammatory cytokines, and ameliorates 
senescent-like changes (Minamino et al., 2009). To compensate for obesity-induced 
insulin resistance, pancreatic β-cells undergo increased proliferation to produce 
excess insulin, however this proliferative response to chronic insulin tolerance cannot 
be sustained, eventually leading to an exhaustion of proliferation, and a decline in β-
cell mass (Sharpless and DePinho, 2007; Donath et al., 2013). Moreover, mice on a 
high fat diet show increased β-cell proliferation compared to control diet mice at 4 
months, however at 12 months, the proliferation rates are actually lower in the mice 
on a high fat diet, which is associated with an increase in SA-β-Gal activity in the β-
cell islets (Sone and Kagawa, 2005).   
Multiple models of how senescent cells might cause age-related tissue decline have 
been proposed (Figure 1-4). In the absence of a compensatory mechanism, if a stem 
cell, or even a non-terminally differentiated cell, were to undergo senescence, this 
would prevent daughter cells being produced and thus hinder the generation of 
proper tissue formation and regeneration leading to a decline in tissue homeostasis 
(Figure 1-4). Cell cycle arrest is a cell-autonomous consequence of senescence, 
however compelling evidence is arising that senescent cells can also elicit a non-cell 
autonomous, or paracrine effect, on neighbouring cells. Interestingly, senescent 
fibroblasts, when cultured next to young fibroblasts, elicit a ‘bystander effect’ which 
causes an increase in DNA damage, and drives cellular senescence in young cells 
(Nelson et al., 2012). It is thought that this effect is driven by ROS mediated by gap 
junction cell to cell contact (Nelson et al., 2012). Other groups have also observed a 
bystander effect, thought to be driven by SASP factors. Moreover, conditioned 
medium taken from either, drug-induced, OIS, or replicative senescence cells was 
able to drive a ROS-generated DDR in bystander cells (Hubackova et al., 2012a). 
Both SASP factors IL-1 and TGFβ were upregulated in senescent cells, and inhibition 
of either the IL1/NFκB or TGFβ/SMAD pathway resulted in an attenuation of both a 




If the senescent cell bystander effect occurs in vivo, this could potentially drive a 
chain-reaction of senescence-induced-senescence in neighbouring cells, thus 
accelerating the rate of senescent cell generation (Figure 1-4). If immune clearance 
was not able to keep up with increased rate, this could complement observations that 
senescent cells accumulate with age (Dimri et al., 1995; Paradis et al., 2001; Melk et 
al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007). These hypotheses 
are however speculative, and although clustering of 4-HNE positive cells has been 
observed in the hepatocytes, further research is required to elucidate if the bystander 
effect occurs in vivo (Nelson et al., 2012).  
Senescent cells have also been implicated in causing a decline in tissue architecture 
through both extracellular matrix degradation and tissue fibrosis (Figure 1-4). 
Furthermore, the SASP includes several proteases, which have the potential to 
cleave ECM proteins, signalling ligands and membrane-bound receptors, thus 
leading to an aberrant microenvironment (Parrinello et al., 2005; Jean-Philippe et al., 
2008). Senescent cells have also been implicated in driving an EMT in epithelial 
cells, thought to act through secretion of IL-6 and IL-8 SASP factors, which may lead 
to increased tissue fibrosis (Laberge et al., 2012). 
Pathological ageing is associated with chronic inflammation, a process which is 
categorised by lymphocyte and macrophage infiltration, fibrosis and cell death; which 
is thought to drive a number of age-related diseases, such as osteoarthritis, 
atherosclerosis and cancer (Freund et al., 2010). Senescent cells have been shown 
to be present at sites of inflammation in numerous age-related pathologies, which 
has led to speculation that the perhaps the SASP is responsible for inducing chronic 
inflammation via persistent secretion of chemokines, cytokines and pro-inflammatory 
growth factors, known to attract immune cells, such as monocyte chemo-attractant 
proteins (MCPs), macrophage inflammatory proteins (MIPs), as well as IL-1, IL-6, IL-
8 and GROα (Coppé et al., 2008). However, further research is required to ascertain 
whether senescent cells are causative in inducing age-associated chronic 
inflammation.  
Due to the difficulty of creating mouse models devoid of cellular senescence, it is 
hard to distinguish correlation from causality when trying to elucidate the role of 
senescence in disease. Moreover, p16Ink4a and p53 are key effectors in the induction 
of senescence in response to various stresses, however disruption of these genes in 
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mice results in premature death from cancer (Sherr, 2000). Furthermore, p53 is also 
a key mediator of apoptosis, making it challenging to discern the effects of 
senescence specifically (Coppé et al., 2010a; Campisi, 2011; Rodier and Campisi, 
2011). To address this issue, the van Deursen group generated a transgenic mouse 
with a novel transgene, coined INK-ATTACK, in which p16Ink4a expressing cells could 
be eliminated via apoptosis upon drug treatment (Baker et al., 2011). The transgene 
was expressed in the BubR1H/H progeroid mouse background, and it was observed 
that both late-life and life-long clearance of p16Ink4a expressing cells could delay 
several age-related pathologies (Baker et al., 2011). These data provide a causal 
role for senescence promoting age-related diseases, at least in the BubR1 model. 
BubR1H/H mice, develop aneuploidy as a result of levels of the mitotic checkpoint 
protein BubR1, are associated with early onset of several age-related diseases and 
have a short life span (Baker et al., 2004; Hartman et al., 2007; Matsumoto et al., 
2007); it will therefore be important to study the effect of senescent cell clearance in 
the development of age-related pathologies in wild-type mice, to ensure that the 





Figure 1-4. Mechanisms of Tissue and Organ Deterioration by Cellular 
Senescence (van Deursen, 2014). Senescent cells have been implicated in leading 
to impaired tissue homeostasis and regeneration, causing paracrine senescence 
through the secretion of TGFβ and IL-1β, and recruiting immune cells, therefore 
leading to inflammation. Aberrant tissue architecture can develop through senescent 
cells causing ECM degradation. Post-mitotic neurones have also been observed the 
display a senescent-like phenotype.  
 
1.7 Post-Mitotic Senescence 
 
A senescent phenotype has now been observed in scenarios in which the required 
function of senescence is not cell cycle arrest, for example in wound healing and 
embryonic development (Jun and Lau, 2010; Muñoz-Espín et al., 2013a; Storer et al., 
2013; Demaria et al., 2014). It is therefore interesting to consider if post-mitotic cells 
can also develop a senescent-like phenotype, and what the physiological relevance 
of this would be. Interestingly, both adipocytes and neurones have been shown to 
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elicit a senescent-like phenotype in vivo (Minamino et al., 2009; Jurk et al., 2012). An 
age-dependent increase in various senescent markers has been observed in both 
murine purkinje cells and cortical neurones, including γH2AX, activated p38 MAPK, 
4-HNE, IL-6, macro-H2A, auto-fluorescence and SA-β-Gal, with individual cells 
displaying multiple markers (Jurk et al., 2012). Mitotic cells have been shown to 
senescence in response to a sustained DDR (d'Adda di Fagagna et al., 2003; 
Fumagalli et al., 2012; Hewitt et al., 2012), and purkinje cells and cortical neurones 
also showed increased IL-6 production, 4-HNE, and activated p38MAPK, in 
G4TERC-/- mice, which have severe telomere dysfunction, and hence a persistent 
DDR (Karl Lenhard et al., 1999). Interestingly, in G4TERC-/-CDKN1A-/- mice, these 
senescent markers were completely rescued in both purkinje cells and cortical 
neurones, suggesting that the development of a senescent phenotype in these cells 
is dependent upon p21 (Jurk et al., 2012). Adipocytes from both mice fed on a high 
calorie diet and G4TERC-/- mice, have also been shown to have an increased 
production of pro-inflammatory cytokines, including tumour necrosis factor-α (TNF-α) 
and chemokine (C-C motif) ligand-2 (CCL2), as well as increased p53 expression, 
and increased SA-β-Gal activity (Minamino et al., 2009). These markers of 
senescence were shown to be rescued in Trp53+/- mice, therefore showing that the 
activated p53-p21 pathway can induce a senescence-like phenotype in both murine 
neurones and adipocytes (Minamino et al., 2009; Jurk et al., 2012). An upregulation 
of inflammatory cytokines, an increase in SA-β-gal activity and increased p53 was 
also observed in adipocytes from human patients, providing evidence that post-
mitotic senescence is not only a phenomenon unique to murine cells (Minamino et 
al., 2009).  
Hitherto, a substantial categorisation of post-mitotic senescence in vivo has not 
extended beyond adipocytes and neurones (Minamino et al., 2009; Jurk et al., 2012).  
Senescence has been observed in cardiomyocytes in vitro, for example H9C2 rat 
cardiomyocytes, which still retain proliferative potential, have been shown to cease 
proliferation and have increased SA-β-Gal activity, or undergo apoptosis, when 
exposed to low or high doses of oxidative or genotoxic stress respectively 
(Spallarossa et al., 2009; Dong et al., 2013). Induced telomere dysfunction, via 
siRNA-mediated downregulation of TRF2, has also been shown to trigger either 
senescence or apoptosis in a dose-dependent manner in H9C2 cardiomyocytes 
(Spallarossa et al., 2009). It will be important to investigate if cardiomyocyte 
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senescence also occurs in vivo, and what the physiological relevance of this maybe. 
Moreover, the significance of permanent cell cycle exit of a non-dividing cell type 
would seem to be inconsequential with regard to tissue homeostasis, however, 
evidence is emerging that cardiomyocytes are not entirely post-mitotic. Moreover, 
during development, cardiomyocytes proliferate rapidly, then after birth, heart 
enlargement relies mainly on cell growth, and it was previously thought that all the 
cardiomyocytes a human would ever have are present at birth (Li et al., 1997). 
However, nuclear bomb testing during the Cold War generated an abundance of 
carbon-14, which was subsequently incorporated into living organisms, and patient 
analysis of carbon-14 in DNA from cardiomyocytes, revealed cardiomyocyte DNA 
containing carbon-14, suggesting that new cardiomyocytes had been generated 
(Bergmann et al., 2009). Subsequent research has confirmed these findings, and 
identified that cardiomyocytes themselves are capable of replication, as opposed to a 
stem cell population (Malliaras et al., 2013; Senyo et al., 2013). Despite this evidence 
for cardiomyocyte proliferation, the role of cell cycle arrest is still questionable, as 
adult human cardiomyocyte division is still a relative rare event, with turnover rates 
around 1% per year in 25 year olds, which gradually decreases to around 0.45% per 
year in 75 year olds (Bergmann et al., 2009). Furthermore, evidence suggests that a 
50 year old human is likely to have around 60% of the same cardiomyocytes present 
at birth (Bergmann et al., 2009). However, cardiomyocyte replication is significantly 
increased at sites adjacent to myocardial stress (Malliaras et al., 2013; Senyo et al., 
2013), and thus one could hypothesise that cardiomyocyte senescence could alter 
regenerative ability following myocardial injury. Among patients who have undergone 
radiotherapy treatment for breast cancer, those which were treated for left breast 
cancer have an increased incidence of cardiac disease compared to those treated for 
right breast cancer (Darby et al., 2003; Taylor et al., 2008; Taylor et al., 2009). 
Moreover, the mechanism for this is not understood, however, X-irradiation is known 
to cause senescence in numerous cell types, and it will therefore be important to 
investigate if senescence is occurring and contributing to disease progression. 
As previously described, cell cycle arrest is not the only phenotype of senescence, 
and it will be will be important to understand the physiological relevance of 
senescence even in post-mitotic / non-rapidly dividing cells, such as neurones, 
adipocytes and cardiomyocytes, to determine if they are associated with a SASP, 
and if this is detrimental to surrounding cells. Another important factor will be to 
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understand what drives cellular senescence in cell types which are not affected by 
significant proliferation-associated telomere shortening and thus should not undergo 
canonical replicative senescence. Hitherto, little research has focused on telomere 
damage in post-mitotic cells, perhaps due to the perceived lack of telomere 






Telomere dysfunction is a major hallmark of cellular senescence, and DDR foci at 
telomeres have been observed to occur independently of telomere length in murine 
enterocytes and hepatocytes in vivo (Hewitt et al., 2012). A senescent-like phenotype 
has also been observed to occur in post-mitotic adipocytes and neurones in vivo 
(Minamino et al., 2009; Jurk et al., 2012). We aimed to ascertain if telomere 
dysfunction occurred in cardiomyocytes, and if this was associated with cellular 
senescence. The main aims were: 
 Can cardiomyocytes elicit persistent telomere dysfunction in vitro, and if so, 
can this drive cellular senescence? 
 Is there an age-associated increase in telomere dysfunction in cardiomyocytes 
in vivo which is associated with a senescent-like phenotype? 





2 Chapter 2 - Materials and Methods 
 
2.1 Chemicals and Reagents 
 
Unless stated otherwise, all chemicals were obtained from Sigma-Aldrich Company 
Ltd (Poole, Dorset, UK). 
 
2.2 Buffers and Solutions 
 
All solutions dissolved in deionised water unless otherwise stated. 
 
Solution Components 
PGB-Triton 0.5% Bovine Serum Albumin, 0.25% Gelatin from cold 
water fish skin (SIGMA, G7765) and 0.5% Triton™ X-100 
in PBS. 
TBS-Triton 10mM Tris, 150mM NaCl and 0.25% Triton™ X-100. 
Adjusted to pH7.0 with HCl. 
Cardiomyocyte 
Buffered Salt Buffer 
116mM NaCl, 20mM HEPES, 1mM NaH2PO4, 5.365mM 
KCl and 831nM MgSO4.   
Cardiomyocyte 
Enzyme Solution 
5mM Glucose, 80U mL-1 Collagenase Type 2 
(Worthington, LS004174), 0.25mg mL-1 in CBSB. 
Fibroblast Lysis 
Buffer 
12.5mM Tris pH7.4, 5mM KCl, 0.1mM Spermine, 0.25mM 




10mM Tris pH7.4, 10mM EDTA, 0.05% SDS and 1M 
NaCl. 
Nuclei Wash Buffer 10mM Tris pH7.4, 15mM NaCl, 60mM KCl, 5mM EDTA 
and 300mM Sucrose. 
2 X SSC 300mM NaCl and 30mM sodium citrate. Adjusted to 
pH7.0 with HCl. 
PNA Wash A 10mM Tris pH7.5 and 70% formamide. 
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PNA Wash B 50mM Tris pH7.5, 150mM NaCl and 0.08% Tween-20. 




70% deionised formamide, 25mM MgCl2, 10mM 
TrispH7.2, 5% blocking reagent (Roche, Welwyn), 4ng 
µL-1 TelC-Cy3/Cy5 PNA probe (C3TA2)3 (Panagene, 
F1002-5/F1003-5) in dH2O. 
Haematoxylin 5g Haematoxylin, 50g Aluminium potassium sulphate, 
0.5g Sodium iodate, 300mL Glycerin, 40mL glacial acetic 
acid, in 700mL dH2O.  
RIPA 150mM NaCl, 1% Triton™ X-100, 0.5% sodium 
deoxycholate, 0.1% SDS and 50mM Tris pH8.0.   
STORM Imaging 
Buffer 
50mM Tris-HCl pH8.0, 10mM NaCl, 100mM MEA,  5 unit 
ml-1 glucose oxidase and 50 unit mL-1 catalase.  
Krebs solution 130mM NaCl, 5.4mM KCl, 1.4mM MgCl2, 0.4mM 
NaH2PO4, 4.2mM HEPES, 10mM glucose, 20mM taurine, 
10mM creatine monohydrate. 
Table 1. Buffers and Solutions  
 
2.3 Cell Culture 
 
2.3.1 Cell lines 
 
Human Cell Lines 
Human embryonic lung MRC5 fibroblasts (ECACC, Salisbury, UK) were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 10% heat 
inactivated foetal bovine serum (FBS) (Biosera, Ringmer, UK), 100µg ml-1 
streptomycin, 100 units ml-1 penicillin and 2mM l-glutamine, incubated in a humidified 
atmosphere at 37°C with 95% air and 5% CO2. 
Mouse Cell Lines 
Mouse Embryonic Fibroblasts (MEFs), isolated from C57BL/6 mice, were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 10% heat 
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inactivated foetal bovine serum (FBS) (Biosera, Ringmer, UK), 100µg ml-1 
streptomycin, 100 units ml-1 penicillin and 2mM l-glutamine, incubated in a humidified 
atmosphere at 37°C with 3% O2 and 5% CO2. 
H9C2 rat cardiac-derived myoblasts were a kind gift from Jeanne Mialet-Perez and 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 
10% heat inactivated foetal bovine serum (FBS) (Biosera, Ringmer, UK), 100µg ml-1 
streptomycin, 100 units ml-1 penicillin and 2mM l-glutamine, incubated in a humidified 
atmosphere at 37°C with 95% air and 5% CO2. 
 
2.3.2 Primary Embryonic Mouse Cardiomyocytes  
 
17.5 day old mouse embryos were dissected from pregnant C57/BL6 mice, and all 
embryos were subsequently used without consideration for gender. Under a 
dissecting microscope, the middle of each embryo’s sternum was cut with scissors to 
open the ribcage, and then the hearts were removed with scissors, and placed into 
ice-cold Cardiomyocyte Balanced Salt Buffer (CBSB) (Table 1) in a 15mL centrifuge 
tube. After all hearts were removed, they were transferred onto a 250µL droplet of 
CBSB on a petri dish in class 2 laminar flow cabinet, and were cut into multiple 
fragments each. Heart fragments were then transferred to Cardiomyocyte Enzyme 
Solution (CES) (Table 1), without trypsin, (1mL per embryo) and incubated at 37°C 
for 5 minutes. During incubation, trypsin was added to the remaining CES, to a final 
concentration of 0.25mg mL-1. After incubation*, the tissue fragments were allowed to 
settle, and then the supernatant was transferred to a 15mL centrifuge tube and 
centrifuged at 700g for 5 minutes. The remaining tissue fragments were re-
suspended in CES, with trypsin, (1mL per embryo), and incubated at 37°C for 30 
minutes, whilst gently shaking the tube each 5-10 minutes. The supernatant from the 
centrifuged tube was then aspirated, and the pellet was re-suspended in 1mL of FBS 
and stored at 4°C. After the 30 minute incubation period, the steps from the asterisk 
were repeated 5-6 times, or until the tissue fragments were totally disintegrated. The 
enzyme solution from each step was added to the same 15mL centrifuge tube, with 
fresh FBS added after each centrifugation, with the collection tube stored at 4°C 
throughout. After the final centrifugation, cells were re-suspended in 5mL 
Cardiomyocyte Growth Medium and transferred to a collagen-coated T25 flask and 
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incubated in a humidified atmosphere at 37°C with 95% air and 5% CO2 for 2 hours. 
After incubation, the growth medium was collected from the pre-plating flask and 
transferred to a 15mL centrifuge tube, and topped up with Cardiomyocyte Growth 
Medium, to a total volume of 10mL. Cells were re-suspended and a sample taken for 
counting on a haemocytometer. The cell suspension was then centrifuged at 700g for 
5 minutes at room temperature, the supernatant was aspirated, and then cells were 
re-suspended in Cardiomyocyte Growth Medium to desired concentration, and 
seeded onto collagen-coated culture vessels. Cells were then incubated in a 
humidified atmosphere at 37°C with 95% air and 5% CO2 for 2-3 days to allow 
cardiomyocytes to settle. Growth medium was then aspirated, and cells were washed 
2-3 times with PBS at 37°C before fresh Cardiomyocyte Growth Medium was added.  
 
Mouse Embryonic Cardiomyocytes were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM), supplemented with 17% Medium 199, 5% heat inactivated foetal 
bovine serum (FBS) (Biosera, Ringmer, UK), 10% Horse serum (SIGMA, H0146), 
100µg ml-1 streptomycin, 100 units ml-1 penicillin and 2mM l-glutamine, incubated in a 
humidified atmosphere at 37°C with 95% air and 5% CO2. 
 
2.3.3 Primary Adult Mouse Cardiomyocytes  
 
Male mice of either 3 or 20 months of age were anaesthetised with 150µL 
pentobarbital and treated with 500 units of heparine. The hearts were then removed 
and assembled with a canula through the aorta for the Langendorff heart assay. The 
hearts were then washed with Krebs solution (Table 1) for 5 minutes, and then 
incubated in digestion solution for 8 minutes. The hearts were then minced into small 
pieces with a pair of surgical scissors, and the fragments were filtered through a 
200µM filter. Liberase activity was then inhibited by adding Krebs solution plus 
12.5µM calcium chloride to the suspension. The cell suspension was then incubated 
for 10 minutes to allow separation of cell types. The supernatant was then discarded, 
and calcium reintroduction was performed by incubating the cells in increasing 
concentrations of calcium chloride (12.5µM, 62µM, 112µM, 212µM, 500µM, 1mM) in 
Krebs solution, and with each increment, the cells were mixed thoroughly and 
incubated at room temperature for 4 minutes. After cell sedimentation, the 
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supernatant was then aspirated. Cardiomyocytes were then seeded onto a laminin-
coated substratum and cultured in M199 culture medium, supplemented with 5% 
heat inactivated foetal bovine serum (FBS) (Biosera, Ringmer, UK), 100µg ml-1 
streptomycin, 100 units ml-1 penicillin, 2µM L-carthinine, 5µM creatine and 5µM 
taurine, incubated in a humidified atmosphere at 37°C with 95% air and 5% CO2. 
Growth medium was then aspirated and replenished after the first 2 hours, and every 
24 hours thereafter. 
 
2.3.4 Cryogenic Storage 
 
Growth medium was aspirated from exponentially growing adherent cells, followed by 
washing with 37°C PBS and then incubated with 37°C trypsin for 3 minutes. The 
trypsin activity was neutralised with the addition of full growth medium to the 
suspension and then cell numbers were counted. The desired number of cells were 
then centrifuged at 150g for 5 minutes. Supernatant was then aspirated, and cells 
were re-suspended in 10% DMSO in foetal calf serum at a concentration of 1 X 106 
cells ml-1. Aliquots of 1mL were then pipetted into cryovials and each transferred to a 
Nalgene™ Cryo freezing container filled with isopropanol. To ensure a slow and 
consistent freezing process, the freezing container was placed at -80°C for 24 hours 
before cryovials were removed and frozen in liquid nitrogen for long-term storage.  
 
2.3.5 Resuscitation of Frozen Cells 
 
Cryovials were removed from liquid nitrogen, and then immediately incubated at 
37°C for 2 minutes. The cells were then transferred to a 75cm2 culture flask 
containing 20mL of 37°C growth medium. After 24 hours, growth medium was 
replenished to remove DMSO and cell debris. 
 
2.3.6 Calculating Cell Density and Population Doublings 
 
To calculate the number of cells within a suspension, 20µL of suspended cell solution 
was transferred to a Fuchs Rosenthal haemocytometer (VWR, International UK). 
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Using an optical microscope (DMIL, Leica Microsystems, UK), the number of cells 
within 8 adjacent squares was then determined, and repeated at 3 random locations 
on the haemocytometer. For each square, only cells within the boundaries, and those 
touching the left or top boundary were counted. The mean number of cells, for every 
8 random squares, was then calculated and multiplied by 1 X 104, to give the density 
of cells per millilitre.  
To calculate the total number of cells in a given suspension, the density of cells (cells 
ml-1) was multiplied by the total volume of suspension (mL). 
To calculate the Population Doubling (PD), both the number of cells seeded, and the 
number of cells harvested is required. The following formula is then applied: PD = X 
+ (ln(N1 / N2))/ln2 
PD = Population Doubling 
X = Previous PD 
N1 = Number of cells seeded 
N2 = Number of cells harvested 
 
2.4 Live Cell Imaging 
 
For live-cell time-lapse microscopy, cells were plated on glass coverslip bottomed 
dishes (Mattek), and incubated for 24 hours to adhere to the glass substratum. 
Images were taken every 10 minutes for the duration of each time-course. Using a 
63X objective (NA=1.4). Z-stacks over 7µm were obtained, using a Zeiss Spinning 
Disk confocal microscope. Cells were incubated at 37°C in a humidified environment 
with air plus 5% CO2.  
 
2.4.1 Foci Dynamic Quantification 
 
DNA damage foci (DDF) from live-cell time-lapse microscopy were tracked using the 




2.5 T-Loop Detection via STORM 
 
The below protocol is optimised for >1X107 MEFs grown on a 175 cm2 culture flask. 
 
2.5.1 Nuclei Isolation 
 
MEFs were washed twice in PBS at 37°C and then incubated in trypsin at 37°C for 3 
minutes. The trypsin was neutralised in MEF growth medium, cell number was 
determined using a haemocytometer, and then cells were centrifuged at 700g for 5 
minutes. The supernatant was aspirated and cells were washed once in PBS at 4°C. 
Cells were then re-suspended in 4°C Fibroblast Lysis Buffer (Table 1) at a 
concentration of 8 X 106 mL-1 and incubated on ice for 10 minutes. 10% NP-40 was 
added to the cell suspension to a final concentration of 0.2% and gently vortexed. 
The tube was then inverted 3 times and incubated for a further 5 minutes on ice. The 
cell suspension was then centrifuged at 1,000g for 5 minutes at 4°C, the cytoplasmic 
fraction-containing supernatant was discarded, and the remaining nuclei pellet was 
washed once with 4°C Nucleic Wash Buffer (Table 1). 
 
2.5.2 DNA Crosslinking 
 
Nuclei were then re-suspended in 100µg mL-1 trioxsalen in nucleic wash buffer, and 
incubated in a 3cm diameter petri dish placed on ice, in the dark, stirring on an orbital 
shaker at 60RPM, for 5 minutes. The petri dish containing nuclei suspension was 
then exposed to 365nm UV light at 3cm from the light source for 30 minutes whilst 
still placed on ice, and stirring on an orbital shaker at 60RPM. During cross-linking, 
microscope slides, with a glass coverslip fixed on top, were assembled into the 
cytospin apparatus (a glass microscope slide is too thick for STORM imaging, and 
thus cells are centrifuged onto a glass coverslip). After cross-linking, the nuclei 
suspension was pipetted numerous times to remove clumping. The nuclei 
suspension was then centrifuged at 1,000g for 5 minutes at 4°C. The supernatant 
was then aspirated and pellet was washed with 4°C nucleic wash buffer. Nuclei were 
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then counted using a haemocytometer and re-suspended in nucleic wash buffer to a 
final concentration of 10 X 106 mL-1.  
 
2.5.3 Chromatin Spread 
 
Nuclei were diluted 1:10 in 37°C spreading buffer (Table 1), and 100µL of suspension 
was added to each cyto-centrifuge tube and centrifuged at 600RPM for 1 minute. The 
glass coverslip was separated from the microscope slide and were then incubated in 
methanol at -20°C for 10 minutes, followed by incubation in acetone at -20°C for 1 
minute. Coverslips were then washed in PBS and dehydrated through a graded 
ethanol series (70, 95 and 100%), for 3 minutes each. At this point, chromatin 




Chromatin spreads were rehydrated in PBS for 15 minutes. After rehydration, 
chromatin spreads were dehydrated through a graded ethanol series (70, 95 and 
100%), for 3 minutes each. 10µL FISH hybridisation mix (Table 1) with TelC-Cy5 
PNA prove was added to a glass microscope slide and then the glass coverslip-
bound chromatin spreads were placed on top and incubated at 80°C for 10 minutes. 
After incubation, the chromatin spreads were incubated in a humidified chamber at 
room temperature overnight. The chromatin spreads were then washed in PNA wash 
A (Table 1) (2 X 15 minutes), followed by washes in PNA wash B (Table 1) (3 X 5 
minutes). Chromatin spreads were then rinsed several times in dH2O, dehydrated 
through a graded ethanol series (70, 95 and 100%), for 3 minutes each and left to air 
dry in the dark. 
 
2.5.5 STORM Imaging 
 
Using conventional silicone grease, a hollow Perspex cylinder of 0.5cm in both height 
and diameter was adhered to the glass coverslip so that the perimeter of the cylinder 
was surrounding the chromatin spread. STORM Imaging buffer (Table 1) was then 
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pipetted onto the chromatin spreads, until the level reached the brim of the cylinder, 
and a glass coverslip was placed on top to create an airtight environment.  
Imaging was performed on a Nikon N-STORM imaging system comprising of a 
NikonTi, Andor iXon 887 camera and Nikon Elements acquisition software. dSTORM 
images were captured at a rate of 50 frames per second with a 647nm laser with an 
excitation intensity of 200mW  
 
2.6 Plasmid Expansion and Purification 
 
Plasmid Elution 
Plasmids were received precipitated on filter paper. To elute the plasmid DNA, a 
small section of filter paper was cut out using sterile scissors and then placed into a 
1.5mL micro-centrifuge tube with 20µL of nuclease-free H2O. A sterile pipette tip was 
used to mix the filter paper with the H2O, and then left to rest at room temperature for 
2 minutes.  
High Efficiency Transformation Protocol 
10µL of NEB Stable Competent E.coli cells (from stock) were thawed on ice in a 
1.5mL microcentrifuge tube for 10 minutes. 1-2µL of eluted plasmid DNA (containing 
100pg – 100ng of plasmid DNA) was added to NEB Stable Competent E.coli cells, 
and then gently flicked 5 times to mix cells and DNA (note: do not vortex). The 
mixture was then placed on ice for 30 minutes. After this, the cells were heat shocked 
at 42°C for 30 seconds, followed by being placed on ice for 5 minutes. 500µL of room 
temperature SOC medium was added to the mixture, and then incubated on an 
orbital shaker at 250RPM at 30°C for 60 minutes. Agar selection plates, with the 
necessary antibiotic drug, were warmed at 30°C. After incubation, the cells were 
mixed thoroughly, by flicking and inverting the tube. 50-100µL of cell suspension was 
then streaked onto an agar selection plate, followed by incubation at 30°C for 24 
hours. 
(Alternatively, for previously transformed NEB Stable Competent E.coli cells stored in 
glycerol at -80°C: a sterile pipette was used to transfer cell stocks to 50-100µL of 
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SOC medium. Cell suspension was then was then streaked onto an agar selection 
plate, and incubated at 30°C for 24 hours). 
Plasmid Expansion 
Using a sterile pipette tip, a single NEB Stable Competent E.coli colony was picked 
and placed in 5mL of LB and then incubated shaking horizontally at 30°C for 6 hours. 
The suspension was then transferred to a vented conical flask containing 100mL LB 
plus antibiotic (50ng mL-1 Ampicillin) and incubated on an orbital shaker at 180RPM 
at 30°C for 24 hours. 
Bacterial Glycerol Stock 
2mL of bacterial cell suspension, from previous ‘Plasmid Expansion’ step, was 
transferred to a 15mL centrifuge tube and then centrifuge at 5000g for 10 minutes at 
room temperature. The supernatant was aspirated and the cell pellet was re-
suspended in 1mL of 30% glycerol: 70% LB (v/v) in a cryovial and placed at -80°C for 
long-term storage. 
Plasmid Isolation 
Plasmids were purified from NEB Stable Competent E.coli cells, following plasmid 
expansion, using the PureYield™ Plasmid Midiprep System (Promega). Briefly, 
100mL of LB and NEB Stable Competent E.coli suspension was transferred into two 
50mL centrifuge tubes and centrifuged at 5000g for 10 minutes at room temperature 
(all steps carried out at room temperature). The two pellets were re-suspended in 
3mL of Cell Suspension Solution and pooled together. 3mL of Cell Lysis Solution was 
added, and the mixture was inverted 5 times and incubated for 3 minutes. 5mL of 
neutralisation was added to the mixture and inverted 10 times. The lysate was then 
centrifuged at 15,000g for 15 minutes. A column stack consisting of a blue 
PureYield™ Clearing Column placed on top of a white PureYield™ binding column 
was assembled onto a vacuum pump. The liquid was poured transferred into the 
column stack and a vacuum applied, until all of the liquid had passed through. 5mL of 
Endotoxin Removal Wash was added to the binding column, and a vacuum applied 
until all the solution had been pulled through. 20mL of Column Wash Solution was 
added to the binding column, and a vacuum applied until all the solution had been 
pulled through. A vacuum was applied for 60 seconds to try the binding column, 
followed by removal and placement onto a paper towel to remove excess ethanol. 
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To elute the DNA, the binding column was first placed into a new 50mL centrifuge 
tube. 600µL of nuclease-free water was added to the binding column, and incubated 
for 1 minute. The binding column was then centrifuged at 2,000g for 5 minutes in a 
swinging bucket rotor centrifuge, followed by collection of the filtrate into a new 
1.5mL microcentrifuge tube. 
Assessment of Nucleic Acid Purity and Quantification 
Using the NanoDrop 2000 software, the DNA - Nucleic Acid option was selected. 1µL 
of nuclease-free water was added to the spectrophotometer (Nanodrop 2000, 
Thermo Scientific), and the ‘blank’ option selected to assess background 
fluorescence. 1µL of plasmid DNA solution was added to the spectrophotometer and 
quantified. A 260/280 ratio of near 1.8 was considered to have a satisfactory level of 
DNA purity. 
Isolated Plasmid Storage 
Isolated plasmid solutions were aliquoted into 1.5mL microcentrifuge tubes and 




All reagent amounts for transfection are stipulated in Table 2. H9C2 cells were 
seeded onto glass coverslips 24 hours prior to transfection.  
Equal volumes of Opti-MEM® were added to two 1.5mL microcentrifuge tubes. 
Purified plasmid DNA was then added to one of the microcentrifuge tubes, gently 
vortexed and left to stand at room temperature for 5 minutes. Lipofectamine® 2000 
was then added to the other microcentrifuge tube and gently vortexed. The contents 
of both microcentrifuge tubes were added together, gently vortexed, and left to stand 
at room temperature for 20 minutes. The mixture was then added dropwise to the 
growth medium, whilst gently moving the culture plate in a figure-of-8 motion. Cells 
were then incubated for 24 hours before replenishing the growth medium. 
Vessel Optimem (µL) DNA (µg) Lipofectamine (µL) 
24-well 12.5 0.25 0.75 
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12-well 25 0.5 1.5 
6-well 50 1 3 
Table 2. Transfection Reagents. 
 
2.8 Conditioned Medium 
 
5 X 10^4 adult cardiomyocytes were seeded onto laminin-coated 6 well plates and 
incubated in 2mL of M199 culture medium, supplemented with 5% heat inactivated 
foetal bovine serum (FBS) (Biosera, Ringmer, UK), 100µg ml-1 streptomycin, 100 
units ml-1 penicillin, 2µM L-carthinine, 5µM creatine and 5µM taurine. After two hours, 
the growth medium was aspirated, the cells were washed with 1 X PBS, and cells 
were cultured in the above culture medium minus the foetal bovine serum. After 48 
hours, the conditioned growth medium was collected, and passed through a sterile 
syringe filter with a 0.22µm pore size. The conditioned medium from isolated mouse 
cardiomyocytes was mixed with normal MAF medium at a ratio of 1:1. MAFs were 
then incubated in this conditioned medium, which was replenished every 48 hours, 
for experimentally defined amounts of time.  
 
2.9 EdU Incorporation 
 
For EdU incorporation assays, 50% of growth medium was aspirated from cell 
cultures, and an equal volume replaced with fresh growth medium containing 20µM 
EdU, to ensure a final 10µM EdU concentration. Cells were then cultured in the 
presence of EdU for desired experimental time period, followed by PBS washes (2 X 
5 minutes) at 37°C, then fixation with 2% PFA for 10 minutes (at this point, cells can 
be stored in PBS at 4°C for several months). Cells were then washed twice 3% BSA 
in PBS (2 X 5 minutes) whilst gently stirring on an orbital shaker at 60RPM. The wash 
solution was removed, and cells were permeabilised with 0.5% Triton® X-100 for 20 
minutes at room temperature, gently stirring on an orbital shaker. 
The subsequent EdU detection steps were carried out according to manufacturer’s 




2.10 Genotoxic Stress 
 
2.10.1 X-Ray Irradiation 
MRC5 fibroblasts were seeded onto 6/12/24 well plates (Corning) and incubated to 
grow overnight. Cells were then exposed to varying levels of irradiation ranging from 
1-50Gy using an X-Ray Irradiator (X-Rad 225, Precision X-Ray INC, N-BRANFORD, 
CT USA). Growth medium was replenished immediately after irradiation. 
2.10.2 Chemical-induced  
 Neocarzinostatin (SIGMA, N9162): Cells were treated with 80 ng ml-1 
neocarzinostatin for 1 hour, followed by 2 X PBS washes at 37°C, then re-
incubated in full growth medium. 
 Hydrogen peroxide (H2O2) (SIGMA, H1009): Cells were treated with 400μM 
H2O2 for 1 hour in serum free medium, followed by PBS washes (2 X 5 
minutes) at 37°C, then re-incubated in full growth medium. 
 Etoposide (SIGMA, E1383): Cells were grown for 10 days in the presence of 
50μM Etoposide with fresh medium and etoposide being added every 3 days. 
2.11 Treatment with Pathway Inhibitors 
 
2.11.1 Inhibition of mTORC1 
 
Cells were treated with 100nM rapamycin in DMSO for varying amounts of time 
depending on experimental design. As a negative control, cells were treated with an 
equal volume of DMSO.  
 
2.12 Knock down by small Interfering RNA 
 
MRC5 cells (PD<25) were seeded onto glass coverslips in 24-well plates, and 
incubated with 500µL growth medium, 24 hours prior to siRNA treatment. 75ng of 
siRNA was diluted in 100µL serum-free medium and briefly mixed by vortexing. 3µL 
HiPerFect Transfection Reagent was added to the mixture and then vortexed for 10 
seconds, followed by incubation at room temperature for 10 minutes. The mixture 
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was then added dropwise to the growth medium, whilst gently moving the culture 
plate in a figure-of-8 motion (this gives a final siRNA concentration of 10nM).  
Knock-down efficiency was performed by western blotting. 
 
2.13 Flow Cytometry 
 
Flow cytometry was carried out using Partec PAS equipment. For calibration 
purposes, fluorescent microspheres were used. For each measurement, 1 X 104 cells 
were analysed. 
 
2.13.1 Mitochondrial Mass 
 
Mitochondrial mass was determined by re-suspending and incubating ~2 X 105 live 
cells with 10μM 10-n-nonyl-acridine orange (NAO) in serum-free DMEM for 10 
minutes at 37°C in darkness. Cells were then centrifuged at 1600 RPM for 2 minutes 
and the supernatant was discarded. Cells were then re-suspended in 3mL serum-
free DMEM and levels of fluorescence were determined via flow cytometry using the 
green fluorescence (FL1) channel. 
 
2.13.2 Reactive Oxygen Species 
 
Mitochondrial superoxide levels were determined using the same protocol as for 
mitochondrial mass, however incubating the live cells in 10μM dihydroethidium 
(ThermoFisher, D-1168) for 30 minutes and then using the red fluorescence (FL3) 
channel for flow cytometry. 
 
2.14 Mice  





A long established colony of inbred C57/BL6 mice (n=10/group) were fed ad libidum, 
with constant access to water, and culled at 3, 15 or 30 months of age, as described 
in (Wang et al., 2009; Cameron et al., 2011).  
Rapamycin Colony 
C57/BL6 mice were age-matched and randomly split into groups (n=10/group). For 
each group, mice were fed ad libidum on either a control or rapamycin diet from 3 
months of age. A control and rapamycin group were then culled at 6.5 months and 15 
months of age. Mouse feed was purchased from TestDiet: 
 Control diet: 5LG6/122 PPM EUDRAGIT 3/8 #1814831 (5AS0). 
 Encapsulated Rapamycin diet: 5LG6/122 PPM ENCAP RAP 3/8 #1814830 
(5ARZ). 
All mice were monitored weekly. 
MAO-A Colony 
Transgenic pαMHC-MAO-A C57/BL6J mice were generated as described in 
(Villeneuve et al., 2013). Mice were culled at 3 or 5 months of age.  
Formalin-fixed paraffin-embedded mouse heart tissues were provided as a kind gift 
from Dr. Jeanne Mialet-Perez, Claudius Regaud Institute, University Paul Sabatier, 
Toulouse, France. 
Catalase-/- and MnSOD+/- Colonies 
Cryo-frozen mouse heat tissues from Catalase-/- and MnSOD+/- genotype male mice 
between the ages of 17 and 27 months were provided as a kind gift from Dr. Jordan 
Miller, Mayo Clinic, Rochester, US. 
 
2.14.2 Animal Housing 
 
All animal husbandry and experimental procedures were performed in compliance 
with the Animals (Scientific Procedures) Act 1986 (ASPA). Mice were housed in a 
temperature-regulated environment (20±2˚C) with a 12 hour light/dark cycle, with 




2.14.3 Mice Tissue Collection and Preparation 
 
All tissues were placed in 10% neutral buffered formalin (VWR, 9713.9010) 
immediately after dissection. After fixation, tissues were dehydrated through a series 
of graded ethanol baths, before being treated with xylene, followed by paraffin 
embedding.  
 
2.15 Human Tissue Collection, Preparation and Ethics 
 
Human heart tissue was obtained from patients undergoing open heart surgery for 
aortic stenosis, with a section of the right atrial appendage being placed in 10% 
neutral buffered formalin (VWR, 9713.9010) immediately after dissection. 
Subsequent processing steps for paraffin embedding were the same as for mouse 
tissue (as described above). Heart surgery was performed by Andrew Owens. 
All tissue samples were obtained under the clause in the Human Tissue act that 
enables anonymised samples to be taken without consent in the context of an 
ethically approved study.  
This study: “The isolation and characterisation of cell lines, including adult stem cells, 
from tissue discarded following cardiothoracic surgery”, was approved by the 




2.16.1 ICC on fixed cells 
 
N.B. All wash steps were carried out stirring on an orbital shaker at 80RPM and all 





Cells were grown on sterile coverslips until 50-80% confluency, washed in PBS (2 X 
5 minutes) and then fixed in 2% PFA for 10 minutes at room temperature. Following 
fixation, cells were washed with PBS (2 X 5 minutes).  
At this point, fixed cells can be stored in PBS at 4°C for several months, or at -80°C 
for longer term storage. 
Permeabilisation 
Fixed cells were incubated in PBG-T (Table 1) for 45 minutes, whilst stirring on an 
orbital shaker at 80 RPM. 
Immunofluorescent Staining 
Cells were then incubated with a primary antibody (Table 3) diluted in PBG-T in a 
humidifier chamber overnight at 4°C. After washing in PBG-T (3 X 5 minutes), cells 
were then incubated with a secondary antibody (Table 4) for 1 hour at room 
temperature in the dark. Darkness was achieved by wrapping the culture plates in 
aluminium foil. Cells were then washed in PBS (3 X 5 minutes), and cells were 
mounted on to glass microscope slides with ProLong® Gold Antifade Mountant 
(ThermoFisher, P36930).     
 
Primary Antibodies: 
































SIGMA, F1804 1:1000 
Table 3. Primary Antibodies for ICC on Cells 
 
Secondary Antibodies: 
Target Host Supplier, Cat# Dilution 
anti-Mouse IgG (H+L), 
Alexa Fluor® 488 
Goat 
Polycloncal 
Invitrogen, A-1101 1:4000 
anti-Mouse IgG (H+L), 
Alexa Fluor® 594 
Goat 
Polycloncal 
Invitrogen, A-11005 1:4000 
anti-Mouse IgG (H+L), 
Alexa Fluor® 647 
Goat 
Polycloncal 
Invitrogen, A-21235 1:4000 
anti-Rabbit IgG (H+L), 
Alexa Fluor® 488 
Goat 
Polycloncal 
Invitrogen, A-11008 1:4000 
anti-Rabbit IgG (H+L), 
Alexa Fluor® 594 
Goat 
Polycloncal 
Invitrogen, A-11012 1:4000 




Invitrogen, A-21447 1:2000 
Table 4. Secondary Antibodies for ICC on Cells 
N.B. All antibodies were dissolved in PBG-T. 
2.16.2 Telomere-FISH on Fixed Cells following ICC 
 
After immunocytochemistry (described above), cells were washed in PBS (2 X 5 
minutes). A fixative of methanol: acetic acid (3:1 respectively) was added for 30 
minutes. Sections were then dehydrated using a cold ethanol gradient of 70%, 90% 
and 100% for 2 minutes each. After air drying, the samples were then incubated in 
PBS at 37°C for 5 minutes, followed by incubation in 4% PFA for 2 minutes. Samples 
were then washed in PBS and dehydrated through an ethanol gradient once more 
(as described previously). Coverslips were then placed onto a glass slide containing 
10μL of hybridisation mix (Table 1) and incubated at 80°C for 10 minutes. Samples 
were then placed into a humidifier chamber and incubated at room temperature for 2 
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hours. Coverslips were then transferred back into the 12 well plate and washed in 
wash buffer (3 X 10 minutes). Cells were then washed in TBS-Tween (0.05%) (Table 
1) (3 X 5 minutes). Samples were then taken through a final ethanol dehydration, air 
dried and then cells were mounted on to glass microscope slides with ProLong® 
Gold Antifade Mountant (ThermoFisher, P36930).     
 
2.16.3 ICC on Paraffin Embedded Mouse and Human Tissue 
 
3µM tissue sections were cut on a microtome, adhered to 4% APES coated slides 
and incubated at 37°C overnight.  
Sections were de-paraffinised by incubating in histoclear (2 X 5 minutes), followed by 
hydration through an ethanol gradient of 100% (2 X 5 minutes), 90% (5 minutes), 
70% (5 minutes) ethanol and then incubated in dH2O (2 X 5 minutes).  
For antigen retrieval, sections were submerged in 0.01M citrate buffer pH6.0 (Table 
1) and then heated with microwaves (800W) until solution was boiling, and then the 
power was reduced (400W) and the solution was simmered for 10 minutes. Sections 
were then left to rest until the citrate buffer reached room temperature, and then they 
were washed twice in distilled water for 5 minutes each. 
 For anti-mouse primary antibodies used on mouse tissue: Sections were 
incubated in M.O.M.™ IgG blocking (Vector Laboraties, MKB-2213) reagent 
diluted 1:25 in TBS-Triton for 1 hour at room temperature. Sections were then 
washed in PBS (2 X 5 minutes) and then incubated in primary antibody (Table 
5), diluted in M.O.M diluents diluted 1:12 in TBS-Triton at 4°C overnight.  
 For all other primary antibodies used on either mouse or human tissue: 
Sections were then incubated in blocking reagent, consisting of normal goat 
serum (NGS) diluted 1:60 in 0.1% BSA in PBS for 30 minutes at room 
temperature. Blocking solution was then tipped off, and sections were 
incubated in primary antibody (Table 5), diluted in blocking reagent, at 4°C 
overnight.  
Sections were then washed in PBS (3 X 5 minutes). 
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 For anti-γH2AX primary antibody: sections were incubated in biotinylated 
secondary antibody (1:200 in blocking serum) (Table 6) for 30 minutes at room 
temperature. Sections were then washed in PBS (3 X 5 minutes) and then 
incubated in avidin DCS (1:500 in PBS) (Table 6) for 30 minutes.  
 For all other primary antibodies: sections were incubated in an Alexa Fluor 
conjugated secondary antibody (1:2000 in blocking serum or M.O.M diluents) 
(Table 6) for 1 hour. 
Sections were then washed in PBS (3 X 5 minutes) and glass coverslips were 
mounted onto the sections with ProLong® Gold Antifade Mountant (ThermoFisher, 
P36930). 
 Primary Antibodies: 
Target Host Species Supplier, Cat# Dilution 
α-Actinin Mouse 
Monoclonal 
SIGMA, A7811 1:200 
γH2AX Rabbit 
Monoclonal 
Cell Signalling, #9718 1:200 
PCM-1 Mouse 
Monoclonal 
Abcam, ab154142 1:200 
TRF2 Mouse 
Monoclonal 
Millipore, 05-521 1:200 
Table 5. Primary Antibodies for ICC on Mouse and Human Tissues 
 
Secondary Antibodies: 
Target Host Supplier, Cat# Dilution 
Anti-Mouse IgG (H+L), 
Alexa Fluor® 647 
Goat 
Polycloncal 
Invitrogen, A-21235 1:2000 
Biotinylated anti-Rabbit IgG 
(H+L) 





N/A Vector Laboratories, 
A-2011 
1:500 




2.16.4 Telomere-FISH on Mouse and Human Tissues following ICC 
 
If required and prior to mounting, FISH was coupled with ICC-stained mouse or 
human tissues. 
Sections were incubated in 4% paraformaldehyde in PBS for 20 minutes at room 
temperature, followed by PBS washes (3 X 5 minutes). Sections were then 
dehydrated through an graded ethanol series (70, 90 and 100%), for 3 minutes each 
at -20°C. Sections were allowed to air dry, then 10µL of telomere-FISH hybridisation 
mix (Table 1) was added to the section and a glass coverslip was placed on top. 
Sections were then placed at 80°C for 10 minutes to denature the DNA. Following 
this, sections were incubated in an opaque humidifier chamber at room temperature 
for 2 hours to allow the probe to hybridise. Following incubation, sections were 
washed in 70% formamide in 2 X SSC (1 X 10 minute), 2 X SSC (1 X 10 minute), 
and PBS (3 X 10 minutes). Glass coverslips were then mounted on to the sections 




For Q-FISH analysis of telomere-FISH performed on either fixed cells or tissue 
sections: spinning disk confocal microscopy was used to image Z-stacks through the 
entire nucleus of each cell with Z-depths of 0.1µM with 100X objective (NA=1.4). 
ImageJ software was used to create maximum intensity Z projections, and then the 





2.18.1 IHC on paraffin embedded tissue 
 
Tissue sectioning, deparaffinisation, antigen retrieval, blocking and primary antibody 
incubation were carried out as described above for ICC on tissue sections, except for 
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the addition of an endogenous biotin blocking step. Moreover, prior to incubation with 
primary antibody, sections were incubated in avidin (SP-2001, Vector Laboratories) 
for 15 minutes at room temperature, followed by a PBS wash (1 X 5 minutes), then 
incubated in biotin (SP-2001, Vector Laboratories) for 15 minutes at room 
temperature, followed by a further PBS wash (1 X 5 minutes).  
Following overnight primary antibody (Table 7) incubation at 4°C, sections were 
washed with TBS-T (2 X 5 minutes) and then incubated in biotinylated secondary 
antibody  (1:200 in blocking solution)  (Table 8) for 30 minutes. Sections were then 
washed in TBS-T (2 X 5 minutes), and then endogenous peroxide activity was 
blocked by incubating sections in 0.9% H2O2 in dH2O for 30 minutes at room 
temperature. Following PBS washes (2 X 5 minutes), sections were incubated in 
VECTASTAIN® ABC Reagent (PK-6100, Vector Laboratories) according to 
manufacturer’s instructions. Sections were then washed in PBS (3 X 5 minutes), 
followed by visual detection of peroxidase activity by treating slides with VECTOR 
NovaRED Peroxidase (HRP) substrate according to manufacturer’s instructions.  
Sections were then washed with dH2O (1 X 5 minutes), counterstained with 
haematoxylin for 1-2 minutes, washed with dH2O (2 X 1 minute), incubated in 1% 
acid alcohol for 5 seconds, washed in dH2O (1 X 1 minute), incubated in ammonia 
water for 20 seconds and washed in dH2O (1 X 1 minute). Sections were then 
dehydrated through an ethanol gradient of 90% ethanol (2 X 30 seconds), 100% 
ethanol (2 X 30 seconds) and then incubated in histo-clear (2 X 5 minutes). Glass 
coverslips were then mounted on top of the sections with DPX. 
Target Host Species Supplier, Cat# Dilution 
P21 Rabbit 
Polyclonal 
Abcam, 7960 1:200 
4-HNE Mouse 
Monoclonal 
JaICA, MHN 1:100 
8-OHdG Rabbit 
Polyclonal 
JaICA, MOG 1:100 
Table 7. Primary Antibodies for IHC on Tissues 
 










Goat Vector Laboratories, 
BA-1000 
1:200 




2.19.1 Crosslinked ChIP Assay 
 
Crosslinked ChIP assay was carried out using 25µg crosslinked chromatin prepared 
from 3 or 30 month ground mouse heart tissue as described in (Mann et al., 2010), 
using anti-γH2AX (phospho S139) (Abcam, ab2893) and species and isotype 
matched control ChIP grade IgG (Abcam, ab46540). 
 
2.19.2 Real-time PCR 
 
Real-time PCR for telomeric repeats was performed as described previously 




Primer Sequence 5’ to 3’ 
Forward CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 
Reverse GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT 
Table 9. Telomere Sequence for RT-PCR for Telomeric Repeats 
 
2.20 Senescence Associated β Galactosidase Activity Assay 
 




Cellular senescence was determined using the Senescence-Associated β 
Galactosidase assay, as described previously (Dimri et al., 1995). Briefly, cells were 
fixed with 2% paraformaldehyde for 5 minutes at room temperature. Following PBS 
washes (2 X 5 minutes), cells were incubated in SA-β-Gal staining solution (Table 1) 
at 37°C in the dark overnight. Cells were then washed in PBS (3 X 5 minutes) and 
then mounted on to glass microscope slides with ProLong® Gold Antifade Mountant 
(ThermoFisher, P36930).     
Using a Leica DM5500B microscope and a Leica DFC420 camera, random fields 
(20X objective) were imaged and cells were scored either positive or negative for SA-
β Gal staining.  
 
2.21 Telomeric Repeat Amplification Protocol (TRAP) Assay 
 
Whole hearts, flash frozen in liquid nitrogen, were ground to a fine powder using a 
liquid nitrogen-chilled pestle and mortar and stored at -80°C. 
To assess telomerase activity, the TeloTAGGG Telomerase PCR ELISA kit (Roche, 
11854666910) was used according to manufacturer’s instructions.  
 
2.22 Protein Expression Analysis 
 
2.22.1 Protein Extraction 
 
Growth medium was aspirated, and then cells were washed once with 4°C PBS. 
Following aspiration of PBS, 80-100µL of 4°C RIPA buffer (Table 1) and 1X protease 
and phosphatase inhibitors (Thermo Scientific, 78442) were added to the cells, which 
were then scraped with a rubber policeman. Cell lysis solution was then transferred 
to a 1.5mL microcentrifuge tube, pre-chilled on ice, and then either used instantly for 




2.22.2 Protein Quantification 
 
Cell lysates were defrosted on ice and then centrifuged at 16,000g for 10 minutes at 
4°C. Protein concentration was determined using the BioRad Protein Assay (Biorad; 
Reagent A, 500-0113; Reagent B, 500-0114; Reagent C, 500-0115) according to 
manufacturer’s instructions. Protein absorbance was then quantified using a 
FLUOstar Omega microplate reader (BMG Labtech), and a regression line, for 
protein concentration estimates, calculated based on absorbance values from known 
BSA protein standards. Protein concentrations were then normalised by mixing 
protein lysates with loading buffer (2X Laemmli buffer (Biorad, 161-0737) and 2-
mercaptoehtanol (SIGMA, M6250) at a ratio of 19:1). Proteins were then denatured 
by incubating in a heating block at 100°C for 5 minutes, and then placed on ice 
temporarily before performing western blotting, or placed at -80°C for long term 
storage.  
 
2.22.3 Western Blot 
 
Gel Electrophoresis  
Ammonium persulphate was diluted in dH2O to a concentration of 100mg mL
-1. A 
10mL resolving gel solution was prepared with the required percentage of acrylamide 
(Table 10), and then pipetted into an empty western blot cassette (Invitrogen, 
NC2010 or NC2015), with dH2O gently pipetted on top to level the acrylamide 
solution. Once polymerised, the dH2O was poured off, and 3mL of stacking gel 
solution (Table 10) was pipetted on top of the resolving gel and left to polymerise, 
with a western-blot comb inserted to create the desired number and volume of 
loading wells. Once the stacking gel polymerised, the cassette was loaded into a 
XCell SureLock™ Mini-Cell Electrophoresis System (Invitrogen, EI001) and running 
buffer (Table 1) was poured in until the cassettes were fully submerged. The 
western-blot combs were then removed and protein samples were pipetted into the 
wells, along with Precision Plus Protein™ Dual Colour Standards (Biorad, 1610374), 
for use as a protein molecular weight estimation ladder. Electrophoresis was then 




1 X Stacking Gel 5ml 5% 8% 10% 12% 15% 
       
Sterile H20 3.4ml     
30% Acrylamide 850ul     
1.5M Tris pH 6.8 1.3ml     
10% SDS 50ul     
10% Ammonium 
Persulphate (w/v in  H20) 50ul     
TEMED 4ul     
            
1 X Resolving Gel 10ml           
      
Protein Size (kDa)  >250 250-120 120-40   40-15  <20 
Sterile H20 6.8ml 5.1ml 4ml 3.3ml 2.3ml 
30% Acrylamide 1.7ml 2.6ml 3.3ml 4ml 5ml 
1.5M Tris pH 8.8 2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 
10% SDS 100ul 100ul 100ul 100ul 100ul 
10% Ammonium 
Persulphate (w/v in H2O) 100uL 100ul 100ul 100ul 100ul 
TEMED 8ul 4ul 4ul 4ul 4ul 
Table 10. Acrylamide gel recipe for western blot 
 
Protein Transfer to PVDF Membrane 
Once electrophoresis had finished, a PVDF membrane (Millipore, IPVH00010) was 
incubated briefly in methanol and then submerged in transfer buffer (Table 1). The 
gel was then placed on top of the PVDF membrane and sandwiched between blotting 
pads (VWR, 732-0594), soaked in transfer buffer (Table 1) and loaded into a Trans-
Blot® SD Semi-Dry Transfer Cell (Biorad) and transferred at 20V for 1 hour.  
Blocking and Antibody Incubation 
Unless otherwise stated, all block and antibody incubations were performed on a 
laboratory rocker set to 12 RPM / ±8° tilt. 
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To block non-specific antibody binding, the membrane was incubated in 5% non-fat 
dry milk and 0.1% Tween® 20 in PBS (PBST-Milk) for 1 hour at room temperature. 
The PBST-Milk blocking solution was removed, and the membrane was incubated in 
primary antibody (Table 11) diluted in PBST-Milk overnight at 4°C. The membrane 
was then washed with dH2O (3 X 5 minutes), and then incubated in secondary 
antibody (Table 12) for 1 hour at room temperature. The membrane was then 
washed in PBS-T (3 X 5 minutes), followed by several rinses in dH2O. 
 
Target Host Species Supplier, Cat# Dilution 
P21 Rabbit 
Monoclonal 
Cell Signalling, #2947 1:1000 
GAPDH Rabbit 
Monoclonal 
Cell Signalling, #5174 1:5000 




Supplier, Cat# Dilution 
anti-rabbit IgG-
Peroxidase  
Goat Sigma, A0545 1:5000 
Table 12. Secondary Antibodies for Western Blot 
 
Chemiluminescent Detection 
Chemiluminescent detection was performed using Clarity™ ECL Western Blot 
Substrate (Bio-rad, 170-5060) according to manufacturer’s instructions, and 
visualised using a Fujifilm Las 1000 Intelligent Darkbox with Luminescent Image 
Reader Las-1000 Software.  
Bands intensity was quantified using ImageJ software, with background subtraction 
and protein-of-interest normalised to a loading control protein. 
 




The following gene expression analysis was performed on freshly isolated adult 
mouse cardiomyocytes. 
 
2.23.1 RNA Extraction 
 
RNA extraction was performed using the RNeasy Mini Kit (QIAGEN), according to 
manufacturer’s instructions. 
 
2.23.2 cDNA Synthesis 
 
cDNA was synthesised by reverse transcription of 0.5µg of RNA per reaction, using 
the High-Capacity cDNA Reverse Transcription Kit (ThermoFisher Scientific; 
4368814), according to manufacturer’s instructions.  
 
2.23.3 Real Time Polymerase Chain Reaction (RT-PCR) 
 
20µL Real time PCR reaction mix (10μL Taq polymerase, 2μL SYBR green, 300nM 
forward and reverse primer, 10ng cDNA and deionised H2O to total volume of 20μL) 
was added to each RT-PCR well. The thermocycler conditions were 95°C for 10 
seconds, 65°C for 30 seconds for 45 cycles, followed by an incremental temperature 
increase for melt-curve analysis. Primer sequences are provided below  
 
 
Target Forward Reverse 
P15 AGATCCCAACGCCCTGAAC  CAGTTGGGTTCTGCTCCGT 
P16 CCGAACTCTTTCGGTCGTACCC   CTGCTACGTGAACGTTGCCCA 
TGFb AGGGCTACCATGCCAACTTCT  CCGGGTTGTGTTGGTTGTAGA 
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MAO-A GGAAGCCCGGGATAGAGTTG  TGGGTTGGTCCCACATAAGC 
GAPDH AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 




3 External Stress Induces Persistent DNA Damage at Telomeres in 
Cardiomyocytes 
 
Previous studies have shown that telomeric damage in both human and murine 
fibroblasts is irreparable, resulting in a persistent DDR signal; a hallmark of DNA-
damage induced cellular senescence (Fumagalli et al., 2012; Hewitt et al., 2012). 
Interestingly, Q-FISH analysis of telomere length in murine hepatocytes and 
enterocytes revealed an age-dependent increase in telomere damage occurring 
independently of telomere length (Hewitt et al., 2012). These data contradict the 
hypothesis that telomere dysfunction occurs mainly as a result of progressive 
shortening of the telomeres, as a consequence of the end-replication problem; a 
process which is accelerated by oxidative stress-induced single strand breaks during 
replication (von Zglinicki et al., 1995; von Zglinicki et al., 2000), suggesting that an 
additional mechanism may also drive telomere dysfunction. Furthermore, this 
suggests a possibility for persistent telomere dysfunction to occur in post-mitotic and 
non-rapidly dividing cells types, which are not subject to proliferation-associated 
telomere shortening; a prospect of special interest, considering that research has 
shown that post-mitotic adipocytes and neurones can also elicit a senescent-like 
phenotype in vivo (Minamino et al., 2009; Jurk et al., 2012). 
The t-loop structure forms an elegant mechanism for physically sheltering the ends of 
chromosomes from being recognised by the DDR machinery, thus preventing end-to-
end fusions resulting from non-homologous end joining (NHEJ) (Griffith et al., 1999). 
However, research has shown that NHEJ can be inhibited in the absence of t-loop 
formation, providing a RAP1/TRF2 complex is bound to as little as 12-telomeric 
repeats (Bae and Baumann, 2007). Interestingly, overexpression of TRF2 has been 
shown to attenuate single-strand break repair at telomeres (Richter et al., 2007) and 
ectopic localisation of TRF2 next to a double-strand break (DSB) inhibits repair 
(Fumagalli et al., 2012). Our group and another, therefore proposed a model in which 
if a physical double strand break were to occur in a telomeric region, this would be 
irreparable and lead to a persistent DDR (Fumagalli et al., 2012; Hewitt et al., 2012). 
Moreover, this would provide an explanation to our observations of telomere 
dysfunction occurring independently of telomere shortening in vivo (Hewitt et al., 
2012). However, another proposed mechanism for a persistent DDR at telomeres 
independently of telomere length, stipulates that partial TRF2 inhibition could lead to 
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telomere uncapping and a DDR, however still retaining enough TRF2 to inhibit end-
to-end fusions via NHEJ (Cesare et al., 2009).  
Irrespective of the verisimilitude of either proposed theory, and one cannot reject the 
proposition that the two aren’t mutually exclusive, we sought to investigate if post-
mitotic/non-rapidly dividing cell types, which are not subject to proliferation-
associated telomere shortening, could also be associated with persistent telomere 
dysfunction, and if so, does this drive a senescent-like phenotype. To investigate this, 
we used cardiomyocytes as our model, as proliferation is negligible in adult tissue, 
and there are two commonly used in vitro cardiomyocytes models we could utilise, 
namely: E17.5 embryonic mouse cardiomyocytes which retain the ability to contract 
when cultured in vitro and thus are a valuable tool for investigating cardiac diseases, 
and H9C2 rat-derived cardiomyocytes. Hitherto, and to our knowledge, telomere 
dysfunction in cardiomyocytes per se has been overlooked, perhaps because of the 
false assumption that telomere dysfunction is solely a consequence of telomere 
shortening, and thus of little interest in cardiomyocytes.  
Secondly, we also aimed to investigate the nature of genotoxic-stress induced 
telomere damage, to ascertain whether it was a consequence of telomere-uncapping 
or a physical DSB within a telomeric region. 
 
3.1 TAF are Persistent in Mouse Embryonic Fibroblasts following X- 
Irradiation  
 
Our group have previously published that stress-induced DNA damage, via X-
irradiation (IR) or H2O2 treatment in human fibroblasts, leads to both telomeric-
associated DNA damage foci (TAF) and non-telomeric DNA damage foci (non-TAF), 
however, whilst non-TAF are largely repaired, TAF are irreparable (Hewitt et al., 
2012). To begin, we sought to ascertain if we could induce TAF in cardiomyocytes, 
and if so, was this persistent. We isolated E17.5 mouse embryonic cardiomyocytes, 
exposed them to 10Gy IR, and then performed telo-FISH coupled with ICC for 
γH2AX (immuno-FISH) to analyse both TAF and non-TAF at 0, 3, 5 and 10 days 
following IR. The cardiomyocyte isolation procedure produces a heterogeneous 
population of cell types, also including endothelial cells and fibroblasts, so to ensure 
specificity of cardiomyocytes, only cells staining positive for Troponin I were 
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analysed. Our immuno-FISH analysis revealed a significant increase in both TAF and 
non-TAF at 3 days after IR, however, 5 days following IR, the mean number of non-
TAF had significantly decreased compared to the value at 3 days, whereas the 
number of TAF did not significantly change (Figure 3-1A&D). Moreover, from 5 to 10 
days, there was a non-significant (p=0.056) trend towards a decrease in non-TAF, 
whereas the mean number of TAF remained insignificantly changed (Figure 
3-1A&D). We observed a significant enrichment of the percentage of total DDR foci 
which were TAF from day 3 to 5 and day 5 to 10 following IR (Figure 3-1B&D). 
Finally, the percentage of cells positive for TAF remained insignificantly altered for 










Figure 3-1. X-Ray irradiation induces persistent TAF in Mouse Embryonic 
Cardiomyocytes. (A) Mean number of both TAF and non-TAF-, (B) Mean 
percentage of DNA damage foci which are TAF-, (C) and percentage of TAF positive 
cells, in troponin-positive mouse embryonic cardiomyocytes at 3, 5 and 10 days 
following X-irradiation with 10Gy. Data are mean ± SEM of n=3. (D) Representative 
images of embryonic cardiomyocytes at days 0, 3, 5 and 10 following X-irradiation 
with 10Gy. Left panel represents troponin-positive embryonic cardiomyocytes 
(troponin – magenta; DAPI - light blue). Middle panel white arrows indicate co-
localisation between DDR, detected as γH2AX foci (green), and telomeres, detected 
using a telomeric-PNA probe (red) in Z projections of 0.1µM slices. Co-localising foci 
are amplified in the right-hand panel (amplified images represent a single Z-plane 
where co-localisation was observed). Scale bars: left panel - 10µM; middle panel 
5µM; right panel 0.5µM. Statistical analysis performed using One Way ANOVA or two 
tailed t test; * P<0.05, NS (Non-Significant) P>0.05. 
 
3.2 TAF are Persistent in H9C2 Cardiomyocytes following X-
Irradiation 
 
To confirm if persistent TAF could be induced in another cell model, we used H9C2 
rat-derived cardiomyocytes. We treated H9C2 cells with 10Gy IR and then performed 
82 
 
immuno-FISH analysis for both TAF and non-TAF at 0, 3, and 5 days following IR. 
We observed a significant increase in both TAF and non-TAF at 3 days after IR, 
followed by a non-significant decrease in the number of non-TAF at day 5, however 
the number of TAF did not significantly change from 3 to 5 days (Figure 3-2A). We 
observed a non-significant trend towards an enrichment of the percentage of total 
DDR foci which are TAF from day 3 to 5 following IR (Figure 3-2B). Lastly, the 
percentage of cells positive for TAF remained insignificantly altered from day 3 to 5 
following IR (Figure 3-2C).  
 
 
Figure 3-2. X-Ray irradiation induces persistent TAF in H9C2 Cardiomyocytes. 
(A) Mean number of both TAF and non-TAF-, (B) Mean percentage of DNA damage 
foci which are TAF-, (C) and percentage of TAF positive cells, in H9C2 
cardiomyocytes at 3 and 5 days following X-irradiation with 10Gy. Data are mean ± 
SEM of n=3. Statistical analysis performed using One Way ANOVA or two tailed t 
test; * P<0.05, NS (Non-Significant) P>0.05. 
 
Previously, using a AcGFP-53BP1c fusion protein, coupled with microbead-mediated 
incorporation of the telomere-specific PNA probe, our group were able to track DNA 
Damage Response Foci (DDF) and telomeres simultaneously via live-cell time lapse 
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microscopy (Hewitt et al., 2012). Interestingly, we discovered that all IR-induced DDF 
in Mouse Embryonic Fibroblasts (MEFs), which did not co-localise with telomeres 
were transient and therefore reparable, with a maximum lifespan of less than 3 
hours, whereas around 50% of those DDF co-localising with telomeres survived for 
the entire course of the experiment (>6 hours) and are likely irreparable (Hewitt et al., 
2012). We therefore wanted to ascertain if persistent DDF could be induced in 
cardiomyocytes. In collaboration with Anthony Lagnardo in our laboratory, we 
transfected H9C2 cells with an AcGFP-53BP1c fusion protein, irradiated them with 
10Gy, waited 72 hours and then performed live-cell time-lapse microscopy; imaging 
DDF every 10 minutes for 10 hours. Our data show that after 10Gy IR, the majority of 
DDF are resolved within 8 hours, however around 20% of DDF remain persistent, 
with no significant variations in foci dynamics after this time (Figure 3-3A-B). We also 
tracked DDF in untreated H9C2 cells, and observed that the starting number of DDF 
was significantly lower compared to IR-treated cells (data not shown), and the DDF 





Figure 3-3. Live-cell time-lapse microscopy reveals persistent IR-induced DDR 
foci in H9C2 Cells. (A) Representative time-lapse images of H9C2 cells expressing 
AcGFP-53BP1 from 72 hours after 10Gy irradiation at the indicated times (mins). 
Images are maximum intensity projections with a 6.7µM focal depth. Scale bar: 5µM. 
(B) Kaplan-Meyer survival curves for AcGFP-53BP1c DDR foci in H9C2 cells 2 days 
after 10Gy irradiation.  
 
3.3 TAF are Induced Independently of DNA Replication 
 
The H9C2 cardiomyocyte cell line still retain proliferative capability, therefore leaving 
the possibility that observed TAF could be induced as a result of DNA replication 
errors (Kuzminov, 1999). However, cardiomyocyte proliferation in vivo is negligible, 
with data suggesting that less than 1% of the cardiomyocyte population turn over 
annually in young adult humans (Bergmann et al., 2009), and thus we sought to 
determine if TAF could arise independently of DNA replication.  
We incubated H9C2 cells in the presence of a modified thymidine analogue (EdU), 
for 3 hours, followed by irradiation with 10Gy, and then cultured cells for a further 24 
hours in the presence of EdU (Figure 3-4A-C). The prior EdU incubation period 
revealed that H9C2 cells had proliferation potential prior to X-irradiation, however the 
IR treatment significantly decreased the percentage of cells which underwent DNA 
replication during the time course of the experiment (Figure 3-4A-C). We then 
analysed the mean number of TAF in EdU negative cells, and found that the number 
of TAF are significantly increased 24 hours after IR with 10Gy (Figure 3-4D).  
To determine if the length of telomeres affects susceptibility to IR-induced 
dysfunction, we performed Q-FISH analysis, and quantified the intensity of telomeres 
co-localising with a DDR, compared to telomeres not co-localising with a DDR. Our 
data show that, after 10Gy IR, the average length of telomeres co-localising with a 





Figure 3-4.  TAF are Induced Independently of DNA Replication in X-irradiated 
H9C2 Cells. (A) Schematic illustration showing H9C2 cells were incubated in 10µM 
EdU in normal growth medium for 3 hours, following X-irradiation with 10Gy and 
cultured for a further 24 hours in the presence of 10µM EdU in normal growth 
medium. (B) Mean percentage of EdU positive cells. Data are mean ± SEM of n=3. 
(C) Representative images H9C2 cells 24 hours after X-irradiation with 10Gy (DAPI - 
light blue; EdU - pink). Scale bar: 30µM. (D) Mean number of TAF in EdU negative 
cells, 24 hours after 10Gy IR. Data are mean ± SEM of n=3. (E) Histograms 
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displaying telomere intensity for telomeres co-localising (bottom) or not co-localising 
(top) with γH2AX DDR foci in EdU negative cells (n=3). Red lines represent median 
intensity of > 65 telomeres per condition. Statistical analysis performed using two 
tailed t test; * P<0.05. Mann-Whitney tests show a significant increase in telomere 
intensity in TAF compared to non-TAF P<0.05.  
 
 
Hitherto, the irradiation model has been used as a proof-of-principle for the existence 
and persistence of TAF in both embryonic cardiomyocytes and H9C2 rat-derived 
cardiomyocytes. However, we wanted to ascertain if TAF could be induced, 
irrespective of DNA replication, with a more physiologically relevant model of 
oxidative stress i.e. via hydrogen peroxide exposure. Using the same experimental 
plan from above (Figure 3-4A), instead of X-irradiation, we cultured H9C2 cells in 
EdU for 3 hours, and then exposed them to 10µM H2O2 for 2 hours, followed by a 
further culture in the presence of EdU for 24 hours. Similarly to exposure with 10Gy 
IR, we observed a significant decrease in the percentage of cells which underwent 
DNA replication following treatment with H2O2 (Figure 3-5B). Moreover, the mean 
number of TAF is significantly increased in EdU negative H9C2 cells 24 hours after 





Figure 3-5. TAF are Induced Independently of DNA Replication in H2O2-treated 
H9C2 Cells. (A) Schematic illustration showing H9C2 cells were incubated in 10µM 
EdU in normal growth medium for 3 hours, followed by X-irradiation with 10Gy and 
cultured for a further 24 hours in the presence of 10µM EdU in normal growth 
medium. (B) Mean percentage of EdU positive cells. Data are mean ± SEM of n=3. 
(C) Mean number of TAF in EdU negative cells, 24 hours after 10Gy IR. Data are 
mean ± SEM of n=3. Statistical analysis performed using two tailed t test; * P<0.05.  
 
3.4 TAF Induce Senescence in vitro 
 
Research has shown that SA-β-Gal activity, an established marker of senescence, 
becomes elevated in H9C2 cardiomyocytes 3 days after exposure with either 
oxidative stress or genotoxic stress (Spallarossa et al., 2009; Dong et al., 2013). Our 
data show that SA-β-Gal activity also becomes elevated in the majority of H9C2 cells, 
3 days following exposure to 10Gy X-irradiation (Figure 3-6A-B). However, these 
interventions cause DNA damage in a non-specific manner, resulting in elevated 
levels of both TAF and non-TAF, both of which have been implicated in driving 
senescence (Nakamura et al., 2008). We sought to determine if DSBs specifically at 
telomeres could induce senescence in cardiomyocytes. To achieve this, we acquired 
a FLAG-tagged expression plasmid (TRF1-FokI), encoding an endonuclease (FokI) 
conjugated to the shelterin component TRF1. FokI non-specifically cleaves DNA 
adjacent to its recognition site (Sugisaki and Kanazawa, 1981), and thus, when 
conjugated to TRF1, FokI can induce DSBs specifically in telomeric DNA. As a 
control, we used a point-mutated expression plasmid (TRF1-FokI-D450A), with a loss 
of function in endonuclease activity. We transfected H9C2 cells with either TRF1-FokI 
or TRF1-FokI-D450A, and cultured them for 4 days. Immuno-FISH analysis revealed 
an induction of both γH2AX DDF and 53BP1 DDF in TRF1-FokI transfected cells, 
with the vast majority of DDF co-localising with telomeres (Figure 3-7A-B). We 
performed Q-FISH to analyse the length of telomeres co-localising with a DDF 
(γH2AX+/53BP1+) compared to those that were not (γH2AX-/53BP1-). Our analysis 
revealed that TRF1-FokI-induced double-strand cleavage of telomeres occurred 
independently of telomere length, as the distribution of telomere length was the same 










Figure 3-6. X-Irradiation induces Senescence in H9C2 Cardiomyocytes. (A) 
Percentage of SA-β-Gal positive cells in H9C2 cells at 3 days following 10Gy IR. 
Data are for a representative experiment. (B) Representative images of SA-β-Gal 







Figure 3-7. TRF1-FokI Fusion Protein Induces Telomere Specific Double Strand 
Breaks. (A) H9C2 cells 4 days following transfection with a FLAG-tagged TRF1-FokI-
D450A (top row) or TRF1-FokI (middle and bottom row) fusion protein (purple – 
FLAG; red – telo-FISH; green – γH2AX or 53BP1). Images are z projections of 0.1µM 
stacks taken with 100X objective. White arrows indicate co-localisation between 
telomeres and γH2AX/53BP1, with co-localising foci amplified in the right panels 
(taken from single z planes where co-localisation was found). Scale bar: 5µM. (B) 
Graphs represent the percentage of γH2AX (left) or 53BP1 (right) foci co-localising 
with telomeres 4 days following transfection with either a TRF1-FokI-D450A or TRF1-
FokI fusion protein. Data are mean ± SEM of n=3. (C) Histograms displaying 
telomere intensity for telomeres co-localising (bottom) or not co-localising (top) with 
γH2AX (left) or 53BP1 (right) DDR foci for H9C2 cells 4 days following transfection 
with TRF1-FokI fusion protein. Red dotted lines represent median > 60 telomeres per 
condition. Statistical analysis performed using two tailed t test; * P<0.05. Mann-
Whitney tests show no significant difference in telomere intensity between TAF and 
non-TAF, with either γH2AX (left) or 53BP1 (right) DDR foci.  
     
Previous research has shown that fibroblasts transfected with a dominant-negative 
TRF2 (TRF2ΔBΔM), elicit a DDR at telomeres and undergo cellular senescence (Takai 
et al., 2003). This model provides insights into the effects of telomere uncapping, but 
hitherto, it is unknown whether DSBs specifically at telomeres can drive cellular 
senescence. Having shown the specificity of the TRF1-FokI fusion protein to induce 
telomere-specific DSBs (Figure 3-7A-B), we transfected H9C2 cells with either TRF1-
FokI or TRF1-FokI-D450A, cultured them for 4 days, and then assessed various 
senescence markers. Our analysis revealed that H9C2 cells expressing the TRF1-
FokI fusion protein had a significantly reduced percentage of cells positive for the 
proliferation marker Ki-67, an increased cell size, and a significant increase in the 
percentage of cells positive for both the cyclin-dependent kinase inhibitor p21, and 




Figure 3-8. Double Strand Telomeric Breaks Drive Cellular Senescence in H9C2 
Cardiomyocytes. (A) Representative images of senescent markers in H9C2 cells 4 
days following transfection with a either TRF1-FokI-D450A or TRF1-FokI fusion 
protein (purple – FLAG; red – Ki-67; light blue – DAPI; darker cytoplasmic blue – SA-
β-Gal). Scale bars: left panel - 10µM; right panel 20µM. (B) Quantification of mean 
percentage of FLAG-positive cells stained positive for Ki-67. Data are mean ± SEM of 
n=3. (C) Quantification of mean percentage of FLAG-positive cells stained positive 
for p21. Data are mean ± SEM of n=3. (D) Quantification of mean percentage of 
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FLAG-positive cells stained positive for SA-β-Gal activity. Data are mean ±s.e.m of 
n=3. Data are presented as mean of >100 cells representative of 1 experiment. Two 
independent experiments confirmed these findings (not shown). (E) Quantification of 
mean cell size of FLAG-positive cells. Data are mean ± SEM of n=3. Statistical 
analysis performed using two tailed t test; * P<0.05 
 
3.5 Does Genomic Stress Induce Telomere Uncapping? 
 
Telomere dysfunction can be induced via a number of genotoxic stresses (Hewitt et 
al., 2012), however the mechanism for the induction of a DDR at telomeres which are 
not critically short is not yet fully understood. The previous model of endonuclease-
induced telomeric damage provides interesting insights into the effects of DSBs at 
telomeres, but cannot be considered a physiological representation of the induction 
of telomere dysfunction. As previously mentioned, there are two proposed theories 
for the generation of telomere dysfunction in non-critically short telomeres. Our group 
proposed that genomic stress leads to DSBs within telomeric regions, which are 
irreparable and lead to persistent telomere dysfunction (Hewitt et al., 2012). 
Moreover, another group suggested that uncapping of telomeres, which still retain 
enough shelterin proteins to inhibit NHEJ, could elicit a persistent DDR at telomeres 
(Cesare, Kaul et al. 2009). To address this, we utilised the resolving power of super-
resolution fluorescence imaging, specifically: stochastic optical reconstruction 
microscopy (STORM), to visualise t-loop structures  after X-irradiation, a model which 
has shown to induce persistent DDR foci at telomeres (Hewitt et al., 2012).  
To optimise conditions for STORM imaging, we first visualised telomeres of 
proliferating untreated paraformaldehyde-fixed MEF cells. Telomeres were visualised 
using FISH with a telomere-specific PNA probe conjugated to a photo-switchable dye 
(TelC-Cy5). Merged images comparing conventional confocal microscopy against 
STORM imaging show an enhanced resolution of telomere signal with STORM 





Figure 3-9. STORM Microscopy Enhances Resolution of MEF Telomeres 
compared to Conventional Confocal Microscopy. (A) Untreated MEFs were fixed 
on coverslips, and telomeres were detected using FISH with a telomere specific PNA 
probe conjugated to a photoswitchable dye (TelC-Cy5). Images represent MEF 
telomeres visualised with conventional confocal microscopy and STORM imaging at 
100X objective. Lower panels display an amplification of an area of the above image. 
Scale bar: 0.5µM.  
 
Having optimised experimental conditions for the utilisation of the TelC-CY5 PNA 
probe for use with STORM imaging, we next performed chromatin spreads to 
orientate telomeres in a way which the t-loop can be visualised by STORM imaging. 
We show that the t-loop structure can be visualised with STORM imaging, however 
not with conventional confocal microscopy (Figure 3-10A-B). Previous 
experimentation has shown that conventional confocal microscopy does not have the 
resolving power to visualise the t-loop structure (Doksani et al., 2013). 
We then quantified the percentage of t-loops in telomeres from MEFs which were 
untreated, compared to those which had been treated with 10Gy IR. In untreated 
MEFs, we observed that slightly under 25% of all telomeres presented a t-loop 
structure, and there was no significant difference in the  percentage of telomeres with 
t-loops 3 days following X-irradiation with 10Gy (Figure 3-10C). These data would 
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suggest that telomere dysfunction is not dependent upon t-loop uncapping, although 
there are some experimental caveats which prevent the firm assumption of this 




Figure 3-10. 10Gy X-Irradiation does not alter the Percentage of t-loops in 
Chromatin Spreads of MEF Nuclei. (A) MEFs were irradiated with 10Gy and 
incubated for 3 days. Nuclei were then isolated, followed by in situ cross-linking with 
psoralen, chromatin spreading, and telomeres were detected by FISH with a 
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telomere specific PNA probe conjugated to a photoswitchable dye (TelC-Cy5), before 
STORM imaging. (B) (Top Panel) Representation of chromatin-spread telomeres 
(green) and DAPI (blue) via conventional confocal microscopy with 100X objective. 
(Bottom Panel) Representation of chromatin-spread telomeres (green) via STORM 
imaging with 100X objective. (D) Percentage of t-loops in 10Gy irradiated MEF cells. 
Data are mean ± SEM of n=3. Statistical analysis performed using two tailed t test; 




For some time after the discovery of telomeres, an understanding of the mechanism 
which prevented telomeres from undergoing end-to-end fusion remained elusive. 
Research finally emerged which showed that fibroblasts transfected with a dominant-
negative TRF2 became susceptible to end-to-end fusions (van Steensel et al., 1998). 
Soon after, it was discovered that TRF2 could drive the formation of the t-loop 
structure in isolated telomere fragments in vitro, thus physically sheltering the ends of 
telomeres (Griffith et al., 1999). Research then showed that NHEJ in de-protected 
telomeres was dependent on DNA ligase IV (Smogorzewska et al., 2002). More 
recently, it was shown via STORM imaging that TRF2 was essential for the formation 
of t-loops in MEFs in vitro (Doksani et al., 2013). The t-loop therefore provides an 
elegant mechanism to protect the ends of chromosomes from being recognised by 
the DDR machinery, however, evidence is emerging which suggests that the 
mechanisms which protect chromosome ends from being recognised as DNA 
damage, and inhibit end-to-end fusion, could be preventing telomeric DNA repair 
from stochastic DNA damage. Moreover, it was published that cells exposed to X-
irradiation, or other genotoxic stresses such as hydrogen peroxide or 
neocarzinostatin were able to repair non-telomeric DNA damage, however telomere 
damage was irreparable, therefore resulting in a persistent DDR at telomeres (Hewitt 
et al., 2012). Another striking observation was that Q-FISH analysis showed that 
telomere dysfunction in murine enterocytes and hepatocytes was occurring 
independently of telomere length in vivo (Hewitt et al., 2012). A possible explanation 
for this phenomenon has been proposed by our group and another, which suggests 
that a persistent DDR could be elicited at telomeres due to the presence of a physical 
DSB, which remains irreparable due to the inhibitory effect of the shelterin complex 
on the DDR machinery (Fumagalli et al., 2012; Hewitt et al., 2012). This idea is 
supported by data showing that ectopic expression of the shelterin protein TRF2 next 
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to a DSB within non-telomeric DNA leads to an inhibition of repair and a prolonged 
DDR (Fumagalli et al., 2012). However, another proposed models suggest that 
telomere uncapping could be induced in long telomeres due to inhibition of TRF2 
(Cesare et al., 2009), and interestingly, oxidative stress has been shown to disrupt 
the ability of both TRF1 and TRF2 to recognise telomeric DNA (Opresko et al., 2005). 
Furthermore, TRF2 has also been shown to localise to genomic DSB following X-
irradiation (Bradshaw et al., 2005). Together, these data provide evidence that 
oxidative stress can result in a reduction of shelterin components at telomeres, thus 
adding credence to the idea that a DDR at long telomeres could be due to inhibition 
of TRF2 and subsequent uncapping, independently of a DSB. Whilst further research 
is required to fully ascertain the mechanism leading to telomere damage in non-
critically short telomeres, these observations that telomere length-independent 
damage can occur, suggest that telomere dysfunction might also affect non-
proliferative cell types. We sought to ascertain if the phenomenon of telomere 
irreparability was unique to proliferative cells such as fibroblasts, or whether non-
rapidly dividing cells, could also be subject to persistent telomeric damage. To begin, 
we isolated mouse embryonic cardiomyocytes and exposed them to X-irradiation. 
Our data showed that there is an initial increase in both telomeric damage and 
genomic damage following IR, however with time, the majority of genomic damage is 
repaired, yet the telomeric damage remains unaltered, leading to an enrichment of 
the percentage of total damage co-localising with telomeres over time. Furthermore, 
there was no significant change in the percentage of cells positive for TAF over the 
time course of the experiment, suggesting that once a cell acquires a TAF, it is 
persistent. These data confirmed that mouse embryonic cardiomyocyte TAF are also 
persistent upon stress-induced damage, as previously shown in both mouse and 
human fibroblasts (Hewitt et al., 2012). To validate our findings in another cell model, 
we used H9C2 rat-derived cardiomyocytes and performed the same experiment and 
analysis, which revealed similar results; persistent telomeric damage following IR. A 
persistent DDR has previously been shown to activate p21, which in turn causes 
mitochondrial dysfunction and aberrant ROS generation,  which can lead to further 
DNA damage, thus initialising a feedback loop (Passos et al., 2010). Therefore, it 
could be hypothesised that, although TAF persistence over the course of several 
days following IR would imply irreparability, TAF numbers could potentially be 
maintained by a feedback loop resulting in a balanced flux between induction an 
repair, however evidence suggests that only short-lived DDF are generated as a 
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result of senescence-associated ROS in vitro (Passos et al., 2010). To test this in 
cardiomyocytes, live-cell time-lapse microscopy was used, and H9C2 cells were 
transfected with the fusion protein AcGFP-53BP1c, to allow foci dynamics to be 
tracked in real-time. Our group have previously published, using a AcGFP-53BP1c 
fusion protein, coupled with microbead-mediated incorporation of a fluorescent 
telomere specific PNA probe, that all persistent DDR foci over the course of several 
hours co-localise with telomeres, whereas those DDR foci not co-localising with 
telomeres are transient (Hewitt et al., 2012). We had initially planned to emulate this 
experiment using microbead-mediated incorporation of a PNA probe, however 
sensitivity of the H9C2 cells to the microbeads resulted in considerable cell death. 
We therefore transfected H9C2 cells with AcGFP-53BP1c alone, and tracked DDR 
foci in H9C2 cells, 72 hours after 10Gy IR, every 10 minutes for 10 hours. We 
observed that the majority of DDR foci are resolved within 8 hours, however a repair 
plateau is reached at this point, with around 20% of the foci persistent throughout. 
Our data in fixed cells show that at the same time point of 3 days following 10Gy IR, 
around 15% of DDR foci co-localise with telomeres in H9C2 cells. Our observations 
in both fixed cells and live-cells complement one another to suggest that X-irradiation 
can induce irreparable TAF in H9C2 cardiomyocytes. 
One mechanism for the induction of double strand breaks involves replication errors 
from the DNA replication machinery, when replication forks encounter single strand 
breaks in the genome (Kuzminov, 1999). However, the relevance of this in the 
context of cardiomyocytes in vivo is questionable, as the proliferation rates of 
cardiomyocytes is negligible, with estimates suggesting that 60% of cardiomyocytes 
present in humans at birth, still remain at 50 years of age (Bergmann et al., 2009). 
Furthermore, evidence now suggests that mouse cardiomyocytes can undergo 
proliferation, however estimates suggest the rate to be less than around 4% per year 
in young adult mice, which decreases significantly with age (Malliaras et al., 2013; 
Senyo et al., 2013), therefore suggesting that replication-associated telomere 
shortening is not a major factor in both mouse and human cardiomyocytes. We 
therefore wanted to investigate if TAF could be induced in cardiomyocytes 
independently of DNA replication. Our data show that X-irradiation can induce TAF in 
cardiomyocytes that have not undergone DNA replication, as evident by an increase 
of TAF in cells which did not incorporate the thymidine analogue EdU following IR. X-
irradiation is a useful tool for inducing double strand breaks within the genome, 
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however it cannot be considered a physiologically relevant model. To address this, 
we investigated if TAF could also be induced with H2O2 exposure. One group have 
observed an age-dependent increase in cardiac mitochondrial H2O2 production 
(Judge et al., 2005), thus H2O2 treatment more closely emulates physiological 
endogenous oxidative stress. Our data show, that similarly to IR, TAF can be induced 
independently of replication with H2O2 treatment.  
Telomere dysfunction has previously been shown to play a role in driving cellular 
senescence and apoptosis in H9C2 cardiomyocytes. Moreover, low level TRF2 
down-regulation by siRNA induced cellular senescence, whereas high concentrations 
of TRF2 siRNA led to apoptosis (Spallarossa et al., 2009). TRF2 is the quintessential 
shelterin component in t-loop formation, and thus downregulation will lead to 
uncapping of telomeres and a persistent DDR (Doksani et al., 2013). Telomere 
uncapping, as a consequence of steric constraints on the t-loop structure, seems 
unlikely in cardiomyocytes, so we therefore investigated if physical DSBs within 
telomere regions could induce senescence in these cells. By transfecting cells with 
an expression plasmid encoding a TRF1-FokI fusion protein, we were able to induce 
DSBs specifically in telomeric regions, which resulted in H9C2 cells displaying 
various characteristics of senescence, including elevated SA-β-Gal activity and p21 
expression, increased cell size, and a decrease in the percentage of cells positive for 
the proliferation marker Ki-67. The physiological relevance of permanent cell cycle 
arrest in a cell which is unlikely to ever divide is questionable, however other aspects 
of the senescent-phenotype could potentially be detrimental to the surrounding 
tissue. Moreover, research has shown that senescent cells secrete a number of 
factors which can elicit a bystander effect, capable of inducing DNA damage and 
even senescence on neighbouring cells (Hubackova et al., 2012a; Nelson et al., 
2012; Acosta et al., 2013).  
It will be important to understand the threshold of TAF required for inducing 
senescence, not only in cardiomyocytes, but in other cell types as well. Using the 
transient expression plasmid used for this investigation, one cannot control the 
number of cleavage events induced by the TRF1-FokI fusion protein. To address 
this, future research should focus on cloning the fusion protein into an inducible 
system in which expression can be turned on and off, thus being able to manipulate 
the length of time the fusion protein is expressed for. Our data also showed that the 
percentage of DDF in TRF1-FokI cells which co-localised with telomeres was not 
99 
 
100%, and therefore prevents assumptions to be made solely on the telomere-
specific contribution to senescence, especially considering that both telomeric and 
non-telomeric DDF have been shown to contribute to cellular senescence (Nakamura 
et al., 2008). Explanations for the lack of specificity could be due to the endonuclease 
cleaving genomic DNA prior to TRF1 binding to telomeres, or even once bound, 
cleaving genomic DNA which is spatially near. In the latter case, there would be no 
solution other than creating an endonuclease which only cleaved telomeric repeats, 
however, this could also be compromised because the telomere repeat sequence 
has been shown to appear in interstitial chromosomal locations in multiple vertebrate 
species, including humans (Meyne et al., 1990; Weber et al., 1990; Azzalin et al., 
1997; Ruiz-Herrera et al., 2002). However, another explanation could be that the 
TRF1-FokI specifically cleaves telomeres, and the non-telomeric DDF arise due to 
elevated ROS, by a mechanism such as the aforementioned senescence-associated 
feedback loop (Passos et al., 2010), in which case, studying the nature of telomere-
specific dysfunction would require inhibition of the pathway to prevent non-specific 
ROS induced genomic damage, which would paradoxically effect the induction of 
cellular senescence.  
Our data show that the TRF1-FokI fusion protein cleaves telomeres independently of 
telomere length. However interestingly, Q-FISH analysis of telomere length in H9C2 
cells revealed that longer telomeres are more susceptible to IR-induced damage. If 
one assumes that ionising photons are striking the genome stochastically, probability 
suggests that longer telomeres are more likely to endure damage. As previously 
described, the mechanism of stress-induced telomere dysfunction has yet to be 
conclusively elucidated. It is possible that stress-induced DSBs occur and the repair 
is inhibited by the shelterin complex (Hewitt et al., 2012), or alternatively, that stress 
destabilises the t-loop, leading to uncapping and a persistent DDR. Furthermore, 
both may occur independently, or the DDR signal from DSBs could even cause 
uncapping, by a yet unknown mechanism. To investigate this, we utilised the 
resolving power of STORM imaging, to visualise t-loop structures. Initially, we sought 
to couple the chromatin spread technique with immuno-staining for DDR proteins, 
such as γH2AX, to discover whether t-loops could be maintained in the presence of a 
DDR. Alas, we could not couple these two techniques together, potentially due to the 
chromatin isolation procedure leading to the dissociation of DNA-bound proteins. If 
the technique had worked, I would have been able to investigate if a DDR can exist 
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in the presence of a t-loop. Although, if we were to have observed a DDR in the 
presence of t-loops, this would not have proven ipso facto that t-loops can be 
maintained in the presence of double-strand breaks, as DDR signals are known to 
spread up to several megabases (Rogakou et al., 1999; Meier et al., 2007; Iacovoni 
et al., 2010), and thus the physical break could be occurring elsewhere in the 
genome. Contrary to this, if all observed telomeres co-localising with a DDR were 
uncapped, this would provide strong evidence that a DDR induces uncapping.  
Our group have previously published that X-irradiation induces TAF in MEF cells 
(Hewitt et al., 2012). To determine if X-irradiation leads to uncapping, we quantified 
the percentage of t-loops in 10Gy X-irradiated compared to untreated MEFs. Our 
data show that there is no significant difference in the percentage of t-loops after 
10Gy irradiation, suggesting that X-irradiation induces persistent double strand 
breaks in telomeric regions independently of telomere uncapping. Unfortunately, the 
sensitivity of the technique is limited so that such conclusions cannot be asserted. 
Moreover, the procedure requires cross-linking of the DNA with psoralen, which has 
an efficiency of around 1 in 400 base pairs; considering the 3’ overhang is on 
average 100 base pair (McElligott and Wellinger, 1997), this means that only 25% of 
capped telomeres would remain stabilised. Furthermore, previous data from our 
group shows that 10Gy X-irradiation only induces around 5 TAF per nuclei (Hewitt et 
al., 2012), which accounts for just 6.3% of the total telomeres, assuming a total 
telomere count of 80.  Therefore, even if all 5 were truly uncapped, the percentage of 
t-loops would be ((80-5)*0.25)/80= 23.4375%, which compared to 25% is still within 
the margin of standard error, and therefore inconclusive. It would be interesting to 
repeat these experiments in a model of significantly higher telomere dysfunction to 
conclusively elucidate if stress-induced telomere dysfunction is associated with 
destabilisation of the t-loop structure. The TRF1-FokI system could also be utilised to 
determine if t-loops remain stabilised in the presence of a telomeric DSB. This 
distinction could be important considering It has been shown that the downstream 
response pathway for telomere dysfunction is distinct from the genomic DNA damage 
response (Cesare et al., 2013), and thus understanding the distinction between TIF 
and TAF may prove important in the event that the downstream DDR mechanisms 
vary. For example, it has been shown in human fibroblasts that as little as 5 TIF 
predicts the onset of senescence in human fibroblasts (Kaul et al., 2012), however 
this may not be the case for TAF.  
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In summary, our data show that telomere dysfunction can be induced in 
cardiomyocyte cell models, and this damage can arise independently of DNA 
replication. Together, these observations suggest that telomere damage doesn’t 
arise solely as a result of telomere-attrition driven uncapping of the t-loop, and that 
long telomeres are also susceptible to telomere dysfunction. Consequently, this 
suggests that telomere dysfunction can occur in post-mitotic and non-rapidly dividing 
cells which aren’t subject to persistent end-replication associated shortening. Finally, 
we provide evidence that DSBs within telomere regions, regardless of telomere 




4 Effect of Ageing on Telomere Dysfunction in Cardiomyocytes in 
vivo 
 
In the previous chapter, we demonstrated that TAF can be generated in 
cardiomyocytes in vitro, and that this telomere dysfunction can occur independently 
of DNA replication. Our group have previously shown TAF accumulate with age in 
mouse hepatocytes and enterocytes in vivo, and that this damage occurs 
independently of telomere length (Hewitt et al., 2012), These observations of TAF 
occurring independently of DNA replication and telomere shortening, made us 
question if a post-mitotic or non-rapidly dividing cell type could also be subject to 
telomere dysfunction in vivo. Hitherto, most studies which link telomeres to cardiac 
ageing analyse telomere shortening rates in circulating leucocytes (Haycock et al., 
2014; Masi et al., 2014). Whilst this provides a good proxy for systemic organismal 
ageing, and often provides significant predictions to cardiac pathology, the method 
remains strictly correlative. We therefore investigated telomere dysfunction 
specifically in cardiomyocytes in vivo.  
For years, it was thought that cardiomyocytes had no proliferation potential at all, and 
the entirety of a mammalian’s cardiomyocyte life-time cell population would be 
present at birth, and thus, the physiological relevance of permanent cell cycle arrest 
would seem insubstantial. However, analysis of carbon-14 levels of cardiomyocyte 
DNA in people exposed to nuclear bomb tests during the Cold War revealed that 
cardiomyocyte renewal occurs in humans (Bergmann et al., 2009). Furthermore, 
evidence shows that the cardiomyocytes themselves, as opposed to a stem-cell 
population, are capable of self-renewal during normal ageing; a process which is 
increased in areas adjacent to myocardial stress (Malliaras et al., 2013; Senyo et al., 
2013). Besides proliferation cessation, senescent cells have also been shown to 
display a Senescence-Associated Secretory Phenotype (SASP), a secretory 
signalling response thought to attract immune cells to clear senescent cells (Coppé 
et al., 2008; Rodier et al., 2009). However, senescence clearance capability is 
thought to deteriorate with the age-associated decline in immune-system function, 
thus resulting in senescent cell persistence and a continuous SASP (Janko, 2008; 
Wang et al., 2011). Furthermore, the SASP has been demonstrated to elicit a 
bystander effect, which can cause DNA damage and even induce cellular 
senescence in neighbouring cells (Kosar et al., 2011; Nelson et al., 2012; Acosta et 
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al., 2013). This is of interest, as evidence now suggests that cellular senescence isn’t 
a phenomenon confined only to proliferative cells. A significant percentage of 
purkinje, cortical, hippocampal and peripheral neurons from aged mice have been 
reported to elicit many features of cellular senescence, namely: high ROS production 
and oxidative damage, activated p38MAPkinase, high levels of DNA damage, 
heterochromatinisation, interleukin IL-6 production and SA-β-Gal activity (Jurk et al., 
2012). Interestingly, these features were highly elevated in late-generation TERC-/- 
mice, suggesting that telomere dysfunction could be driving a senescent-like 
phenotype in these cells. These effects were rescued in TERC-/-CDKN1-/- mice, 
suggesting that telomere dysfunction leads to a senescent-like phenotype via p21 
activation (Jurk et al., 2012). 
In the previous chapter we showed that cardiomyocytes can elicit a persistent DDR 
at telomeres which can drive senescence in vitro, however it is unknown if persistent 
telomere dysfunction occurs in cardiomyocytes in vivo and if they are associated with 
senescence. 
To our knowledge, no studies have looked at telomere dysfunction occurring in 
cardiomyocytes specifically in vivo, and thus the aim was to investigate this, and if 
this is associated with cardiomyocyte cellular senescence. 
 
4.1 X-irradiation Induces TAF in Mouse Cardiomyocytes in vivo 
 
In the previous chapter, we showed that X-irradiation induced TAF were persistent in 
vitro in mouse embryonic cardiomyocytes and H9C2 rat-derived cardiomyocytes. We 
then wanted to investigate if TAF could be induced in cardiomyocytes in vivo and if 
this damage was persistent. 1 month old mice were exposed to 2Gy whole body X-
irradiation, followed by an 11 month recovery period, before culling at 12 months of 
age. We observed a significant increase in the mean number of cardiomyocyte TAF 





Figure 4-1. Whole body X-irradiation Induces TAF in Mouse Cardiomyocytes. 
(A) 1 Month old mice were treated with 2Gy whole body irradiation, followed by a 
recovery period of 11 months before culling at 12 months of age. (B) Mean number 
of TAF in α-actinin positive cardiomyocytes. Data are mean ± SEM of n=3. Statistical 
analysis performed using two tailed t test; * P<0.05.  
 
4.2 TAF Increase in Mice Cardiomyocytes with Age Independently of 
Telomere Length 
 
Telomere dysfunction is considered a biomarker for cellular senescence, and has 
been shown to accumulate with age in various tissues in a range of different 
organisms from mice to primates (Herbig et al., 2006; Hewitt et al., 2012).  Having 
observed that TAF can be induced in mouse cardiomyocytes by X-irradiation, in 
collaboration with Clara Correia-Melo from ours and the von Zglinicki laboratory,  we 
then investigated if TAF could occur in mouse cardiomyocytes in vivo, and if there 
was an age-dependent accumulation of telomere dysfunction. Quantifying only α-
actinin positive cardiomyocytes, we observed an age-dependent increase in both the 
mean number of TAF and the mean percentage of  cardiomyocytes positive for TAF 
(Figure 4-2A-C). However, when we quantified the number of non-TAF, we found no 
significant changes with age (Figure 4-2D-E) To validate the observation that a DDR 
could occur at cardiomyocyte telomeres, in collaboration with Jelena Mann, we 
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performed chromatin-immuno precipitation for γH2AX on whole ground frozen hearts, 
followed by quantitative real-time PCR for the detection of telomeric repeats. We 
observed a non-significant trend towards an enrichment of γH2AX at telomeric 






Figure 4-2. TAF Accumulate with Age in Mouse Cardiomyocytes. (A) 
Representative images of γH2AX immuno-FISH in 3 and 30 month old α-actinin 
positive mouse cardiomyocytes (magenta – α-actinin; red – telo-FISH; green – 
γH2AX). Images are z projections of 4.5µM stacks taken with 100X objective. Arrows 
indicate co-localisation between telomeres and γH2AX, with co-localising foci 
amplified in the right panels (taken from single z planes where co-localisation was 
found). Scale bars: left panels: 2.5µM; right smaller panels 0.5µM (B) Mean number 
of TAF – (C) Mean percentage of TAF positive – α-actinin positive cardiomyocytes in 
3, 15 and 30 month old mice. Data are represented as the mean for individual 
animals, with the horizontal line representing group mean. (D) Mean number of non-
TAF – (E) Mean percentage of non-TAF positive – α-actinin positive cardiomyocytes 
in 3, 15 and 30 month old mice. Data are represented as the mean for individual 
animals, with the horizontal line representing group mean. (F) Fold enrichment of 
γH2AX at telomere repeats by real-time PCR. Graph represents fold enrichment of 
γH2AX at telomeric repeats between IgG control, 3 and 30 month whole mouse 
hearts, for 3 independent ChIP experiments. Statistical analysis performed using One 
Way ANOVA; * P<0.05, NS (Non-Significant) P>0.05 
 
Having observed an age-dependent increase in TAF in mouse cardiomyocytes 
(Figure 4-2A-C), we wanted to determine if telomere length or telomerase activity 
were associated with this increase in telomere dysfunction. Using q-FISH analysis, 
we found that there was a slight, but significant, decrease in the mean telomere 
intensity per nucleus of cardiomyocytes from mice aged 3 compared to 30 months 
old (Figure 4-3A). Cardiac-specific adeno-associated virus activation of TERT has 
previously been shown to offer cardiac protection following myocardial infarction, and 
has been associated with longer telomeres and increased numbers of the 
proliferation markers Ki-67 and pH3 (Bär et al., 2014). To assess TERT activity, we 
used liquid nitrogen-frozen, ground whole hearts, and performed TeloTAGGG 
Telomerase PCR ELISA (an extended TRAP assay). Our data show there is no 
significant difference in telomerase activity in whole mouse hearts between 3 and 30 
months of age (Figure 4-3B). However, a caveat to consider is the lack of either a 
negative or positive control for telomerase activity, and thus one cannot rule out the 
possibility that the observed telomerase activity could be below the threshold for 
detection of a positive signal.  
In proliferative tissue, telomere shortening occurs due to the end-replication problem 
coupled with oxidative stress associated attrition (von Zglinicki et al., 1995; von 
Zglinicki et al., 2000). Age-dependent telomere shortening has been reported in 
mouse enterocytes (Flores et al., 2008; Wang et al., 2009), however, another study 
observed an age-dependent increase in telomere dysfunction in enterocytes 
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independently of telomere shortening (Hewitt et al., 2012). We sought to determine if 
the age-dependent increase in telomere dysfunction (Figure 4-2A-C) was associated 
with telomere length. We performed Q-FISH analysis, and quantified the intensity of 
telomeres co-localising with a DDR, compared to telomeres not co-localising with a 
DDR in 30 month old mice. Our data show that there is no significant difference 
between the lengths of telomeres which co-localise with a DDR, compared to those 
that do not (Figure 4-3C). 
 
 
Figure 4-3. TAF Accumulate in Mouse Cardiomyocytes Independently of 
Telomere Length. (A) qFISH analysis comparing mean telomere intensity per nuclei 
of 3 and 30 month mouse cardiomyocytes. >100 nuclei were analysed per condition, 
and data are represented as the mean for individual animals, with the horizontal line 
representing group mean. (B) Quantitative PCR-ELISA TRAP assay comparing 
telomerase activity of 3 and 30 month mouse whole heart lysates. Data are mean ± 
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SEM of n=4. Scale bar: 0.5µM. (C) Representative image of telomere co-localising 
(a) or not (b) with γH2AX foci (red – telomere; green – γH2AX) taken from a single Z 
plane at 100X objective. Adjacent graphs represent quantification of telomere and 
γH2AX signal intensity. Histograms displaying telomere intensity for telomeres co-
localising (bottom) or not co-localising (top) with γH2AX DDR foci. Red dotted lines 
represent median > 100 telomeres per condition. Statistical analysis performed using 
two-tailed t test; * P<0.05, NS (Non-Significant) P>0.05. Mann-Whitney tests show no 
significant difference in telomere intensity between TAF and non-TAF in 30 month old 
mouse cardiomyocytes (P>0.05).  
 
4.3 TAF Accumulate in Human Cardiomyocytes Independently of 
Telomere Length  
 
Having shown an age-dependent accumulation of TAF in mouse cardiomyocytes, 
occurring independently of telomere shortening (Figure 4-2 & Figure 4-3), we then 
wanted to ascertain if human cardiomyocytes were also susceptible to telomere 
dysfunction. We acquired human right atrial appendage tissue from patients 
undergoing surgery for aortic stenosis, and thus the cardiomyocytes from this region 
should not be associated with any disease pathology. Immuno-FISH analysis 
revealed that there is an age-dependent increase in mean number of TAF and 
percentage of TAF positive cells, in pericentriolar material 1 (PCM-1) positive human 
cardiomyocytes (Figure 4-4A-C). We then performed Q-FISH analysis, and quantified 
the intensity of telomeres co-localising with a DDR, compared to telomeres not co-
localising with a DDR in both the 46-65 and 74-82 year old age groups. Our data 
show that there is no significant difference between the lengths of telomeres which 






Figure 4-4. TAF Accumulate with Age in Human Cardiomyocytes. (A) Mean 
number of TAF – (B) Mean percentage of TAF positive – PCM1-positive human 
cardiomyocytes from 46-65 and 74-82 year old human heart tissue. Data are 
represented as the mean for individual patients, with the horizontal line representing 
group mean. (C) Representative images of γH2AX immuno-FISH in PCM1-positive 
111 
 
human cardiomyocytes (blue – DAPI; yellow – PCM1; red – telo-FISH; green – 
γH2AX). Images are z projections of 4.5µM stacks taken with 100X objective. Arrows 
indicate co-localisation between telomeres and γH2AX, with co-localising foci 
amplified in the right panels (taken from single z planes where co-localisation was 
found). Scale bars: left panel - 5µM, middle panel – 2.5µM, right panels – 0.25µM (D) 
Histograms displaying telomere intensity for telomeres co-localising (bottom) or not 
co-localising (top) with γH2AX DDR foci for cardiomyocytes taken from patients 46-
65 (left) and (74-82) years old. Red dotted lines represent median intensity > 45 
telomeres per condition. Mann-Whitney tests show no significant difference in 
telomere intensity between TAF and non-TAF in either, 46-65 or 74-82 year old 
patients (P>0.05). 
 
An intermediate state of telomeres has been proposed in which telomere uncapping 
could occur due to inhibition of TRF2 (Cesare et al., 2009). Furthermore, In vitro, it 
has been shown by STORM imaging that knock down of the shelterin component 
TRF2 results in uncapping of the t-loop (Doksani et al., 2013). We therefore 
investigated if TRF2 abundance varied at dysfunctional telomeres. Firstly, we 
observed that as expected, TRF2 co-localised with telomeres (Figure 4-5A). Next, Q-
FISH analysis, of the mean abundance of TRF2 bound to telomeres co-localising 
with a DDR, compared to the abundance at telomeres not co-localising with a DDR 
revealed no significant differences; TRF2 abundance at human cardiomyocyte 





Figure 4-5. TAF occur Independently of TRF2 Abundance in Human 
Cardiomyocytes. (A) Representative images of TRF2 immuno-FISH in PCM1-
positive human cardiomyocytes (blue – DAPI; yellow – TRF2; red – telo-FISH; green 
– γH2AX). Images are z projections of 4.5µM stacks taken with 100X objective. Scale 
bar: 0.5µM. (B) Histograms displaying TRF2 fluorescence intensity for TRF2 foci co-
localising with telomeres and either: not co-localising with γH2AX (left) or co-
localising with γH2AX (right) in human cardiomyocytes. Red dotted lines represent 
median intensity > 75 telomeres per condition. Mann-Whitney tests show no 
significant difference in TRF2 intensity between TRF2 abundance at TAF and non-
TAF (P>0.05).  
 
4.4 Cardiomyocytes are Associated with Senescent Markers. 
 
Cellular senescence in vivo has been associated with numerous age-related 
diseases, as reviewed in (Muñoz-Espín and Serrano, 2014). Moreover, drug-induced 
clearance of p16(Ink4a) positive cells delayed age-related disorders in the BubR1 
progeroid, INK-ATTAC,  mouse model (Baker et al., 2011). We sought to investigate 
if there is an age-dependent increase in senescent cells in cardiomyocytes. In 
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collaboration with Damien Maggiorani from the Mialet-Perez group, we isolated 
cardiomyocytes from 3 and 20 months old mice and performed qRT-PCR gene 
expression analysis and found that there is a significant age-dependent increase in 
p15, p16 and TGF-β (Figure 4-6A) 
 
 
Figure 4-6. Senescence-Associated Genes are Upregulated with Age in Mouse 
Cardiomyocytes. (A) Gene expression analysis of senescence markers, by Real-
Time PCR of isolated mouse cardiomyocytes from mice 3 and 20 months of age. 
Data are represented as the mean for individual mice, with the horizontal line 
representing group mean. Statistical analysis performed using two-tailed t test; * 
P<0.05. 
 
Having observed an upregulation of senescent markers at the mRNA level, we 
wanted to investigate if any other markers of senescence were also up-regulated with 
age in cardiomyocytes. In collaboration with Jodie Birch from our laboratory, we 
observed an age dependent increase in p21 protein expression, as quantified by 
percentage of cardiomyocytes staining positive for p21 by IHC (Figure 4-7A-B).  
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Recent research has shown that centromeric satellite DNA becomes unravelled upon 
the induction of senescence in both mouse and human fibroblasts, a phenomenon 
coined senescence-associated distension of satellites (SADs) (Swanson et al., 
2013). In collaboration with Mikolaj Ogrodnik from both ours and the von Zglinicki 
laboratory, we investigated if SADS also occurred during cardiomyocyte ageing, and 
found an age-dependent increase in SADs events in mouse cardiomyocytes (Figure 
4-7C-E). The lipid peroxidation marker has been shown to associate with various 
senescence markers in murine neurones (Jurk et al., 2012), and we observed that 
there is also an age-dependent increase in 4-HNE positive cardiomyocytes (Figure 
4-7F-G). Cardiac fibrosis has been observed to increase with age in numerous 
species from mice to humans (Burkauskiene et al., 2006; Dai et al., 2009), and thus 
we investigated fibrosis to confirm normal cardiac ageing in our mouse colony, and in 
collaboration with Gavin Richardson, we observed a significant increase in Sirius red 









Figure 4-7.  Senescence Markers Increase with Age in Mouse Cardiomyocytes. 
(A) Quantification of the percentage of cardiomyocytes staining positive for p21 by 
IHC. Data are represented as the mean for individual mice, with the horizontal line 
representing group mean. (B) Representative images of p21 IHC in cardiomyocytes 
from mice aged 3 and 30 months (nuclear counter stain – blue; p21 – brown). (C) 
Quantification of the average number of SADS events per cell in mouse 
cardiomyocytes aged 3 and 30 months. Data are mean ± SEM of n=3. Scale bar: 
15µM. (D) Quantification of the mean percentage of SADS positive mouse 
cardiomyocytes aged 3 and 30 months. Data are mean ± SEM of n=3.  (E) 
Representative images of SADS events in 3 and 30 month old mouse 
cardiomyocytes (blue – DAPI; green foci – centromeres). Arrow represents a SADS 
event. Scale bar: 10µM. (F) Mean percentage of 4-HNE positive cardiomyocytes in 3, 
15 and 30 month old mice. Data are represented as the mean for individual animals, 
with the horizontal line representing group mean. (G) Representative images of 4-
HNE IHC in 3, 15 and 30 month old mouse cardiomyocytes (blue – nuclear counter 
stain; brown cytoplasmic staining – 4-HNE). Scale bar: 15µM. (H) Representative 
image of fibrosis via Sirius red staining in mice aged 3 and 30 months (white; 
fibrosis). Scale bar: 50µM. Statistical analysis performed using One way ANOVA or 
two-tailed t test; * P<0.05.  
    
4.5 An Age Dependent Bystander Effect from Mouse Cardiomyocytes  
 
Having shown that there is an age-dependent increase in senescence markers in 
mouse cardiomyocytes in vivo, we wanted to determine if aged cardiomyocytes could 
have a detrimental effect on surrounding cells. Interestingly, we observed that TGF-β 
is significantly upregulated with age in mouse cardiomyocytes (Figure 4-6), and this 
has been shown to be one of the key proteins associated with eliciting a detrimental 
bystander effect in fibroblasts (Acosta et al., 2013). We wanted to determine if aged 
cardiomyocytes could elicit a detrimental bystander effect on neighbouring cells. We 
specifically isolated cardiomyocytes from 3 and 20 month age mice, from the same 
cohort showing an age-dependent increase in senescence markers. We then 
cultured the cardiomyocytes for 48 hours, before collecting conditioned medium from 
them. Following this, we cultured MAFs in conditioned medium from 3 and 20 month 
old mice for 4 days. On the last day, we cultured cells in the presence of the modified 
thymidine analogue EdU for 8 hours and then assessed proliferation levels in this 
time period as measured by EdU incorporation. Our data show that MAFs cultured in 
conditioned medium from cardiomyocytes from 20 month old mice had a significantly 
lower incorporation of EdU, compared to MAFs cultured in conditioned medium 







Figure 4-8. Conditioned Medium from Old Mouse Cardiomyocytes Reduces 
Proliferation of Fibroblasts. (A) Cardiomyocytes from 3 and 30 month old mice 
were isolated and cultured for 48 hours. Conditioned medium was then collected. 
MAFs were cultured in conditioned medium + normal growth medium (1:1), for 4 
days, with medium replenished after 2 days. Following this, cells were incubated in 
the presence of 10µM EdU before fixation.   (B) Quantification of the mean 
percentage of MAFs positive for EdU incorporation Data are mean ± SEM of n=3 (C) 
Representative images of EdU incorporation from MAFs cultured in conditioned 
medium from cardiomyocytes isolated from 3 or 20 months old mice (blue – DAPI; 
red – EdU). Statistical analysis performed using two-tailed t test; * P<0.05. 
 




Having shown the phenomenon of telomere dysfunction occurring in cardiomyocytes 
in vivo, we wanted to determine if this could also occur in other non-rapidly dividing/ 
post-mitotic cells. Immuno-FISH analysis revealed that there is an age-dependent 
increase in mean number of TAF and percentage of TAF positive cells, in quad 
muscle myocytes from 3 to 15 to 30 months of age (Figure 4-9A-B).  
 
 
Figure 4-9. TAF Accumulate with Age in Mouse Quad Muscle Myocytes. (A) 
Mean number of TAF – (B) Mean percentage of TAF positive in quad muscle 
myocytes in 3, 15 and 30 month old mice. Data are represented as the mean for 




Following on from our observations that persistent TAF could be induced in 
cardiomyocytes independently of cell division in vitro, we wanted to ascertain if TAF 
could be induced in cardiomyocytes in vivo, and if there was an age-dependent 
association and increase in senescent markers. Cardiomyocytes provide a good 
model for assessing the persistence of damage, as due to negligible proliferation 
(Figure 4-3), damage can rarely be diluted via cell division. To begin, as a proof-of-
principle we used whole body X-irradiation on 1 month old mice, and observed a 
significant increase in the number of TAF after an 11 month recovery period, 
suggesting that the damage is persistent.  Unfortunately, we did not assess a group 
immediately after X-irradiation, to determine if TAF numbers had altered during the 
subsequent 11 month recovery period. Moreover, as discussed for our in vitro data 
for TAF persistence in the previous chapter, unless foci dynamics are constantly 
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monitored in real-time, one cannot conclusively confirm persistence. Furthermore, 
research has shown that persistent DDR results in activation of several downstream 
pathways, which results in mitochondrial dysfunction, and reactive oxygen species 
generation, which in turn causes further DNA damage, thus initialising a feedback 
loop (Passos et al., 2010)(Correia-Melo et al., 2016). However unlikely, it is therefore 
plausible that DDF could constantly be being turned over, whilst retaining a 
consistent number. However, considering our group and others have published that 
TAF are persistent in fibroblasts in vitro (Fumagalli et al., 2012; Hewitt et al., 2012), 
coupled with our observations that TAF are persistent in cardiomyocytes in vitro, an 
interpretation of the X-irradiation data is that TAF which are induced as a direct result 
of ionising radiation are irreparable and persisted for the following 11 months. 
However, live cell time-lapse microscopy in vitro experiments only tracked the 
persistence of TAF for a matter of several hours (Hewitt et al., 2012), and fixed cell 
TAF time course experiments only for several weeks,  and thus the long term 
persistence of TAF in vivo, cannot be conclusively deduced.  
X-irradiation was only used as a proof-of-principle to induce TAF, however, patients 
who have been exposed to excessive ionising radiation have an increased risk of 
developing cardiovascular disease (Adams et al., 2003; Mone et al., 2004; Little, 
2010; Shimizu et al., 2010). This increased risk of heart disease in patients exposed 
to ionising radiation could be due to systemic effects rather than cardio-specific, 
however female patients who have had radiotherapy for left breast cancer, have a 
significantly higher risk of developing cardiovascular disease, compared to those 
patients treated for right breast cancer (Darby et al., 2003; Taylor et al., 2008; Taylor 
et al., 2009). In this context, understanding the nature of ionising radiation induced 
cardiac damage therefore has therapeutic importance.  
Next we showed that there is an age-dependent increase in TAF in both mouse and 
human cardiomyocytes. In addition, we also report an age-dependent increase in 
quad myocyte TAF, therefore confirming the existence of telomere dysfunction in 
another myocyte cell type. The potential mechanisms driving TAF generation in a 
non-rapidly dividing cell type will be discussed further in the next chapter. To confirm 
that we were observing DDR proteins in the telomeric regions, and not merely foci 
spatially close enough to provide false-positives from lack of microscopy resolving 
power, we performed ChIP for γH2AX, followed by RT-PCR specifically for telomeric 
repeats in mouse heart tissue. The methodology used for this experiment used 
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ground whole hearts, and thus all cardiac cell types and not just cardiomyocytes 
were analysed. Nevertheless, this confirmed the presence of a DDR in telomeric 
repeats in cardiac cell types in vivo, however as discussed in the previous chapter, 
the possibility remains that physical damage could have occurred elsewhere in the 
genome, as the γH2AX signal has been shown to be amplified, and can spread for 
several kilobases (Rogakou et al., 1999; Meier et al., 2007; Iacovoni et al., 2010). 
Regardless, we observe a significant age-dependent increase in TAF, whereas non-
TAF remain unaltered with age. This suggests that there is a significant distinction 
between what we observe to be TAF compared to non-TAF. If one were to 
hypothesise that all damage was occurring downstream and not at telomeres 
specifically, the only explanation for this would be that a DDR in telomeric regions is 
less readily resolved compared to the rest of the genome. Or if we assume the 
damage is occurring at telomeres, then there is evidence suggesting that telomere 
damage is irreparable (Fumagalli et al., 2012; Hewitt et al., 2012) and thus TAF 
would be significantly higher than non TAF. In addition, there is also evidence 
showing that guanine triplets, as found in telomeres, are more sensitive to oxidative 
stress-induced damage (Henle et al., 1999; Oikawa et al., 2001); these ideas are not 
mutually exclusive and could both contribute to the observation that TAF are 
significantly increased with age, whereas non-TAF are not. As discussed in the 
previous chapter, the nature of telomere dysfunction still remains elusive, whether 
the observed DDF are a result of uncapping, or a physical break in the DNA. There 
also remains the possibility that the observed telomere DDF are due to telomere 
uncapping, and evidence shows that the recognition of telomeres by TRF1 and TRF2 
is disrupted following oxidative damage (Opresko et al., 2005). However, our analysis 
of TRF2 abundance at telomeres co-localising with a DDR, compared to those which 
are not, would suggest that there is no association between TRF2 abundance and 
incidence of telomere dysfunction, suggesting that ROS-induced TRF2 inhibition-
mediated uncapping is unlikely to be driving telomere dysfunction in human 
cardiomyocytes.  
It has been proposed that an intermediate state of telomeres, which are uncapped 
and signal a DDR, but retain significant shelterin to inhibit NHEJ, are mainly due to 
steric constraints on short telomeres (Cesare et al., 2009). Furthermore, research 
has shown that late generation TERC-/- mice, which have critically short telomeres, 
display decreased cardiomyocyte proliferation, and an increase in cardiac 
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hypertrophy and apoptosis (Leri et al., 2003). Whilst we did not detect any variation in 
telomerase activity between young and old mice, we did observe a slight, but 
significant age-associated decrease in telomere length in cardiomyocytes from 3 
compared to 30 month old mice. Mouse cardiomyocytes have been shown to 
turnover, albeit at rates of less than 4% annually (Malliaras et al., 2013; Senyo et al., 
2013), however this may explain the slight decrease in telomere length we observed. 
Interestingly, telomere length has also been shown to decrease in the neurones of 
patients with Alzheimer’s disease (Franco et al., 2006), thus raising the possibility 
that telomere shortening may possibly occur due to a yet unknown mechanism, 
independent from DNA replication-induced end-replication problem and 
accompanying oxidative stress-accelerated attrition (von Zglinicki et al., 1995; von 
Zglinicki et al., 2000) .Regardless of this, our data suggest that cardiomyocyte 
telomere shortening is not responsible for the age-dependent increase in telomere 
damage, as in both human and mouse cardiomyocytes we observed that telomere 
dysfunction was occurring independently of length, suggesting that uncapping due to 
steric constraints on the t-loop are unlikely to be driving age-associated telomere 
dysfunction.  
As discussed in the previous chapter, the use of telomerase knock out mice, 
produces telomere shortening unlikely to be experienced under physiological 
conditions, and especially in cardiomyocytes,   however if both TAF and TIF are 
shown to activate the same downstream signalling pathways, then it will provide a 
valuable tool for predicting the physiological impact of TAF on cells and tissue. 
Research has shown that post-mitotic adipocytes and neurones can elicit a 
senescence-like phenotype (Minamino et al., 2009; Jurk et al., 2012), including a 
persistent DDR; which has been shown to trigger the SASP in fibroblasts (Rodier et 
al., 2009). However, until now, there has been little evidence suggesting a 
senescent-like phenotype in cardiomyocytes in vivo. P21 has been shown to halt cell 
cycle following DNA damage, and if persistent can activate p38-MAPK upregulation 
which can lead to mitochondrial dysfunction and ROS production, followed by p16 
activation in human fibroblasts (Passos et al., 2010; Freund et al., 2011). Our RT-
PCR and IHC analysis revealed an age-dependent upregulation of p15, p16 and p21 
all of which have been associated with an accumulation during senescence (Alcorta 
et al., 1996; Serrano et al., 1997; Robles and Adami, 1998; Hitomi et al., 2007). TGF-
β is an important SASP component as it has been associated with driving paracrine 
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senescence is neighbouring cells (Acosta et al., 2013). Furthermore, inhibition of 
TGF-β in senescent cells has been shown to attenuate the increase in ROS 
production and DDR activation in bystander cells (Hubackova et al., 2012a). We 
therefore investigated if cardiomyocytes elicited an age-associated bystander effect. 
Isolated cardiomyocytes from adult mice only survive for around 48 hours in cell 
culture, which wouldn’t provide sufficient time to perform bystander experiments. We 
therefore collected conditioned medium from isolated cardiomyocytes within this time 
period and used this to culture MAFs for several days. Our data show that MAFs 
cultured in medium from aged cardiomyocytes have significantly decreased rates of 
proliferation, suggesting cardiomyocytes can also elicit a bystander effect. Due to 
sparsity of conditioned medium, we were unable to perform further experimentation 
into categorising the bystander effect for other markers of senescence. In addition, it 
will also be important to perform the bystander experiments in the presence of 
neutralising antibodies to ascertain which SASP factors are responsible for driving 
paracrine senescence in cardiomyocytes.  
Epigenetic changes have also been shown to be a hallmark of cellular senescence in 
various cell types, for example senescence-associated heterochromatin foci (SAHF) 
appear following senescence and are associated with the stable repression of E2F 
target genes (Narita et al., 2003). However, the use SAHF as a marker for cellular 
senescence is questionable as they appear to be absent from all senescent mouse 
cells and numerous senescent human cell types (Narita et al., 2003; Kennedy et al., 
2010). Another epigenetic modification which has been observed is the unravelling of 
centromeres, known as senescence-association distension of satellites (SADS) 
(Swanson et al., 2013). Interestingly, SADS have been observed to occur in both 
mouse and human senescent cells, and by numerous senescence inducers, 
including both oxidative stress and oncogenic Ras overexpression (Swanson et al., 
2013). Another important finding is that SADS also appear during the induction of 
senescence in cells from patients with Hutchinson Guilford Progeria disease 
(Swanson et al., 2013). Our data show an age-dependent increase in SADS in 
murine cardiomyocytes, and provide another marker to determine a senescent-like 
phenotype in cardiomyocytes in vivo. 
Our analysis also revealed an age-dependent increase in the lipid peroxidation 
marker 4-HNE. Although 4-HNE is not generally considered to be a marker of cellular 
senescence per se, it’s accumulation has been shown to associate with various other 
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senescence markers, including elevated SA-β-Gal activity and increased γH2AX foci 
(Wang et al., 2009; Nelson et al., 2012). 4-HNE can lead to stable 4-HNE protein 
adducts, by covalently modifying lysine, cysteine and histidine residues of proteins, 
which can lead to severe functional impairment of both soluble and membrane 
proteins (Crabb et al., 2002; Negre-Salvayre et al., 2003; Ferrington and Kapphahn, 
2004). Proliferative cells can dilute lipid peroxidation through cell division, however, 
considering the majority of cardiomyocytes present at birth are still present at 50 
years of age (Bergmann et al., 2009), cardiomyocytes can have to endure a lifetime 
of oxidative damage accumulation. For example, post-mitotic cells are prone to 
lipofuscin accumulation (Ulf and Alexei, 2002), therefore understanding the 
mechanisms driving this are of therapeutic importance.  
Using a combination of different cellular senescence markers, we have shown, for 
the first time, that there is an age-dependent accumulation of a senescent phenotype 
specifically in cardiomyocytes in vivo. On a cell-autonomous level, senescence would 
act to prevent cardiomyocyte proliferation, which may seem inconsequential 
considering the low rate of cardiomyocyte proliferation (Bergmann et al., 2009), 
however, cardiomyocyte replication has been shown to increase during times of 
myocardial stress (Senyo et al., 2013), and thus senescence may attenuate the 
ability for cardiac repair after an infarction. Furthermore, our in vitro data show an 
increase in cardiomyocyte hypertrophy after senescence-initiation and cardiomyocyte 
hypertrophy is associated with various cardiomyopathies (Berenji et al., 2005). It will 
be therefore be important to ascertain whether TAF are associated with 
cardiomyocyte hypertrophy in vivo. Although cardiomyocyte hypertrophy is a 
physiological response to exercise, pathological hypertrophy is detrimental, as it is 
not associated with increased pumping, however is associated with myocardial 
fibrosis, which we and others have shown accumulates with age in the heart 
(Lombardi et al., 2003). On a non-cell autonomous level, senescence is associated 
with a SASP, which involves the secretion of pro-inflammatory cytokines, and chronic 
inflammation is a hallmark of pathological ageing, and has been observed in 
cardiomyopathies, such as atherosclerosis (Libby, 2002; Coppé et al., 2008). In 
addition, senescent cells have been shown to elicit a bystander effect in neighbouring 
cells, which can induce DNA damage and further senescence (Hubackova et al., 
2012a; Nelson et al., 2012; Acosta et al., 2013).  
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To conclude, hitherto most studies investigating the role of telomeres in cardiac 
function have been correlative, by comparing telomere length in leucocytes and 
inferring (Masi et al., 2014). We have shown for the first time that there is an age-
dependent increase in telomere damage in both mouse and human cardiomyocytes, 
occurring independently of telomere length. We also observed an age-dependent 
increase in markers of senescence in cardiomyocyte in vivo and signs of aged 
cardiomyocytes being capable of eliciting a bystander effect. Our in vitro data using 
the TRF1-FokI fusion protein provides evidence that TAF trigger the development of 
senescence in cardiomyocyte in vitro, however, in order to truly ascertain if 
cardiomyocyte TAF drive cardiomyocyte senescence in vivo, a similar fusion protein 
would need to be targeted specifically to cardiomyocytes in vivo. Furthermore, to 
assess if cardiomyocyte senescence had an effect on cardiac function, it would then 
be important to couple the cardiomyocyte specific TRF1-FokI model, with a model 
such as the INK-ATTACK transgenic mouse (Baker et al., 2011) , in which senescent 
cardiomyocytes could be specifically removed. However, despite evidence that 
cardiomyocyte proliferation is increased at sites adjacent to myocardial infarction 
(Malliaras et al., 2013; Senyo et al., 2013), it is unknown if replenishment of 
cardiomyocytes would occur following removal of senescent cardiomyocytes, and 
thus if the level of senescent cardiomyocytes were high, this could seriously alter 
tissue homeostasis.  
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5 Effects of Oxidative Stress/Rapamycin on Cardiomyocyte 
Telomere Dysfunction 
 
In the previous chapter, we demonstrated an age-dependent increase in TAF in both 
mouse and human cardiomyocytes. In addition, we saw an age-dependent increase 
in various senescence markers. Interestingly, we observed an age-dependent 
increase in the lipid peroxidation marker 4-HNE, which provides a proxy for the levels 
of oxidative stress endured by the cell (Onorato et al., 1998). Having previously 
shown that oxidative stress could induce telomere damage independently of cell 
division in vitro, and observing there is an age-dependent increase of TAF in non-
rapidly dividing cardiomyocytes, we sought to ascertain if oxidative stress could drive 
telomere dysfunction in vivo. To investigate this, we used several mouse models for 
increased oxidative stress, namely, cardiac-specific overexpression of MAO-A, 
Catalase -/- and MnSOD-/+. 
Finally, ROS levels have been shown to increase following replicative, oncogene- or 
stress-induced senescence (Gabriele et al., 2003; Ramsey and Sharpless, 2006; 
Passos et al., 2007; Lu and Finkel, 2008b). Furthermore, ROS have been implicated 
in contributing to the persistence of cellular senescence, for example, by replenishing 
short-lived DNA damage foci, thus maintaining an ongoing DDR, which activates 
p21, and is thought to activate a signalling cascade, which is thought to lead to 
mitochondrial dysfunction, which causes aberrant ROS production, which in turn 
causes further DNA damage, therefore instigating a feedback loop (Passos et al., 
2010). Interestingly, the mTOR inhibitory drug rapamycin has been shown to reduce 
ROS levels both in vitro and in vivo (Shin et al., 2011) (Miwa et al., 2014a), and can 
increase the lifespan of yeast (Powers et al., 2006; Medvedik et al., 2007), 
nematodes (Robida-Stubbs et al., 2012), fruit flies (Bjedov et al., 2010) and mice 
(Harrison et al., 2009; Anisimov et al., 2011; Miller et al., 2011). mTOR has been 
shown to play important roles in senescence, for example, our group has recently 
published research showing that mTOR phosphorylation following a DDR, leads to 
PGC-1b dependent mitochondrial biogenesis, and that this increase in mitochondrial 
density is responsible for driving many features of the senescent phenotype (Correia-
Melo et al., 2016). Furthermore, inhibition of mTOR by rapamycin has been shown to 
attenuate the increase in the secretion of inflammatory cytokines such as IL1A and 
IL6 by senescent cells  (Laberge et al., 2015). Moreover, mice fed with rapamycin 
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have been shown to release lower levels of hydrogen peroxide from mitochondria in 
both murine brain and liver tissues (Miwa et al., 2014b). 
We therefore investigated if rapamycin treatment could attenuate the senescent 
phenotype in vitro through reducing intra-cellular ROS levels and subsequent DNA 
damage, and finally if a rapamycin supplemented diet could reduce an accumulation 
of TAF with age in mice, and if this was associated with a decrease in a senescent-
like phenotype in cardiomyocytes. 
   
5.1 MAO-A Overexpression Drives TAF in vivo 
 
We have previously shown in vitro that hydrogen peroxide can induce TAF 
independently of cell division. Our data showing accumulation of 4-HNE suggests 
that cardiomyocytes are exposed to high levels of oxidative stress, which 
compliments previous data showing an age-dependent increase in cardiac 
mitochondrial ROS production (Judge et al., 2005). Interestingly, cardiac-specific 
over-expression of the pro-oxidant protein monoamine oxidase-A (MAO-A) results in 
increased oxidative stress in cardiomyocytes and leads to the development of 
cardiomyopathy (Villeneuve et al., 2013). MAO-A is a enzyme which catalyses the 
oxidative deamination of monoamines; producing ammonia, aldehyde and H2O2 as 
by-products (Villeneuve et al., 2013), and MAO-A expression has been observed to 
increase during replicative senescene in human fibroblasts (Passos et al., 2007). RT-
PCR analysis revealed that there is an age-dependent increase in monoamine 
oxidase A (MAO-A) mRNA levels in mouse cardiomyocytes from 3 to 20 months 




Figure 5-1. An Age-Dependent Increase in MAO-A Expression in Mouse 
Cardiomyocytes. (A) Gene expression analysis of MAO-A by Real-Time PCR of 
isolated mouse cardiomyocytes from 3 and 20 months of age. Data are represented 
as the mean for individual mice, with horizontal line representing group mean. 
Statistical analysis performed using two-tailed t test; * P<0.05. 
 
We investigated if cardiac-specific over-expression of MAO-A could induce TAF in 
mouse cardiomyocytes. Immuno-FISH analysis revealed that cardiac-specific MAO-A 
overexpression can significantly increase the mean number of TAF and percentage 
of TAF positive cells, in mouse cardiomyocytes from mice aged 3 months (Figure 
5-2A-B). This is also associated with a significant increase in the percentage of cells 
positive for 4-HNE, as shown by IHC (Figure 5-2C-D). As previously mentioned, 
MAO-A activity produces by products other than oxidants, for example ammonia and 
aldehyde (Villeneuve et al., 2013), therefore to ascertain if TAF were induced as a 
result of oxidative stress, or by another mechanism, we supplemented the diet of 
MAO-A mice with the antioxidant N-acetylcysteine (NAC). Our subsequent immuno-
FISH analysis revealed that a NAC-supplemented diet significantly reduced both the 
mean number of TAF, and the percentage of TAF positive cardiomyocytes (Figure 
5-2E-F).  
Fractional shortening is a commonly used cardiac functional readout (Villeneuve et 
al., 2013), which represents the percentage of shortening of the left ventricular 
diameter at the end-diastole compared to end-systole. We performed fractional 
shortening analysis and discovered that wild-type mice have significantly higher 
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fractional shortening percentage than MAO-A transgenic mice at 3 months of age 
(Figure 5-2G). Furthermore, supplementing the diet of MAO-A transgenic mice was 
able to rescue the decline in fractional shortening (Figure 5-2H) 
Finally, we performed correlation analysis, comparing both mean number of TAF and 
mean percentage of TAF positive cells, against fractional shortening, irrespective of 
genotype or diet supplementation. Our analysis revealed a significant inverse 
relationship between TAF (both mean and mean percentage of TAF positive cells) 






Figure 5-2. MAO-A Overexpression drives TAF generation in mouse 
cardiomyocytes in vivo. (A) Mean number of TAF – (B) Mean percentage of TAF 
positive –  cardiomyocytes from 3 month old WT and MAO-A transgenic mice. Data 
are represented as the mean for individual animals, with the horizontal line 
representing group mean. (C) Mean percentage of 4-HNE positive cardiomyocytes in 
cardiomyocytes from WT and MAO-A transgenic mice. Data are represented as the 
mean for individual animals, with the horizontal line representing group mean (D) 
Representative images of 4-HNE IHC in WT and MAO-A transgenic mice (blue – 
nuclear counter stain; brown cytoplasmic staining – 4-HNE). (E) Mean number of 
TAF – (F) Mean percentage of TAF positive – cardiomyocytes from MAO-A 
transgenic mice supplemented with vehicle (Control) or antioxidant (NAC). Data are 
represented as the mean for individual animals, with the horizontal line representing 
group mean. (G-H) Fractional shortening analysis between (G) Wild-type compared 
to MAO-A transgenic at mice (H) MAO-A transgenic mice supplemented with vehicle 
(Control) or antioxidant (NAC). Data are mean ± SEM of n=3. (I-J) Correlation 
analysis of the mean number of TAF (I) or percentage of TAF positive cells (J) versus 
fractional shortening (%) in both WT and MAO-A mice. Statistical analysis performed 
using two-tailed t test; * P<0.05. Correlations were analysed using Pearson’s 
correlation coefficient; P value <0.05 considered significant. 
 
5.2 A Reduction in MnSOD or Catalase Activity can Drive TAF 
Generation in vivo 
 
Having shown that oxidative stress can drive TAF generation in cardiomyocytes via 
cardiac-specific MAO-A overexpression, we sought to investigate if other mouse 
models of elevated oxidative stress could also induce telomere dysfunction.  
Catalase is an important antioxidant enzyme which catalyses the reaction of 
hydrogen peroxide into water and oxygen. Catalase expression has been shown to 
decrease with age in mouse brain and is associated with an increase in oxidative 
damage (Mo et al., 1995).  Interestingly, over-expression of mitochondrial catalase 
(mCAT) in mice attenuates of H2O2 production, oxidative stress and mitochondrial 
deletions, as well as delaying the development of both cataracts and cardiac 
pathologies, and extending lifespan (Schriner et al., 2005b). Overexpression of 
mCAT can also attenuate the age-dependent development of cardiomyopathies in 
mice which have mutations in in mitochondrial DNA polymerase gamma, which are 
associated with elevated ROS, cardiac fibrosis, hypertrophy and dilatation (Dai et al., 
2010). We therefore wanted to ascertain if oxidative stress caused by aberrant 
catalase expression could also elevate TAF in cardiomyocytes and our immuno-FISH 
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analysis revealed that catalase-/- mice have both a significantly elevated mean 
number of TAF and mean percentage of TAF positive cells (Figure 5-3A-B).  
Superoxide dismutases (SOD) are a family of antioxidant enzymes which catalyse 
the dismutation of superoxide to hydrogen peroxide and oxygen. Manganese 
superoxide (MnSOD) is a SOD which resides within mitochondria, and thus plays an 
important role in the detoxification of reactive oxygen species produced as a by-
product of oxidative phosphorylation. Homozygous mutant mice for MnSOD die 
within a couple of weeks and present multiple pathologies including: metabolic 
acidosis, accumulation of lipid in liver and skeletal muscle, and dilated 
cardiomyopathy (Li et al., 1995). Heterozygous mutants MnSOD-/+ are viable, 
however are associated with an age-dependent elevation in vascular oxidative stress 
(Brown et al., 2007). We used this model to investigate cardiomyocyte TAF 
generation and immuno-FISH analysis revealed that MnSOD-/+ mice have both a 
significantly elevated mean number of TAF and mean percentage of TAF positive 
cells (Figure 5-3C-D).  
 
 
Figure 5-3. Catalase-/- and MnSOD-/+ models of Elevated Oxidative Stress also 
Drive TAF in Cardiomyocytes in vivo. (A) Mean number of TAF – (B) Mean 
percentage of TAF positive –  cardiomyocytes from WT and Catalase -/- transgenic 
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mice. Data are represented as the mean for individual animals, with the horizontal 
line representing group mean. (C) Mean number of TAF – (D) Mean percentage of 
TAF positive – cardiomyocytes from WT and MnSOD-/+ transgenic mice. Data are 
represented as the mean for individual animals, with the horizontal line representing 
group mean. Statistical analysis performed using two-tailed t test; * P<0.05. 
 
5.3 mTOR Inhibition Impacts on ROS and Senescence in Human 
Fibroblasts 
 
Mitochondria have long been implicated in oxidative stress-induced ageing 
phenotypes (Harman, 1972), and interestingly our group have recently published 
research which shows that many features of the senescent phenotype, including pro-
inflammatory cytokine are dependent on increased mitochondrial density through a 
pathway involving mTORC1 phosphorylation (Correia-Melo et al., 2016). 
Furthermore, we show that during senescence, mitochondrial density is increased via 
mTOR activation, which leads to PGC-1b-dependent mitochondrial biogenesis. We 
therefore investigated if mTOR inhibition could attenuate this increase in 
mitochondrial biogenesis and subsequent increases in ROS and cellular senescence 
in cells which had undergone severe genotoxic stress.  For this part of the study, we 
switched from using cardiomyocytes as our model, to human fibroblasts, as 
fibroblasts have a greater proliferation rate in vitro, which allows for an increase in 
experimental scope, as well as displaying a high resistance to apoptosis, thus 
making them ideal for investigating cellular senescence.  
Flow cytometry analysis revealed a dose-dependent increase in mitochondrial mass 
following X-irradiation (Figure 5-4A). Furthermore, correlation analysis showed that 
this X-irradiation dose-dependent increase in mitochondrial mass also correlated with 
numerous senescence markers such as an increase in SA-β-gal activity, an increase 
in p21 expression (by western blot), a decrease in percentage of cells positive for Ki-
67 proliferation marker, and an increase in γH2AX DNA damage foci (Figure 5-4B). 
Kinetic analysis revealed that both mitochondrial mass and ROS levels increase 
significantly until day 2 following X-irradiation with 20Gy, until they form a plateau 
which is continued until the final time point at day 10. When ROS is normalised to 
mitochondrial mass, there is no significant difference following exposure to 20Gy X-






Figure 5-4. Mitochondrial mass increases with X-irradiation and is associated 
with Cellular Senescence. (A) Mitochondrial mass 3 days following X-irradiation 
with 0, 5, 10 or 20Gy, as measured by NAO fluorescence via flow cytometry. (B) 
Correlation analysis between mitochondrial mass and SA-β-Gal activity, p21 
expression (measured by western blot), percentage of Ki-67 positive cells and mean 
number of γH2AX foci per cell, following varying doses of X-irradiation. Data are 
mean ± SEM of n=3. (C) Kinetic analysis of mitochondrial mass (as measured by 
NAO fluorescence via flow cytometry), ROS (as measured by DHR fluorescence via 
flow cytometry) and ROS/mitomass, following 20Gy X-irradiation in MRC5 fibroblasts. 
Data are mean ± SEM of n=3. 
 
Next, we wanted to ascertain if the X-irradiation induced increase in mitochondrial 
mass was causative of observed ROS increases, by inhibiting the mitochondrial 
mass increase following X-irradiation. The mechanistic target of rapamycin (mTOR) 
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pathway has been widely associated with playing a key role in mitochondrial 
homeostasis, by affecting mitochondrial biogenesis and mitophagy, and mTORC1 
has specifically been shown to control mitochondrial biogenesis (Morita et al., 2013). 
To begin, we treated MRC5 fibroblasts with different genotoxic stresses, either in the 
presence of a vehicle control (DMSO) or rapamycin, and then quantified 
mitochondrial mass 3 days after. In young proliferating MRC5 cells, rapamycin has 
no effect on mitochondrial mass after treatment for 3 days. In MRC5 cells that have 
undergone genotoxic stress by either X-irradiation, etoposide, neocarzinostatin or 
hydrogen peroxide, the mitochondrial mass becomes significantly increased 3 days 
following treatment. However, if cells are cultured in the presence of rapamycin, there 
was no significant increase in mitochondrial mass, 3 days following treatment with 
any of the genotoxic stress treatments (Figure 5-5A).  
Having shown that rapamycin treatment can abrogate a genotoxic-stress-induced 
increase in mitochondrial mass, we then wanted to ascertain if this had an effect on 
intracellular ROS levels. To detect ROS, we used flow cytometry with the superoxide 
indicator dihydroethidium (DHE), which exhibits blue fluorescence, until it becomes 
oxidised and then exhibits bright red fluorescence. In collaboration with Graeme 
Hewitt from ours and the Korolchuk laboratory, we found that ROS levels are 
significantly increased in MRC5 cells, 3 days following X-irradiation with 20Gy. 
Rapamycin treatment has no effect on ROS levels in untreated MRC5 cells, but 
significantly decreases ROS in X-irradiated cells compared to X-irradiated non-
treated cells (Figure 5-5B). 
To investigate if the decrease in ROS is due to inhibition of mTORC1 and not an off-
target effect of rapamycin, we also performed siRNA to knock-down mTORC1 and 
observe ROS following X-irradiation. Using 2 different siRNAs targeted to mTORC1 
and a scramble siRNA control, our data show that treatment with either mTORC1 
siRNA has no effect on ROS on non-irradiated MRC5 cells, compared to treatment 
with scrambled siRNA. Confirming previous data (Figure 5-5B), we show that X-
irradiation significantly increases ROS levels, however we also show that this 





Figure 5-5. X-irradiation- induced increases in mitochondrial mass can be 
attenuated with rapamycin treatment. (A) Mitochondrial mass in MRC5 cells 3 
days following genotoxic with either 20Gy X-irradiation, continual etoposide treatment 
(50µM), 1 hour treatment with neocarzinostatin (80ng ml-1), or 1 hour treatment with 
H2O2 (400µM), in the presence of either vehicle control (DMSO) or rapamycin 
(100nM); as measured by NAO fluorescence via flow cytometry. Data are 
representative of 3 independent experiments per condition. (B) Intracellular ROS 
levels in MRC5 fibroblasts, as measured by DHE fluorescence, via flow cytometry, 
with or without rapamycin (100nm) and NAC (2.5mM), 3 days following 20Gy X-
irradiation. Data are mean ± SEM of n=3.  (C) Effect of mTOR knock-down using 
siRNA on ROS measured by DHE fluorescence, 3 days following 20Gy X-irradiation. 
Data are mean ± SEM of n=3. Statistical analysis performed using two-tailed t test; * 
P<0.05. 
 
Having observed that mTOR inhibition, via rapamycin or siRNA treatment, could 
attenuate the appearance of ROS following numerous genotoxic stresses, we sought 
to ascertain if this would have any effect on the development of a senescent 
phenotype. MRC5 fibroblasts were treated with a range of genotoxic stresses, either 
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X-irradiation, etoposide, neocarzinostatin, or H2O2. After 10 days, SA-β-Gal activity 
was significantly elevated after each treatment compared to an untreated control. For 
each treatment, we also cultured cells in the presence of rapamycin, and observed a 
significant reduction in SA-β-Gal activity compared to the vehicle control for each 
condition. The level of SA-β-Gal was still significantly higher than non-treated 
controls for each of the rapamycin-treated genotoxic stress exposed cells (Figure 
5-6A-B). After X-irradiation, p21 levels are significantly increased after 2 days, 





Figure 5-6. mTOR inhibition attenuates genotoxic stress induced senescence. 
(A) Mean percentage of MRC5 cells staining positive for SA-β-Gal activity 10 days 
following genotoxic stress with 20Gy X-irradiation, continual etoposide treatment 
(50µM), 1 hour treatment with neocarzinostatin (80ng ml-1), or 1 hour treatment with 
H2O2 (400µM), in the presence of either vehicle control (DMSO) or rapamycin 
(100nM). Data are mean ± SEM of n=3. (B) Representative SA-β-Gal images 
(Cytoplasmic blue – SA-β-Gal; pink – nucleus). Scale bar: 40µM. (C) p21 expression 
(measured by western blot) in MRC5 cells 1, 2 and 3 days following genotoxic stress 
with 20Gy X-irradiation, continual etoposide treatment (50µM), 1 hour treatment with 
neocarzinostatin (80ng ml-1), or 1 hour treatment with H2O2 (400µM), in the 
presence of either vehicle control (DMSO) or rapamycin (100nM). Data are mean ± 
SEM of n=3. Statistical analysis performed using two-tailed t test; * P<0.05. 
 
 
5.4 mTOR Inhibition Impacts on DDR During Senescence in Human 
Fibroblasts 
 
Having observed that mTOR inhibition could attenuate ROS accumulation after 
senescence-inducing stimuli, we sought to ascertain if this was acting via a DDR. 
Research has shown that both telomeric and non-telomeric foci contribute to the 
initiation of cellular senescence (Nakamura et al., 2008), and ROS have been 
implicated in replenishing short-lived DNA damage foci following senescence 
(Passos et al., 2010). We investigated if rapamycin treatment could attenuate this 
increase in secondary DNA damage foci, and if this was ROS dependent.   
To begin, we treated MRC5 cells with various genotoxic stresses, and cultured them 
for 10 days either in the presence of a vehicle control (DMSO) or rapamycin, before 
performing immuno-FISH to quantify both TAF and non-TAF. Our analysis revealed 
there is a significant increase in both telomeric and non-telomeric DNA damage foci, 
10 days following genotoxic stress with either: X-irradiation, etoposide, 
neocarzinostatin or H2O2, compared to untreated control cells. However, those cells 
cultured in the presence of rapamycin had a significantly reduced mean number of 
non-TAF for each genotoxic stress treatment, whereas the mean number of TAF was 
unaltered (Figure 5-7A-B).  
To test whether the reduction in non-telomeric foci was due to rapamycin 
suppressing ROS generation, in collaboration with Graeme Hewitt from ours and the 
Korolchuk laboratory, we induced genotoxic stress in MRC5 cells with 20Gy X-
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irradiation, and then cultured cells for a further 3 days in presence of rapamycin or 
NAC, or both together. Similar to before (Figure 5-7C), we observed an increase in 
both TAF and non-TAF after X-irradiation, but a decrease in only non-TAF following 
rapamycin treatment. Moreover, we found that NAC treatment alone also reduces the 
number of non-TAF to similar levels as to with rapamycin treatment alone, and 
likewise TAF remain unaffected. Furthermore, when we treat X-irradiated cells with 
both rapamycin and NAC, non-TAF are reduced to the same level as with either 
treatment separately i.e. there is no cumulative effect. To confirm that NAC treatment 
was reducing ROS levels in X-irradiated MRC5 cells; as before, we treated cells with 
20Gy and cultured them for 3 days in the presence of rapamycin or NAC, or both 
together, and then quantified intra-cellular ROS levels using flow cytometry analysis 
of DHE fluorescence. Neither rapamycin, NAC or a combination of the two have any 
significant effect on ROS levels in non-irradiated control cells. Expanding on our data 
showing that rapamycin significantly reduces ROS levels in X-irradiated cells (Figure 
5-5), we also observed that NAC treatment reduced ROS to a similar level (Figure 
5-7D). Moreover, the combination of rapamycin and NAC reduced ROS levels to a 
similar level as with each treatment alone, once again signifying no cumulative effect 
(Figure 5-7E). 
To test whether mTORC1 inhibition impacted on DDF stability, we transfected MRC5 
fibroblasts with an AcGFP-53BP1c fusion protein, which allowed time resolved live-
cell microscopy kinetic tracking of DDF after X-irradiation. In collaboration with Glyn 
Nelson from the von Zglinicki laboratory, we X-irradiated transfected MRC5 cells with 
20Gy, and then cultured them in either a vehicle control (DMSO) or rapamycin, 
before conducting live-cell microscopy 3 days after IR. We observed that short-lived 
53BP1 foci (<15 hours) were significantly reduced in irradiated cells treated with 











Figure 5-7. mTOR Inhibition Reduces Replenishment of Short-lived foci 
following X-irradiation via ROS attenuation. (A) Mean number of TAF and non-
TAF in MRC5 cells, 10 days following genotoxic stress with 20Gy X-irradiation, 
continual etoposide treatment (50µM), 1 hour treatment with neocarzinostatin (80ng 
ml-1), or 1 hour treatment with H2O2 (400µM), in the presence of either vehicle 
control (DMSO) or rapamycin (100nM), data are mean ± SEM of n=3. (B) 
Representative images of γH2AX immuno-FISH in MRC5 fibroblasts 3 days after x-
irradiation with 20Gy, treated with either DMSO or rapamycin. Images are Huygens 
(SVI) deconvolved Z-projections of 3µM stacks taken with a 100X oil objective. White 
arrows indicate co-localisation between γH2AX and telomeric signal, and co-
localising foci are amplified in the right panel (amplified images are from single Z-
planes where co-localisation was found). Graphs represent quantification of γH2AX 
and telomere signals in selected regions of interest (dotted lines). Scale bar: 5µM. 
(C) Mean number of TAF and non-TAF in MRC5 cells, 3 days following X-irradiation 
with 20Gy, in the presence of either vehicle control (DMSO) or rapamycin (100nm) 
and NAC (2.5mM). Data are mean ± SEM of n=3. Scale bar: 5µM. (D) Mean DHE 
fluorescence in MRC5 cells, 3 days following X-irradiation with 20Gy, in the presence 
of either vehicle control (DMSO) or rapamycin (100nm) and NAC (2.5mM). Data are 
mean ± SEM of n=3. (E) Confocal time series of MRC5 expression AcGFP-53BP1c 3 
days after 20Gy X-irradiation at the indicated times (min), with and without rapamycin 
treatment. Images are compressed stacks (maximum intensity projections) with a 
4.5µm focal depth. 53BP1 foci with lifespans of less than 15 hours are labelled in red. 
Representative traces of AcGFP-53BP1c foci in one MRC5 nucleus with (rap) and 
without (DMSO) rapamycin are shown on the right. Each bar represents the track of 
one individual focus recorded for the indicated time interval. Scale bar: 5µM. 
Statistical analysis performed using One way ANOVA or two-tailed t test; * P<0.05. 
 
It has previously been published that a persistent DDR during senescence is involved 
in a feedback loop which drives mitochondrial dysfunction and increased ROS 
production (Passos et al., 2010). Having shown that mTOR inhibition can attenuate 
this increase in ROS and markers of senescence following treatment with 
senescence-inducing stimuli, we wanted to ascertain if these effects were acting 
through this pathway, by inhibiting the DDR. In collaboration with Clara-Correia Melo 
from ours and the von Zglinicki laboratory, we treated MRC5 fibroblasts with 20Gy X-
irradiation, supplemented them with either or both rapamycin and the ATM inhibitor 
Ku55933, 3 days following IR, and then analysed the cells at day 10 post-IR. 
Similarly to rapamycin treatment, ATM inhibition was also shown to inhibit 
senescence-associated increases in mitochondrial mass, however there was no 
cumulative effect when combined (Figure 5-8A-B). Furthermore, our data show that 
separately, both ATM inhibition and mTOR inhibition can attenuate the number of 
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γH2AX foci, decrease SA-β-gal activity, and reduce p21 expression, however, again, 
there is no accumulative effect upon treatment with both (Figure 5-8C-E). 
 
Figure 5-8. An epistatic association between mTOR and ATM inhibition in 
attenuating the development of X-irradiation-induced senescence. (A) A 
schematic illustration showing that proliferating MRC5 fibroblasts were treated with 
20Gy X-irradiation, and treated with either an ATM inhibitor (Ku55933) or rapamycin 
or a combination of both 3 days following IR, and then fixed at day 10 post-IR for 
analysis. (B) Mean mitochondrial mass (NAO fluorescence. Data are mean ± SEM of 
n=3. (C) Mean number of γH2AX foci per cell. Data are mean ± SEM of n=3. (D) 
Mean percentage of SA-β-Gal positive cells. Data are mean ± SEM of n=3. (E) Mean 
p21 expression via western blot. Data are mean ± SEM of n=3. Statistical analysis 
performed using two-tailed t test; * P<0.05. 
 




Having shown that mTORC1 inhibition can reduce the accumulation of DNA damage 
which arises from an increase in ROS after exposure to genotoxic stress, we wanted 
to investigate what effect mTORC1 inhibition would have on DNA damage and 
senescence in cardiomyocytes in vivo. Rapamycin supplementation has been shown 
to delay a number of age-related changes in mice, including alterations in tendons, 
endometrium, adrenal glands, liver and heart (Wilkinson et al., 2012), and can extend 
the lifespan of a number of different organisms (Bjedov et al., 2010; Zhang et al., 
2014). We supplemented the diet of male C57BL/6 mice with rapamycin from 3 
months of age, and then culled one group at 6.5 months of age and other at 15 
months. At 6.5 months, there is no difference in either mean number of TAF or the 
mean percentage of TAF positive cardiomyocytes for mice fed on either a control or 
rapamycin diet. We observed a significant increase in both the mean number of TAF 
and the mean percentage of TAF positive cardiomyocytes from 6.5 months to 15 
months of age in the control-fed mice. Moreover, 15 months old mice fed on a 
rapamycin diet had a significantly less mean number of TAF and the mean 
percentage of TAF positive cardiomyocytes compared to their age-matched control-
fed mice (Figure 5-9A-B). Furthermore the TAF levels in cardiomyocytes from 15 
month rapamycin-fed mice were not significantly different to control-fed mice of only 
6.5 months of age (Figure 5-9A-B). Our analysis revealed that there is no significant 
variation in the level of non-TAF in cardiomyocytes between control-fed mice of 6.5 
months and 15 months of age, and a rapamycin diet had no effect on either group 
(Figure 5-9C). Finally, we show that rapamycin treatment attenuates the 
accumulation of the lipid peroxidation marker 4-HNE and the cyclin-dependent kinase 













Figure 5-9. Rapamycin supplemented diet reduces age-associated TAF 
accumulation, oxidative stress and senescence markers. (A) Mean number of 
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TAF – (B) Mean percentage of TAF positive – cardiomyocytes in mice aged 6.5 and 
15 months, on either a control or rapamycin supplemented diet. Data are represented 
as the mean for individual animals, with the horizontal line representing group mean. 
(C) Mean number of non-TAF in cardiomyocytes in mice aged 6.5 and 15 months, 
either on either a control or rapamycin supplemented diet. Data are represented as 
the mean for individual animals, with the horizontal line representing group mean. (D-
E) Quantification of the percentage of cardiomyocytes staining positive for 4-HNE (D) 
or p21 (E) by IHC, 15 month old mice fed on either a control or rapamycin 
supplemented diet. Data are represented as the mean for individual patients, with the 
horizontal line representing group mean. Statistical analysis performed using One 




ROS are continuously formed in living cells, both via endogenous mechanisms, such 
as oxidative phosphorylation, as well as external sources such as ionising radiation. 
It is estimated that around 0.1%-1% of oxygen used during oxidative phosphorylation 
is converted to superoxide anion (Chance et al., 1979). Moreover, cardiomyocytes 
contain an extremely high mitochondrial density, and thus produce considerable 
amounts of superoxide anion (Kaul et al., 1993). Whilst superoxide is not a strong 
oxidant, and has limited reactivity, it is converted to H2O2 by superoxide dismutase, 
which is a considerably more potent oxidant. ROS have been shown to oxidise 
bases, which can lead to mutation, as well as produce SSB, which if two are in close 
proximity on complementary DNA stands, are thought to generate DSB (Bont, 2004). 
Although ROS are involved in physiological processes, such as cell signalling 
(D'Autréaux and Toledano, 2007), and microbial defence (Dupre-Crochet et al., 
2013), if the level of ROS generation exceeds the rate in which natural antioxidant 
mechanisms can stabilise ROS, then oxidative stress ensues.   
Previously, we have shown that TAF can be induced in vitro by exposing cells to 
oxidative stress, via H2O2 treatment, and this can occur independently of DNA 
replication. Following on from this, we observed that TAF accumulate in vivo, and this 
correlated with an increase in the oxidative stress marker 4-HNE. Mitochondrial ROS 
production has also been shown to increase with age in both the heart (Judge et al., 
2005) and the vascular system of rats (Ungvari et al., 2007). Interestingly, H2O2 
production has been shown to increase in rat hearts with age, which is dependent 
upon increases in MAO-A expression (Maurel et al., 2003). MAO-A catalyses the 
oxidative deamination of monoamines, and produces H2O2 as one of the by-products 
145 
 
of this reaction, and cardiac-specific over-expression of MAO-A results in elevated 
ROS leading to increases in DNA oxidation, with mitochondrial DNA especially 
sensitive (Villeneuve et al., 2013). In particular, mitochondrial 8-oxoguanine (8-oxo-
dG) was observed, which during replication can lead to the incorrect pairing of 
adenine with 8-oxo-dG, which upon further DNA replication drives a C to A and G to 
C mutation of the genetic code. Moreover, it has been hypothesised that increased 
mitochondrial mutations lead to an inefficient ETC, which is more prone to electron 
leakage, and ROS generation, which in turn leads to more genetic mutations, 
therefore instigating what has been coined a ‘vicious cycle’ positive feedback loop 
(Alexeyev et al., 2004). Elevated ROS are known to increase lipid peroxidation, and 
our data from the previous chapter show a significant age-dependent increase in 4-
HNE, which has also been shown to be associated with other senescence markers, 
such as γH2AX and SA-β-Gal (Wang et al., 2009; Wang et al., 2010; Nelson et al., 
2012), and is considered to be the most toxic aldehyde formed as a consequence of 
lipid peroxidation (Esterbauer et al., 1991). Interestingly, our gene expression 
analysis in isolated mouse cardiomyocytes revealed an age-dependent up-regulation 
of MAO-A, and thus we wanted to further investigate if ROS could induce TAF in 
vivo. To specifically test the effect of elevated ROS on cardiomyocytes, we acquired 
cardiac tissue from a transgenic mouse model which over-expresses MAO-A 
specifically in cardiomyocytes and analysed TAF. Previous research has shown that 
the levels of MAO-A expression in the cardiomyocyte-specific MAO-A over-
expressing mice are comparable to those found in aged mice, and thus can be 
considered a physiologically relevant model (Villeneuve et al., 2013). Our data show 
that MAO-A overexpression can lead to a significant increase in TAF in mice, which 
as expected, is coupled with an increase in the oxidative stress marker 4-HNE. 
Furthermore, 4-HNE accumulation has previously been shown to be associated 
various senescent markers, including γH2AX and SA-β-Gal (Wang et al., 2009; 
Wang et al., 2010; Nelson et al., 2012). MAO-A is involved in oxidative deamination 
of dietary amines and neurotransmitters, which produce, not only H2O2 as a by-
product, but also ammonia, as well as aldehyde from the corresponding amine 
(Kaludercic et al., 2014). Moreover, to test if the observe TAF increases were ROS-
dependent, we supplemented the drinking water of a MAO-A transgenic mouse 
group with the anti-oxidant N-acetyl-cysteine (NAC), and observed that the increases 
in TAF were attenuated. Unfortunately, we did not have corresponding control 
groups, which were fed on an antioxidant diet, and thus there still remains the 
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possibility the observed decreases were due to attenuation of the age-dependent 
oxidative damage that we have previously observed. It would have also been 
beneficial to have performed 4-HNE staining on the NAC treated mice to observe if 
the anti-oxidant was attenuating the accumulation of oxidative damage with time, 
although once again, the non-transgenic controls would have been beneficial to 
conclude that the changes were not attenuation of physiological age-dependent 
changes, as opposed to MAO-A-dependent effects. Finally, it would be interesting to 
investigate if MAO-A inhibition could attenuate the age-dependent increase in 
cardiomyocyte TAF.  
To further investigate if oxidative stress could lead to telomere dysfunction, we 
analysed TAF in catalase -/- mice. Catalase is responsible for the conversion of H2O2 
into water and oxygen, and in mammalian cells it is mainly localised to the 
peroxisomes, where H2O2 generation from various oxidases is high (van den Bosch 
et al., 1992). Interestingly, catalase has also been discovered to be expressed in 
mouse and rat cardiac mitochondria (Radi et al., 1991; Rindler et al., 2013). In 
response to being fed a high fat diet, cardiac H2O2 levels become elevated, due to 
the increase in fatty acid oxidation required for fat metabolism, and consequently, 
both cardiac mitochondrial catalase content and activity also become elevated 
(Rindler et al., 2013). We observed an increase in telomere dysfunction in 
cardiomyocytes of catalase-/- mice, which compliments both our in vitro data 
providing evidence that H2O2 treatment can induce TAF independently of cell 
division, as well as our in vivo data showing an increase in TAF in MAO-A over-
expressing cardiac tissue. It would be interesting to investigate the relative effects of 
organelle-catalase modulation on TAF, for example mitochondrial-specific 
overexpression of catalase leads to an increase in lifespan and delayed development 
of cardiomyopathy in mice, whereas peroxisomal- or nuclear-specific over-expression 
of catalase had no effect (Schriner et al., 2005a). 
It is thought that an age-dependent reduction in the activity of electron transport 
complexes I and IV in cardiac mitochondria leads to elevated electron leakage and 
thus increased mitochondrial ROS generation (Navarro and Boveris, 2007). 
Interestingly, mice which have a decreased birth weight due to deprived in utero 
nutrition, show increased incidence of cardiovascular disease, which is thought to 
arise due to accelerated ageing caused by elevated oxidative stress. Moreover, by 
supplementing the diet of these mice with coenzyme Q10, an antioxidant and integral 
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ETC component, many of the accelerated ageing phenotypes such as DNA damage, 
telomere shortening, oxidative stress and cellular senescence, were reversed (Tarry-
Adkins et al., 2013), thus further implicating aberrant ROS production in cardiac 
ageing. To ascertain if mitochondrial ROS could be specifically contributing to TAF, 
we acquired hearts from MnSOD-/+ mice and performed TAF analysis. MnSOD is the 
primary superoxide anion scavenger in mitochondria, and MnSOD activity is reduced 
by around 50% in MnSOD-/+ mice, which is accompanied with elevated 
mitochondrial oxidative damage, and an increase in mitochondrial dysfunction, as 
quantified by a decrease in complex I respiration (Van Remmen et al., 2001). Our 
data show that TAF are significantly decreased in MnSOD-/+ mice, thus showing that 
mitochondrial ROS production can lead to telomere dysfunction if MnSOD activity is 
decreased. Furthermore, research has shown that there is an age-dependent 
decrease in cardiac MnSOD protein expression (Lu et al., 2014), which may be a 
contributing factor to the age-dependent increase in TAF in cardiomyocytes.  
Together, these data provide strong evidence that elevated ROS can lead to 
telomere dysfunction in cardiomyocytes in vivo, although the mechanism for this is 
not entirely understood. Cardiomyocyte proliferation is negligible and therefore the 
replication-induced conversion of a SSB to a DSB is unlikely, and thus one 
explanation for the observed increase in TAF is that ROS happens to cause two SSB 
in close proximity to one another so that a DSB is formed (Bont, 2004). The statistical 
likelihood of this would appear low, however data suggests that telomeres are more 
susceptible to oxidative stress-induced SSBs compared to the rest of the genome 
(Petersen et al., 1998), and triple guanine repeats, as found in telomeric DNA, are 
particularly sensitive to oxidative damage (Henle et al., 1999), and it is possible the 
telomere repeat code may have evolved specifically to be more susceptible to 
oxidative damage in order to protect genomic DNA from damage. Furthermore, 
budding yeast telomeres have been shown to often cluster at the nuclear periphery 
(Hediger et al., 2002), and thus are spatially more susceptible to interacting with ROS 
diffusing across the nuclear membrane. However, contrary to this, lymphocyte 
telomeres have been shown to have a higher propensity for a central nuclear 
localisation (Amrichová et al., 2003). Although, research has shown that during post-
mitotic nuclear assembly, HeLa cells telomeres become enriched at the nuclear 
periphery, a process thought to be driven by an interaction between the shelterin 
component RAP1 and the nuclear envelope protein Sun1 (Crabbe et al., 2012). It 
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would be interesting to assess the nuclear localisation of telomeres in 
cardiomyocytes in vivo, and to also investigate if those found near the peripheries are 
more prone to TAF. Moreover, the latter analysis may be flawed in fixed cells if 
cardiomyocyte telomeres have plasticity in their movement, for example in U2OS 
telomeres, live-cell imaging revealed that the majority of telomeres are physically 
constrained to a radius of around 0.5µM, however a significant minority were seen to 
move far greater distances (Molenaar et al., 2003). To address this, it would be 
necessary to perform 3D live-cell imaging, using both a fluorescent DDR and 
telomere marker, with exogenous treatment of a membrane-permeable oxidative 
reagent, and analyse if there is an altered propensity for damage accumulation 
depending upon nuclear localisation.  
It could also be surmised that the occurrence of DSB from the accumulation of SSB 
in times of elevated oxidative stress are not particularly rare occurrences, and are 
even more likely to occur at telomeres, considering it has been shown that UV-
induced telomeric SSBs are less efficiently repaired when located at telomeres (Kruk 
et al., 1995). Moreover, research has shown that X-irradiation-, oxidative stress- and 
genotoxic stress-induced telomere damage is persistent, and likely irreparable 
(Fumagalli et al., 2012; Hewitt et al., 2012). In this instance, telomeres would be 
more susceptible to accumulation of SSB than genomic DNA, due to decreased 
repair capability, resulting in an increased probability of DSBs forming, which once 
formed are irreparable (Fumagalli et al., 2012; Hewitt et al., 2012).   
Finally, another scenario to consider is that ROS do not physically cause TAF, 
however as they are important signalling molecules (D'Autréaux and Toledano, 
2007), their aberrant generation could lead to the activation of cellular pathways 
which cause telomere dysfunction by some unknown mechanism.  
Interestingly, when we collated all of the data from the MAO-A study and performed 
correlation analysis, we found that there was a significant inverse relationship 
between TAF abundance in cardiomyocytes and cardiac function, as measured by 
fractional shortening. From these data, one cannot infer that TAF drive cardiac 
dysfunction, however it would appear that TAF can be used a marker for cardiac 
dysfunction. Considering that telomere damage is thought to be irreparable 
(Fumagalli et al., 2012; Hewitt et al., 2012), and a large number of cardiomyocytes 
present at birth survive until organismal death (Bergmann et al., 2009), 
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cardiomyocyte telomere damage may represent a molecular diary of cardiac stress 
endured throughout the lifetime of an organism. As previously described, in order to 
truly ascertain the effects of TAF in vivo, a cardiomyocyte-specific mouse model such 
as the TRF1-FokI would have to be generated. 
In this and previous chapters, we have provided evidence for ROS driving telomere 
dysfunction in cardiomyocytes both in vitro and in vivo. It has previously been shown 
that ROS levels become elevated as a consequence of cellular senescence, at 
around 2 days following either X-irradiation, or telomere-dependent senescence 
induction via TRF2 inhibition (Passos et al., 2010). Furthermore, this elevation in 
ROS was shown to maintain a flux of short-lived DDF, thus instigating a persistent 
DDR (Passos et al., 2010), one of the key hallmarks of cellular senescence. An 
increase in both mitochondrial mass and ROS have been observed in response to 
oncogenic RAS activation, and thus it is thought that mitochondria-derived ROS 
could be specifically driving this stabilisation of senescence (Passos et al., 2007; 
Moiseeva et al., 2009; Passos et al., 2010). In agreement with these data, 2-4 days 
following either, oxidative- or genotoxic stress-induced senescence in human 
fibroblasts, we observed a dose-dependent increase in mitochondrial mass, which 
was accompanied with an increase in ROS. When mitochondrial mass was 
normalised to ROS, there was no change following IR, suggesting that the increase 
in mitochondrial mass could be responsible for increased ROS production. In addition 
to this, we observed a significant correlation between mitochondrial mass and 
various markers of senescence, including decreased Ki67, increased γH2AX DDF, 
and an elevation of both SA-β-Gal activity and p21 expression. The mechanistic 
target of rapamycin (mTOR) pathway, and specifically activation of mTORC1, has 
been shown to drive mitochondrial biogenesis (Morita et al., 2013). We therefore 
investigated if mTOR was involved in this senescence-associated increase of 
mitochondria, by treating cells with the mTORC1 inhibitor rapamycin. Moreover, we 
found rapamycin treatment to prevent the senescence-associated increase in 
mitochondrial mass following either oxidative- or genotoxic stress. Furthermore, 
mTORC1 inhibition by either rapamycin treatment or siRNA also prevented ROS 
elevation, as measured by DHE, following X-irradiation. Considering this abrogation 
of the senescence-associated ROS increase, we investigated if levels of DNA 
damage and markers of senescence were also affected. We observed that 
continuous rapamycin treatment could decrease both SA-β-Gal activity and p21 
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expression, 10 days following genotoxic or oxidative stress with either X-irradiation, 
etoposide, NCS or H2O2; and interestingly we observed a decrease in the levels of 
non-telomeric DDF, however TAF were insignificantly altered. One explanation for 
this observation could be that rapamycin treatment increases the rate of DNA 
damage repair, which considering that telomeric DDF have been shown to be 
irreparable (Fumagalli et al., 2012; Hewitt et al., 2012), would result in a decrease in 
only non-telomeric DDF, as observed, however evidence suggests that rapamycin 
treatment actually suppresses both homologous recombination and NHEJ by 
impairing the recruitment of Rad51 and BRCA1 to DNA repair foci (Chen et al., 
2011). Another possibility is that rapamycin treatment attenuates the ROS-dependent 
feedback loop shown to replenish short-lived DNA damage foci (Passos et al., 2010), 
and it has previously been published that short-lived foci are non-telomeric (Hewitt et 
al., 2012), thus fitting our data. To test this idea, we supplemented cells with NAC, 
and found a similar decrease in non-TAF following X-irradiation compared to 
rapamycin treatment, however, when both NAC and rapamycin were combined, we 
observed no additive effect, suggesting that rapamycin was reducing non-TAF 
through decreasing the senescence-associated increase in ROS. Additionally, NAC 
and rapamycin treatment had similar effects on ROS levels following X-irradiation, 
with no additive effect when combined. We performed live-cell imaging, using an 
AcGFP-53BP1c fusion protein, to assess the nature of the DDF foci decreased by 
rapamycin treatment following X-irradiation. We observed a decrease in the number 
of short-lived DNA damage foci, and although this experiment was not performed 
with a live-cell telomere marker, we have previously published that short-lived foci do 
not co-localise with telomeres, and considering our data in fixed cells shows only 
non-TAF decreasing, it seems plausible to conclude that rapamycin treatment 
attenuates the senescence-associated secondary ROS-driven short-lived DDF 
(Passos et al., 2010). Furthermore, our data support mTORC1 inhibition to be 
attenuating the senescent phenotype through an abrogation of ROS-driven DDR, as 
when we inhibit the key DDR protein ATM following senescence induction, we 
observe similar effects to rapamycin treatment, such as a decrease in SA-β-Gal 
activity and reduction in DDR, however we observed no accumulative effect when 
both ATM and rapamycin inhibitors are combined.  
It may appear contradictory, that we have previously shown that ROS can induce 
TAF in vivo, yet we only observe an increase in non-TAF as a consequence of 
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secondary ROS generation in vitro. We hypothesised that the DSB in vivo could be 
generated from the accumulation of SSB in close proximity on complementary 
strands. In our in vitro model, we quantified telomere dysfunction at a maximum of 10 
days following senescence-inducing treatments, whereas in our in vivo models, the 
minimum observation period was 3 months, therefore providing significantly longer 
amounts of time for the generation of DSB to occur.   
We have shown there is an age-dependent increase in TAF in cardiomyocytes in 
vivo, that TAF can be induced via oxidative stress in vivo, and that mTORC1 
inhibition can attenuate the development of senescence via decreasing the level of 
ROS and subsequent DNA damage in vitro. We therefore wanted to ascertain if 
mTORC1 inhibition could have an effect on TAF in vivo. By supplementing the diet of 
mice with rapamycin, our data show that mTORC1 inhibition from 3 months of age, 
has no effect on TAF accumulation in mouse cardiomyocytes at 6.5 months of age, 
but can significantly prevent the age-dependent increase in TAF seen between 6.5 
and 15 months of age. Our data also show that rapamycin treatment prevents the 
accumulation of a senescent-phenotype in cardiomyocytes, as quantified by an 
attenuation of the age-associated increase of lipid peroxidation marker 4-HNE, and 
expression of cyclin-dependent kinase inhibitor p21. ROS production has also been 
shown to increase with age in rat hearts (Judge et al., 2005), and our group have 
shown that mice fed on a diet supplemented with rapamycin have decreased 
mitochondrial content, as quantified by mitochondrial volume fraction and mtDNA 
copy number (Correia-Melo et al., 2016). One interpretation could therefore be that 
mTORC1 inhibition attenuates age-dependent mitochondrial mass increases, 
therefore lowering oxidative stress, resulting in less DNA damage, and thus delaying 
the development of senescence. It would therefore seem inconsistent that we did not 
see a decrease in non-TAF, however we always observe greater variation in non-
TAF, likely due to the constant flux of generation and repair (Passos et al., 2010), 
and thus we might not have had a large enough population size to detect any  subtle 
differences. TAF, however, are thought to be irreparable (Fumagalli et al., 2012; 
Hewitt et al., 2012), therefore intrinsically having less variation at any given moment, 
making them a considerably more robust marker for genotoxic stress with time. It has 
been reported that mTORC1 inhibition can improve cardiac function and reduce 
cardiac hypertrophy (Shioi et al., 2003; McMullen et al., 2004). Moreover, 
hypertrophy is a common phenotype of senescent cells (Demidenko and 
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Blagosklonny, 2009), and we have shown that TAF can induce hypertrophy in 
cardiomyocyte in vitro. An interesting experiment would be to see if rapamycin 
treatment could attenuate TAF-induced hypertrophy in vitro. 
To conclude, our data show as a proof-of-principle, that oxidative stress can increase 
telomere dysfunction in cardiomyocytes, and we have shown in the previous chapter 
that TAF are associated with numerous markers of senescence in cardiomyocytes. 
Furthermore, we show that mTORC1 inhibition, which reduces ROS production, can 
attenuate both increases in TAF and the development of a senescent-like phenotype 
in cardiomyocytes both in vitro and in vivo. It will be important for future research to 
specifically induce DSB at telomeres to determine if TAF are causative, or merely a 







Since the initial discovery that somatic cells have only a finite replicative capacity 
(Hayflick and Moorhead, 1961; Hayflick, 1965), numerous discoveries have 
contributed to cellular senescence becoming a field of scientific research in its own 
right. Senescence has been shown to be involved in an eclectic mix of physiological 
processes, including embryonic development (Rajagopalan and Long, 2012; Muñoz-
Espín et al., 2013a; Storer et al., 2013), wound healing (Jun and Lau, 2010) and 
tumour suppression (Serrano et al., 1997). Contrary to these beneficial roles, 
senescent cells have been implicated in eliciting a bystander effect which can induce 
paracrine senescence (Hubackova et al., 2012a; Nelson et al., 2012; Acosta et al., 
2013), drive age-related diseases in vivo (Baker et al., 2011) and even produce a 
pro-tumourigenic micro-environment (Alspach et al., 2013). One of the main drivers 
of these detrimental effects is the SASP (Coppé et al., 2008), which is thought to 
signal an immune response for clearance of senescent cells (Xue et al., 2007; Kang 
et al., 2011). However, an accumulation of senescent cells has been observed in 
several tissues across numerous mammalian species (Dimri et al., 1995; Paradis et 
al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007), 
suggesting there is an age-dependent imbalance between the generation and 
clearance of senescent cells, and/or there are a subset of cellular cells which are 
resistant to clearance. Moreover, persistent senescent cells and thus a chronic SASP 
are what are thought to contribute to age-related pathologies. Interestingly, evidence 
is mounting which suggests that cellular senescence is not a phenomenon pertaining 
to proliferative cells alone, and that post-mitotic cells, including adipocytes and 
neurones, can also elicit a senescent-like phenotype (Minamino et al., 2009; Jurk et 
al., 2012). Although permanent proliferation cessation may seem inconsequential in a 
cell type which does not replicate, it will be important to determine if post-mitotic 
senescent cells are associated with a SASP which may contribute to the pathological 
effects described above.  
Irreversible cell cycle arrest was first observed to occur once cells grown in culture 
reached a specific, and reproducible, number of population doublings, and this 
process was named ‘replicative senescence’ (Hayflick, 1965). The number of times a 
cell can divide before undergoing replication has been coined the ‘Hayflick limit’, and 
this number varies between cell types and species. Telomeres have been heavily 
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implicated in governing the Hayflick limit of a cell, as due to the end-replication 
problem (Olovnikov, 1971; Watson, 1972), telomeres get progressively shorter with 
each cell division, a process which is accelerated by oxidative stress-induced SSBs 
(von Zglinicki et al., 1995; von Zglinicki et al., 2000), until they reach a critical length, 
where the t-loop structure is thought to become ‘uncapped’ and elicit a DNA damage 
response which signals for cell cycle arrest (Griffith et al., 1999). Our group observed 
there is an age-dependent increase in telomeres eliciting a DDR in murine 
enterocytes and hepatocytes in vivo, however remarkably, Q-FISH analysis revealed 
that a DDR was being elicited at telomeres independently of telomere length, and this 
observation was also made by another group in primate neurones (Fumagalli et al., 
2012; Hewitt et al., 2012). These data confounded the dogma that telomere 
dysfunction occurs solely as a result of telomere shortening, and we proposed that 
double strand breaks within telomere regions could be driving this DDR, a 
phenomenon we coined telomere-associated DNA damage foci (TAF) (Hewitt et al., 
2012).  
Considering the aforementioned observations, we questioned whether telomere 
damage could be driving a senescent-like phenotype in a non-rapidly dividing cell 
type, which should not be subject to excessive proliferation-associated telomere 
shortening, and thus would be unlikely to undergo canonical replicative senescence. 
We used cardiomyocytes as our model, as primary embryonic cardiomyocytes can 
be isolated and cultured, and the H9C2 rat cardiomyocyte line are susceptible to 
transfections.    
Our group and another had previously published that telomere damage is irreparable 
in fibroblasts (Fumagalli et al., 2012; Hewitt et al., 2012), which is of interest in 
cardiomyocytes, considering that the majority of cardiomyocytes persist throughout 
the entirety of a human lifespan (Bergmann et al., 2009). We confirmed in two 
separate cell lines that TAF are persistent in murine cardiomyocytes. DSBs can be 
generated at replication forks, due to replication errors when a SSB is encountered 
by the DNA replication machinery (Kuzminov, 1999). Furthermore, cardiomyocytes in 
vivo retain proliferative potential, however, the rates are extremely low (Bergmann et 
al., 2009), and thus DSBs are likely to occur infrequently as a result of replication 
errors. One issue is that our cell lines still retained considerable rates of proliferation, 
and thus the formation of DSBs could have been occurring due to replication errors, 
therefore not providing a physiologically relevant model. To address this, we 
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analysed DSB formation in the presence of a detectable fluorescent nucleoside, 
therefore showing that DSBs could form independently of cell division via oxidative 
stress or X-irradiation. Having observed telomere damage could occur in 
cardiomyocytes in vitro, it was then important to ascertain if telomere damage had an 
effect on cardiomyocytes. Oxidative stress via H2O2 treatment, and X-irradiation, 
although useful as a proof-of-principle for the induction and persistence of telomere 
damage, are not telomere specific, and thus inferences on the specific effect of 
telomere damage cannot be concluded. We therefore induced telomere-specific 
DSBs using a fusion protein of the FokI endonuclease, conjugated to the shelterin 
component TRF1. Our data showed that TAF could induce a senescent-like 
phenotype in cardiomyocytes, as shown by a decrease in proliferation marker Ki67, 
an increase in SA-β-Gal activity, and increased expression of p21. Previous evidence 
suggests, a minimum of 5 dysfunctional telomeres in human fibroblasts are required 
for the cell to enter cellular senescence (Kaul et al., 2012). To address the exact 
threshold of TAF required to induce a senescent phenotype in cardiomyocytes in 
vitro, it will be important to develop an inducible TRF1-FokI fusion protein to create a 
spectra of telomere damage.  
We next observed that there is an age-dependent increase in TAF in both mouse and 
human cardiomyocytes occurring independently of length in vivo. Furthermore, these 
increases in TAF correlated with various markers of senescence including cyclin-
dependent kinase inhibitors and various SASP factors. Of note, IL-6 and TGF-β were 
shown to be upregulated, both of which have been implicated in driving a detrimental 
bystander effect (Hubackova et al., 2012b; Acosta et al., 2013). Furthermore, we 
showed that conditioned medium from isolated adult cardiomyocytes could attenuate 
cell division in mouse fibroblasts, suggesting that cardiomyocytes can also elicit a 
bystander effect. It will be important to follow up these experiments to see if 
cardiomyocytes can induce other characteristics of senescence, and what the key 
drivers of this process are. Although we showed that TAF could specifically induce 
senescence in cardiomyocyte in vitro, the in vivo data is only correlative. It would be 
important to develop a mouse model, such as a cardiomyocyte-specific TRF1-Foki 
fusion protein, to specifically damage cardiomyocytes telomeres.  
Finally, we wanted to ascertain the mechanism in which telomere damage could be 
induced in cardiomyocytes in vivo. We had shown that TAF could be generated in 
cardiomyocytes in vitro via oxidative stress with H2O2 treatment, and interestingly, 
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one of the genes we observed to be upregulated with age in mouse hearts encodes 
the protein MAO-A, which produces H2O2 as a by-product, and has been shown to 
result in an age-dependent increase in H2O2 in rat hearts (Maurel et al., 2003). We 
observed that increased oxidative stress via cardiomyocyte specific MAO-A 
upregulation, or using catalase -/-, or MnSOD+/- mouse models, led to an increase in 
TAF. ROS have previously been shown to contribute to the stability of cellular 
senescence through generation of DDF which maintain a persistent DDR (Passos et 
al., 2010). We showed that the development of senescence, following genotoxic 
stress, could be attenuated by treating cells with rapamycin, which abrogated the 
senescence-associated increase in ROS. Moreover, supplementing the diet of mice 
with rapamycin resulted in an attenuation of age-related oxidative damage, TAF 
accumulation and p21 expression. Previous studies have shown rapamycin to extend 
the lifespan in numerous species (Bjedov et al., 2010; Zhang et al., 2014), and also 
to delay age-related cardiomyopathies, even when supplemented to aged mice for a 
period of just 3 months (Flynn et al., 2013). RNAseq analysis revealed that these 
rapamycin fed mice showed decreases in hypertrophy and inflammation markers, 
both of which are associated with senescence, thus it is possible that rapamycin may 
act to abrogate any existing senescence phenotype through ROS attenuation, whilst 
decreasing the rate of further damage accumulation. Furthermore, rapamycin 
treatment has been shown to reduce hydrogen peroxide release in mouse brain and 
liver, thought to be a result of reducing the abundance of mitochondrial complex I 
matrix subunits (Miwa et al., 2014b). 
To conclude, evidence is mounting that telomere shortening isn’t the only molecular 
phenomenon pertaining to telomere-related ageing (Fumagalli et al., 2012; Hewitt et 
al., 2012). Indeed, animal models exhibiting critically short telomere lengths are not 
physiologically comparable to the natural ageing process, and research across 
several mammalian species observed an inverse relationship between telomere 
length and lifespan (Gomes et al., 2011), which would suggest that short telomeres 
are not an important driver in organismal ageing. We have provided evidence that 
TAF can induce senescence in cardiomyocytes in vitro, that there is an age-
dependent increase in TAF in cardiomyocytes in vivo, which can be generated by 
oxidative stress, and cardiomyocytes display an age-related development of a 
senescent-like phenotype, which is associated with TAF. It will be important in the 
future to generate models which specifically induce telomere damage independently 
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of length in vivo, to truly ascertain if TAF are causative in driving cardiomyocyte 
senescence in vivo, and furthermore, to then develop models which specifically 
reverse the senescent phenotype or remove senescent cells, to assess the role of 
cardiomyocyte senescence in cardiac ageing.  
Finally, our data provide evidence that cardiomyocytes are associated with a 
senescent-like phenotype that this is associated with telomere damage. Although it is 
difficult to deduce causation over correlation with regard to telomere damage and 
cardiomyocyte senescence, it is difficult to argue against TAF emerging as a robust 
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